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 The budding yeast Shu complex, a heterotetramer of Shu1, Shu2, Csm2, and Psy3, is important 
for homologous recombination (HR)-mediated chromosome damage repair and was first 
characterized a decade ago as promoting Rad51-dependent HR in response to replicative stress, 
but its mechanistic function and conservation in eukaryotes has remained unknown. Here we 
provide evidence that the Shu complex is evolutionarily conserved throughout eukaryotes, where 
it is comprised of a clear Shu2 orthologue physically associating with Rad51 paralogues. The Shu 
complex itself physically interacts with the rest of the HR machinery during DNA damage repair. 
Finally, we uncover that the mechanistic function of the Shu complex as a stimulatory co-factor of 
Rad51 filament formation in vitro, likely explaining the in vivo function of the eukaryotic Shu 
complex in suppressing error-prone repair. Moving forward, our findings provide a framework for 
studying the function of the human Shu complex, which will have broad importance in our 
understanding of DNA damage repair. 
The Shu Complex is a conserved regulator of Rad51 filament formation 
Stephen Kenneth Godin, PhD 
University of Pittsburgh, 2015
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1.0  INTRODUCTION 
Cells are constantly bombarded with a complex mixture of endogenous and exogenous sources of 
stress that can lead to DNA damage. Exogenously, the cells face multiple sources of DNA damage, 
such as ultraviolet (UV) light exposure, which can cause cyclobutane pyrimidine  dimers (CPD), 
exposure to natural sources of psoralen from foods which can cause interstrand crosslinks in DNA, 
and exposure to radioactive radon in the home, which can cause DNA double-strand breaks 
(DSBs). Cells also face numerous endogenous forms of DNA damage as well. During normal 
metabolism, multiple forms of reactive oxygen species, e.g. superoxide, are created which can give 
rise to different modifications of the DNA bases that could potentially lead to DSBs. As a cell tries 
to replicate through damaged DNA during S-phase, replication forks often stall and/or collapse, 
giving rise to further, spontaneous DNA damage such as DSBs.  
In order to protect the stability of the genome from these numerous sources of damage, 
eukaryotic cells utilize a wide variety of DNA damage recognition and repair pathways and 
mechanisms to remove the different lesions that arise in the DNA, which are briefly summarized 
here and in greater detail in (1). To deal with the modified bases that arise from H2O2, free radicals, 
and from certain forms of methylation damage, cells employ the base excision repair (BER) 
pathway to remove damaged bases and a limited patch of DNA around the lesion. The kinds of 
damage generated by UV light exposure, such as covalently linked bases, e.g. CPD, are recognized 
and removed by the nucleotide excision repair pathway (NER), that functions to recognize the 
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structural distortion in the DNA helix generated by these lesions, and then excises a patch of 
nucleotides around the linked dimer to allow repair. To cope with the DSBs generated by radiation 
exposure, eukaryotic cells can utilize non-homologous end joining (NHEJ), which functions to 
recognize a DSB, minimally process the ends to remove damaged bases, then ligate both ends of 
the break back together. This is potentially an error-prone pathway, as there is little proofreading 
that takes place and this process can result in insertions or deletions at the break site. Alternatively, 
the cell can utilize homologous recombination (HR), which is usually considered an error-free or 
high-fidelity alternative to NHEJ, and as the primary focus of this dissertation, is discussed in 
detail below.  
1.1 HOMOLOGOUS RECOMBINATION 
Homologous recombination is a DNA double-strand break repair pathway important for 
genomic stability (2). Mutations in many HR genes underlie numerous human diseases, including 
cancer, Fanconi anemia, ataxia telangiectasia, Bloom, Werner, Rothmund-Thomson, and 
Nijmegen breakage syndromes (3-10). When HR is impaired, mutant cells are often hyper-
sensitive to DNA damaging agents, accumulate gross chromosomal rearrangements, and exhibit a 
mutator phenotype (2,11,12).  
The HR pathway is utilized at many types of lesions including a direct DSB or a damaged 
replication fork (12). HR-initiating lesions at replication forks are incredibly varied and include 
missing nucleotides at abasic sites and altered DNA bases that block DNA polymerase activity 
and stall replication forks. Similarly, inter-strand crosslinks that prevent the opening of the DNA 
helicase also block replication fork progression, and are repaired and bypassed, in part, by the HR 
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pathway during inter-strand crosslink repair (12). Additionally, HR is utilized when replication 
forks encounter a single-stranded DNA (ssDNA) break that causes the fork to collapse into a one-
ended DSB. Due to the wealth of knowledge about HR at direct DSBs, such as those induced by 
IR or endonuclease-induced breaks, HR is first discussed in the context of these direct breaks for 
the rest of this section and in Figure 1. Section 1.2 will cover models of HR at replication forks 
(Figure 2), and is the primary focus of this dissertation. In all cases, yeast protein names are used 
when describing each step of HR, although human names are frequently included for clarity. Table 
1 lists the human, budding yeast, fission yeast, C. elegans, and fruit fly homologues for the major 
HR proteins that are discussed in this dissertation and in Figures 1 and 2.  
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Figure 1. Homologous recombination pathways and proteins. 
A schematic indicating how HR can be channeled into synthesis-dependent strand annealing (SDSA), break-
induced replication (BIR), or through a double-Holliday junction into different kinds of crossover and non-
crossover repair outcomes. Yeast proteins are shown on the left in black, while human proteins are shown on 
the right in red. 
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1.1.1 Resection 
During HR, the DSB is first recognized and then resected by a specific set of nucleases to 
give rise to 3' single-stranded DNA overhangs (ssDNA). DNA end resection is first initiated by 
the Mre11-Rad50-Xrs2 (MRX) complex in budding yeast or the MRE11-RAD50-NBS1 (MRN) 
complex in human cells (13). After the MRX complex binds to the DSB ends, the endonuclease 
Sae2/CtIP interacts with the complex and stimulates resection in the 5' to 3' direction to generate 
3' ssDNA overhangs (14-16). The short-range resection by Sae2/CtIP and the MRX/MRN complex 
is expanded by the redundant activities of the 5'-3' exonuclease Exo1/EXO1 and a complex of the 
Sgs1/BLM helicase with the endonuclease Dna2/DNA2 (17-20). The ssDNA that is generated is 
immediately coated by the ssDNA binding protein replication protein A (RPA). RPA coated DNA 
protects the DSB ends from further degradation and signals to the cell the presence of unrepaired 
DNA damage (21,22). 
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Table 1. The major homologs of the HR proteins discussed for five  eukaryotic model systems.  
Graphical summaries of the Rad51 paralogue complexes are included. 
 
1.1.2 Rad51 filament formation, structure, and components 
The next step of HR is the formation of a Rad51 filament on the ssDNA (2), which is essential for 
the strand exchange and homology search steps that allow HR to occur. Rad51 filament formation 
is tightly regulated to prevent excessive recombination and genomic instability. The first barrier 
to Rad51 filament formation is the presence of RPA, which blocks Rad51 binding to ssDNA (2). 
The inhibition of RPA is overcome by the activity of Rad51’s regulators. In budding yeast, these 
include Rad52 and two Rad51 paralogues, Rad55 and Rad57, which form an obligate heterodimer 
in vitro (Table 1, (21,23-26)). These proteins function by forming nucleation sites for Rad51 to 
bind to RPA-coated ssDNA and by promoting the elongation of Rad51 filaments by directing 
incoming Rad51 monomers to bind to DNA-bound Rad51 monomers. Recent models have 
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indicated that Rad52 and Rad55-Rad57 do not function to destabilize RPA, as RPA remains bound 
to the sites of DNA damage in vivo, and in vitro, RPA is interspersed inside Rad51 filaments 
(23,27).  
To prevent unnecessary HR, the activity of Rad52 and Rad55-Rad57 are controlled by 
post-translational modifications, such a SUMOylation and phosphorylation respectively, which 
are regulated by DNA damage checkpoint signaling (28-31). For instance, Rad55-Rad57 have 
been shown to be phosphorylated by Rad53 in response to alkylation damage such as by methyl 
methanesulfonate (MMS) treatment. This phosphorylation has been shown to be important for 
promoting full resistance to MMS (29). Similarly, Rad52 is a known target of the SUMO pathway, 
and SUMOylation regulates Rad52’s localization and activity during stress (32). These regulatory 
systems ensure that functional Rad51 filaments form only at sites of damage and only after proper 
DNA damage checkpoint signaling appropriately modifies the regulators of Rad51 filament 
formation.  
Rad51 filaments are additionally regulated by other proteins, such as the anti-recombinase 
Srs2, whose major function is to prevent excessive HR by removing Rad51 from ssDNA (33,34). 
Srs2 is a helicase that translocates along ssDNA and, when it physically encounters a Rad51 
molecule causes it to release the ssDNA (33,34). Rad51’s ability to bind ATP is required for its 
association with ssDNA, and Srs2 is able to stimulate Rad51 to hydrolyze its ATP and release 
ssDNA (33,34). This activity of Srs2 is strictly ATP-dependent, as mutations in Srs2’s ATPase 
domain prevents its helicase activity and Rad51-disassembly functions (33,34). Srs2’s anti-
recombinase activity is also strongly inhibited by the Rad51 paralogues, Rad55-Rad57, which are 
able to block the destabilization of Rad51 by Srs2 in vitro (35), although the mechanism by which 
they inhibit Srs2 has not fully been characterized. Additionally, other proteins involved in HR are 
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known to interact with Srs2, such as the Shu complex, which is discussed in greater detail below, 
although the functional significance of this interaction remains unknown. 
Despite the central importance of the Rad51-ssDNA nucleoprotein filament in HR, many 
questions remain unanswered about the structure and components of the Rad51 filament in vitro 
and in vivo. As of the start of this dissertation work, the prevailing knowledge in the field was that 
as Rad51 binds to RPA-coated DNA, RPA was displaced to make room for Rad51. However, 
recent work has strongly contradicted this model. Work from Eric Greene’s lab, using cutting-
edge, single-molecule DNA curtain assays, has found that as Rad51 binds to RPA-coated ssDNA, 
In a DNA curtain assay, numerous pieces of ssDNA are visualized simultaneously for protein 
binding, allowing higher-throughput single-molecule studies than many other techniques. RPA is 
not displaced. Instead, the DNA elongates as Rad51 binds, and RPA remains interspersed inside 
the larger Rad51 filament, perhaps functioning to break up several monomers of Rad51, thus 
maintaining the flexibility of the nucleoprotein filament (27). Further work from the same group 
has suggested that this may function to improve the efficiency of the Rad51-dependent homology 
search steps that define homologous recombination.  
Recent work has strongly indicated that Rad51 filaments are not homogenous as many 
electron or atomic form microscopy (EM and AFM respectively) images would suggest (as an 
example, see chapter 4), and likely contain numerous other proteins involved in HR. For instance, 
Claire Wyman’s group have recently visualized human RAD51 filaments using a new technique 
called combined total internal reflection fluorescence and scanning force microscopy (TIRF-
SFM), which allows a RAD51 filament to be visualized in conjunction with fluorescently labeled 
proteins such a RAD54. Using this technique, they were able to discover that RAD54 binds to both 
ends of the RAD51 nucleoprotein filament and is present inside the RAD51 filament. The 
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observation that RAD54 can integrate into the middle of a RAD51 filament has important 
implications in RAD51 strand invasion and turnover as discussed below (36). Additionally, Eric 
Greene’s group has also visualized Rad51 filaments using their DNA curtains technique, and has 
identified several exciting phenomena. In addition to the small clusters of RPA interspersed 
throughout the Rad51 filament, mentioned above, they also found that Rad52 is also interspersed 
throughout the filament, preferentially in a complex with RPA. They find that Rad52, far from 
causing RPA turnover as had previously been predicted, actually stabilizes RPA within the Rad51 
filament, suggesting the presence of RPA in the filament may be critical for HR., They also found 
that Rad52-RPA complexes will coat the external surface of the Rad51 filament, which has broad 
implications for how the second end of a DSB is captured and stabilized at the break site in addition 
to raising the exciting possibility that other proteins may coat the Rad51 filament as well.   
The idea that Rad51 filaments may contain multiple classes of proteins has raised several 
important questions in the field. For example, Rdh54, which is structurally very similar to Rad54, 
may also integrate into the filament and would help explain its role in destabilizing Rad51 
filaments on double-stranded DNA (37,38). Additionally, if Rad51 filaments can contain other 
proteins, would they also contain the Rad51 paralogues, such as Rad55-Rad57? The similar 
structure of Rad55 and Rad57 to Rad51 might serve to allow them to integrate seamlessly into a 
larger filament of Rad51. The capability to integrate into the filament would likely contribute 
significantly to their ability to regulate and stimulate Rad51 filament formation. Similarly, if 
Rad55-Rad57 are present inside the filament it would suggest a clear mechanism by which Rad55-
Rad57 can inhibit Srs2, as was reported in Wolf Dietrich-Heyer’s laboratory (35). In this work, 
Rad55-Rad57 was found to block the ability of Srs2 to unwind Rad51-coated DNA. If Rad55-
Rad57 were integrated into the Rad51 filament formation, a logical model for how this activity 
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would function would be to serve as a physical barrier or block that prevents the Srs2 helicase 
from freely translocating along DNA, disassembling Rad51 filaments. In order to determine the 
function of the different regulators of HR it will be essential to determine how these proteins 
interact with the Rad51 filament. 
1.1.3 Rad51-dependent strand invasion and resolution of HR 
Once a Rad51 filament forms, it is stimulated to invade duplex DNA by the Swi/Snf 
translocase Rad54 and search for a homologous stretch of DNA (39,40). Several recent advances 
have changed our views of how Rad51-dependent strand invasion occurs. Using DNA curtains to 
directly visualize Rad51 filaments, Eric Greene’s group have reported that Rad51 filaments are 
broken into multiple segments by clusters of Rad52 and RPA (27). They predict that this 
segmentation is critical to allow each patch of Rad51 in the larger filament to perform its own 
homology search, dramatically improving the predicted efficiency of the homology search (27,41). 
Critically, this data is supported by their recent observation that the minimal number of nucleotides 
needed for Rad51 to interrogate DNA for homology is eight, and that just fifteen nucleotides is 
sufficient to allow stable association of the Rad51 nucleoprotein filaments with a homologous 
stretch of DNA (41). These findings support a model where the larger filament of Rad51 is 
intentionally split into many smaller filaments by complexes of Rad52-RPA to allow several 
smaller segments of Rad51 to independently carry out the homology search. Previous studies have 
suggested variable tract lengths for Rad51 filaments during HR, ranging from 100 to 4000 
nucleotides. Given how Rad51 filaments tend to extend DNA and reduce flexibility, these clusters 
of Rad52-RPA may additionally act by breaking up the relatively rigid Rad51 filament, to 
introduce flexibility into the Rad51 filament during homology search (27).  
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After Rad51 filaments identify the homologous template, they are induced to form a stable 
strand invasion product by the activity of Rad54 and Rdh54 (Figure 1). Once the strand invasion 
product forms, Rad51 monomers at the end of the strand invasion product need to be disassembled 
by Rad54 to allow DNA polymerases to access the heteroduplex DNA, a process that requires the 
ability of both Rad51 to hydrolyze its ATP and release dsDNA (42-44). The recent observation 
that human RAD54 can be integrated into the RAD51 filament, where it occupies both the ends of 
the filament as well as internal sites suggests that RAD54 may be able to disassemble the RAD51 
filament from the inside-out as well as from the ends (36). Interestingly, work in budding yeast 
has found that the invading ssDNA is extended by an average of 1700 base pairs (45,46), which is 
significantly greater than the minimal amount of homology required for the extended strand 
invasion product to find a homologous sequence on the other side of the DSB. For instance, work 
from Eric Greene’s laboratory has suggested that with as little as 15 BP of homology past the DNA 
break site, the extended strand should be capable of reannealing to the other side of the break to 
allow repair (41), while commonly used gene knockout strategies in budding yeast have found that 
50 base pairs of homology is sufficient to allow robust HR to occur (47). Why such long tracts of 
DNA are copied during strand invasion and extension remains an open question in the field. 
After the strand invasion product is extended, the newly extended ssDNA end needs to be 
disassembled from the template DNA to allow reannealing and ligation to the other side of the 
break. Resolution of HR can take the form of several, multi-step processes outlined here and in 
Figure 1 which can result in either crossover or non-crossover outcomes. In the simplest form of 
repair, called synthesis dependent strand annealing, the second end of the DSB is not engaged, the 
heteroduplex is unwound to allow the extended ssDNA end to reanneal to the other side of the 
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DSB, and the remaining gaps are then filled in and ligated (Figure 1, SDSA). This repair process 
forms a fully intact DNA helix without a crossover (2).  
Alternatively, the second end of a DSB can be “captured”, forming a double Holliday 
junction (dHJ). The mechanisms underlying second end capture of the DSB have remained mostly 
unresolved, although recent observations that complexes of Rad52-RPA will coat a filament of 
Rad51 have suggested that these proteins and their ssDNA binding activity may be essential for 
the capture of the second end of a DSB. Once formed, the double Holliday junction can be cleaved 
by various nucleases, most commonly Mms4-Mus81 and Yen1 in budding yeast. Cleavage by 
nucleases can result in both non-crossovers and crossovers depending on how the dHJ is cleaved 
(Figure 1, left and right sides respectively). Alternatively, the double Holliday junction can be 
unwound to a hemicatene structure and dissolved by Sgs1-Top3-Rmi1 ((Figure 1, center, (2,48-
52)). Disruption of the normal resolution of double Holliday junctions, such as in an sgs1∆ cell, 
leads to an extreme sensitivity to DNA damaging agents, a hyper-recombinogenic phenotype, and 
slow growth caused by the accumulation of these unrepaired, or misrepaired, double Holliday 
junctions. Importantly, disruption of the HR machinery, which generates these double Holliday 
junctions, can dramatically suppress the phenotypes of mutations in Sgs1, Top3, or Rmi1 (Figure 
1).  
In an alternative form of HR called break induced replication (Figure 1, BIR), the second 
end of a DSB is never captured and the strand invasion product becomes a full-fledged replication 
fork (53). BIR appears to be primarily used to repair replication forks that collapse into a one-
ended DSB, although BIR can also be observed in various assays at an inducible DSB when the 
second-end of the break is never captured (54). While BIR is technically HR, as it appears to 
require Rad52 in all instances studied, there appear to be both Rad51-dependent and independent 
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mechanisms of initiating BIR (55). Importantly, BIR has recently emerged as a critical repair 
pathway in different cancer cells experiencing replicative stress (53). Additionally, several kinds 
of gross chromosomal rearrangements observed in cancers seem to arise from BIR at replication 
forks, which makes understanding this form of HR critical for the treatment of cancer (53). While 
BIR plays an important role during replicative stress in cancer cells, other forms of HR, which are 
discussed in detail below, appear to be the primary form of HR used at a stalled replication forks 
in otherwise healthy cells. 
1.2 HOMOLOGOUS RECOMBINATION AT A REPLICATION FORK 
While use of direct DSB systems, such as inducible endonucleases, were invaluable for elucidating 
the critical steps of HR, the most physiologically relevant substrate for HR in normal cells is likely 
to be ssDNA gaps accumulating at a stalled replication forks (12,56,57). These ssDNA gaps can 
accumulate whenever a replication fork encounters a lesion that blocks polymerase extension, such 
as a methylated base, as generated by MMS treatment, abasic sites caused by aborted base excision 
repair, protein-DNA adducts such as those formed from crosslinking agents, or even the 
photoproducts generated in DNA by UV treatment. Additionally, replication forks that encounter 
a ssDNA break can collapse into a one ended DSB that can be repaired by a break induced 
replication-like method, as shown in Figure 1. This dissertation focuses almost exclusively on the 
kinds of HR thought to initiate from ssDNA gaps produced at stalled replication forks, which is 
discussed in greater detail below and in Figure 2.   
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Figure 2. A schematic of two proposed models for post-replicative repair at a replication fork. 
Error-prone post-replicative repair is shown in the top right as bypass by translesion synthesis polymerases, 
while two different models for error-free post-replicative repair by homologous recombination are shown on 
the bottom. Yeast proteins are included in black.  
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In a broad sense, the steps of HR at a replication fork are likely very similar to direct DSBs, 
comparing the different pathways in Figure 1 and Figure 2. After a replication forks stalls, there is 
resection mediated by the MRX complex that generates ssDNA gaps (56). As has been shown for 
Exo1(58), these gaps are further extended by the same set of nucleases as in a direct DSB. The 
ssDNA gaps (Figure 2, gap invasion) have been hypothesized to be the sites where HR initiates, 
and as such they are predicted to accumulate RPA before Rad51 filaments form (12).  
Despite their central role in the models of HR at replication forks, direct evidence that HR 
initiates from ssDNA gaps at stalled replication forks has only very recently been produced. Dana 
Branzei’s group purified the stalled replication forks produced in MMS treated cells and visualized 
them by EM (59). They found different HR structures in the MMS-treated strains, such as 
structures resembling Holliday junctions, double Holliday junctions, and the hemicatenanes 
predicted to form during Sgs1-mediated dissolution of dHJs (as shown in Figure 2). Critically, 
these substrates all appear to initiate from gaps of ssDNA present in the dsDNA rather than ssDNA 
ends like those found at DSBs (Figure 2, gap repair). These striking findings strongly support the 
prevailing models where ssDNA gaps at replication forks are substrates for Rad51-mediated HR, 
and that Rad51-mediated HR is in turn critical for fork progression in response to damaged DNA.   
Although direct evidence for HR at replication forks has only recently emerged, a wealth 
of genetic evidence has been reported detailing the pathways that regulate bypass of different 
lesions at a replication fork, called post-replicative repair (PRR). The PRR pathway can be broken 
into two components, the potentially error-prone translesion synthesis  (TLS) pathway, and the 
error-free PRR pathway, which is carried out through HR-mediated bypass of lesions at a stalled 
fork (Figure 2). Error-prone PRR relies upon the availability of the TLS polymerases, as encoded 
by REV1, REV3, and REV7 (60,61). PRR is initiated by a complex of Rad6-Rad18, which 
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monoubiquitinates PCNA (Pol30), which then recruits the error-prone PRR machinery. Error-free 
PRR, however, is initiated by the polyubiquitination of PCNA which is largely dependent upon 
the Mms2-Ubc13 complex and Rad5 (60). Once PCNA is polyubiquitinated, HR mediated bypass 
of the lesions that caused the replication fork to stall is initiated. HR at the replication forks has 
been found to require all of the normal HR machinery such as Rad51 and Rad52, in addition to a 
novel regulator of HR that seems to work exclusively at replication forks, the Shu complex (60,61).  
1.3 THE SHU COMPLEX 
The budding yeast Shu complex (suppresser of Hydroxyurea sensitivity) was first characterized a 
decade ago in Dr. Rodney Rothstein’s laboratory as genes whose deletion would suppress the slow 
growth, hydroxyurea (HU), and MMS sensitivity of SGS1 or TOP3 mutants (62,63). The initial 
characterization of the Shu complex found that it functions as an obligate heterotetramer comprised 
of Shu1, Shu2, Csm2, and Psy3, where deletion of any one gene would similarly suppress sgs1∆ 
and top3∆ cells’ phenotypes. This original characterization of the Shu complex found that it acted 
in the Rad52 epistasis group during treatment with MMS, indicating that the Shu complex 
functioned during HR. Moreover, due to the suppression of the phenotypes of sgs1∆ and top3∆ 
cells, it was presumed that the Shu complex acted early in HR to help promote the formation of 
the double Holliday junctions that cause toxicity in sgs1∆ cells. Interestingly, loss of the Shu 
complex, despite their modest sensitivity to DNA damaging agents when compared to Rad52, 
creates a mutator phenotype identical to deletion of Rad52, suggesting that the mutator phenotype 
generated by loss of Rad52 may be caused by impaired function of the Shu complex. Finally, this 
work found that the Shu complex’s mutator phenotype was entirely dependent upon the translesion 
 17 
polymerase Rev3, which importantly placed the Shu complex as acting at the kinds of stalled and 
broken DNA replication forks where translesion polymerases could act. These findings were 
largely reconfirmed in a separate manuscript by the Xiao group, which additionally expanded upon 
the observation that the Shu complex’s mutator phenotype was caused by Rev3, to place the Shu 
complex in the error-free branch of post-replicative repair (PRR) downstream of MMS2, UBC13, 
and RAD5 (60). 
A year after the budding yeast Shu complex was characterized, Paul Russel’s group 
identified potential Shu complexes in both fission yeast and humans, which suggested that the Shu 
complex may be conserved throughout eukaryotic lineages (64). This work found that the budding 
yeast Shu2, which contains a SWIM domain that regulates zinc binding, has a clear homologue in 
fission yeast. Importantly, this homologue of Shu2 was found to physically associate with Srs2, 
confirming a high-throughput yeast-2-hybrid screen that found budding yeast Shu2 also interacts 
with Srs2 (63). This homologue of Shu2 was named Sws1, SWIM domain-containing and Srs2-
interacting protein 1 (64). The fission yeast Sws1 was found to physically associate with two 
divergent Rad51 paralogues, Rdl1 and Rlp1. Critically, disruption of Sws1, Rlp1, or Rdl1, 
produced a phenotype of weak sensitivity to MMS, and suppression of the slow growth and HU 
and MMS sensitivity of the fission yeast homologue of Sgs1, Rqh1. These phenotypes are very 
similar to those observed after disruption of the budding yeast Shu complex, supporting the 
hypothesis that these are functionally similar complexes. Importantly, this work also found that 
disruption of Sws1 would significantly decrease Rad51-dependent HR using a recombination 
assay that can measure Rad51-dependent and independent repair outcomes, producing the first 
piece of evidence that the Shu complex might act upstream of Rad51 filament formation. These 
findings were further supported by work from Ian Hickson’s laboratory that found the budding 
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yeast Shu complex was likely acting at the same epistasis steps of Rad51 and Rad54 to promote 
the formation of Rad51-dependent repair intermediates, again placing the Shu complex at an early 
step of Rad51-dependent repair (65). By studying fission yeast Sws1, the authors also identified a 
Shu2/Sws1 homologue in humans, called SWS1 (64). They found that SWS1 also interacts with a 
Rad51 paralogue, RAD51D, and that loss of SWS1 would result in defects in RAD51 focus 
formation in IR-treated human cells. These findings were corroborated by a publication in 2011 
that found that human SWS1 forms an obligate heterodimer with a novel Rad51 paralogue, 
SWSAP1 (SWS1-associated protein 1), and that disruption of either gene leads to an identical 
phenotype of MMS sensitivity (66). Interestingly, this work also discovered that SWS1-SWSAP1 
is capable of interacting with most of the human Rad51 paralogues and that the human Shu 
complex has DNA binding capabilities. These two critical papers laid out many important 
foundations for our understanding of the Shu complex, such as the fact that the Shu complex is 
likely conserved throughout eukaryotes where it is comprised of a SWIM-domain containing 
protein interacting with Rad51 paralogues, and that its function is likely to promote Rad51-
dependent repair in each organism studied.  
The observation that the fission yeast and human forms of SWS1 form complexes with the 
Rad51 paralogues led to speculation that some members of the budding yeast Shu complex may 
also be Rad51 paralogues, but this was not confirmed until 2012 when two groups published the 
crystal structure of Csm2 and Psy3 (67,68). These papers both determined that Csm2 and Psy3, 
despite sharing little sequence similarity with one another or with Rad51, structurally look like one 
another and the core of Rad51, making them novel, divergent Rad51 paralogues. Additionally, 
these papers both found that Csm2 and Psy3 together contain a DNA binding activity, and that 
Shu1 and Shu2 were dispensable for this activity. The finding that the Shu complex was comprised, 
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in part, of Rad51 paralogues was an incredibly important finding for the field. Most other examples 
of Rad51 paralogues, such as Rad55-Rad57, the Shu complexes in fission yeast and humans, and 
the Rad51 paralogue complexes in human (BCDX2 and CX3 complexes) are all known to 
associate with Rad51 or to regulate its function (24,69). Combined with all the previous data 
discussed on the known functions of the Shu complex in promoting Rad51-dependent HR at an 
early step, the observation that the Shu complex contained Rad51 paralogues strongly supported a 
model where the Shu complex would likely also regulate Rad51’s activity.  
1.4 RELEVANCE OF THE HUMAN SHU COMPLEX TO HUMAN HEALTH 
In addition to the basic science benefit of understanding the mechanistic function of this novel 
complex in promoting HR, there were several compelling reasons to study the Shu complex due 
to its importance in human health. Many of the putative members of the human Shu complex, 
especially the Rad51 paralogues, have repeatedly been found to play an important role in cancer 
development. Hundreds of epidemiological studies have found that individuals who inherit 
homozygous mutations in the Rad51 paralogues have an elevated risk of cancer (70-75). Originally 
these studies principally found these mutations predispose carriers to breast and ovarian cancers, 
but subsequent work has also found elevated risk of colorectal cancer for some mutations (70-75). 
Certain individual mutations, such as the XRCC3 threonine 241 to methionine mutation have 
turned up in hundreds of studies finding a potential role for this mutation in cancer development 
(75). Despite this central role of the Rad51 paralogues in cancer predisposition, studying the 
causative effects of these mutations on cancer are hampered by the difficulty in studying the human 
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proteins, discussed in detail in section 1.4, as well as the fact that, to-date, no well-supported 
mechanistic function for the Rad51 paralogues in humans has been demonstrated.  
Beyond a role in cancer development, mutations in RAD51C were recently characterized 
as causing Fanconi Anemia, leading to RAD51C being categorized as FANCO (76). A major 
question raised by this study is how do different mutations in RAD51C result in cancer 
predisposition in some patients, but other mutations result in the development of Fanconi Anemia. 
Moreover, the finding that the Rad51 paralogues in humans had potential separation-of-function 
mutations that would distinguish their roles in HR from their role in interstrand crosslink repair, 
which underlies Fanconi Anemia, raised excitingly possibilities that these naturally occurring 
mutations would help elucidate the functions of these proteins in each repair pathways. However, 
the ability to use these separation-of-function mutations was stymied by the poor mechanistic 
understanding of the Rad51 paralogue complexes in humans, as well as the essential nature of 
these proteins in human DNA repair. In order to study these critically important regulators of 
human health, it became apparent that establishing the mechanistic function of these complexes in 
a more tractable model system might be the most productive approach to take.  
1.5 USE OF THE BUDDING YEAST MODEL SYSTEM 
Owing to the important role of the putative human Shu complex members in diseases such as 
cancer and Fanconi anemia, the focus of this dissertation project was on understanding the 
mechanistic function of the Shu complex. However, there were multiple obstacles present to 
studying the Shu complex in mammalian systems that made using the budding yeast system 
preferable. Several groups had tried to make mice models by disrupting the Rad51 paralogues and 
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have found that these genes are essential for viability, as the mice display early embryonic lethality 
(77-80). In human cell culture, disruption of these proteins has also proven problematic as they 
appear essential for growth in culture as well (Maria Jasin, correspondence), and similar, 
unpublished work from our lab has found that lentiviral knockdown of SWS1 in different human 
cell lines prevents sustained growth of the cells. Together, the essential nature of the putative Shu 
complex genes has made studying the mechanistic function of the Shu complex difficult in human 
cells or mouse models. Fortunately, the Shu complex and Rad51 paralogue genes are not essential 
in budding yeast and can readily be disrupted in vivo (62,81,82). This has enabled researchers to 
study the phenotype of the full deletion of the Shu complex, which has led to several important 
discoveries about the Shu complex that have helped place its roles at an early stage of HR. The 
fact that the Shu complex can readily be disrupted in budding yeast, allowing easy, high-
throughput analysis of the phenotype of cells without the Shu complex was one important reason 
we chose to study the mechanistic function of the Shu complex using the budding yeast system.  
The second critical limitation to studying the Shu complex in humans is that the human 
versions of the Shu genes, especially the Rad51 paralogues, have proven to be difficult to purify 
and work with due to their insolubility (83). The studies where these proteins have been purified 
have necessitated purifying many proteins simultaneously, e.g. RAD51B, RAD51C, RAD51D, 
and XRCC2 in the BCDX2 complex, which makes in vitro studies more difficult, costly, and time 
consuming to perform with the human Rad51 paralogues (83). Fortunately, these problems are 
lessened when using the budding yeast proteins. The Rad51 paralogues Rad55-Rad57 have been 
purified and studied in vitro for nearly twenty years (24), and the recent papers crystallizing Csm2-
Psy3 have found that the Shu complex is readily purified as a pair of dimers (Csm2-Psy3 and Shu1-
Shu2), as a trimer (containing Psy3-Shu1-Shu2), or as a tetramer (Csm2-Psy3-Shu1-Shu2). 
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Critically, at least Csm2-Psy3 have been shown to readily form crystals, enabling many potential 
studies which are discussed further in the discussion (chapter 5). Furthermore, many of the 
mechanistic studies involving HR have utilized budding yeast proteins such as Rad51, Rad52, 
Srs2, or Rad54, so any future in vitro work we would want to perform on the Shu complex would 
likely benefit from having available known protocols to purify and work with these other HR 
proteins (24,33,34). Given our ongoing collaborations with both crystallographers at the 
University of Pittsburgh and other experts in in vitro biochemical studies of HR proteins, we felt 
that the budding yeast Shu complex was an excellent candidate for rapid, effective studies on the 
mechanistic function of the Shu complex in eukaryotes.  
Beyond the reasons directly related to the Shu complex, the budding yeast model system 
offered numerous benefits relative to human cell culture or other model systems. These included 
intangible benefits, such as a laboratory-wide expertise in yeast techniques that enabled new 
protocols in yeast to be rapidly implemented, as well as a close relationship with Rodney 
Rothstein’s laboratory, which originally characterized the budding yeast Shu complex and was 
able to provide invaluable advice and material support in the form of related yeast strains. 
Additionally, our laboratory was equipped with several unique pieces of equipment that made 
specialized study of the budding yeast Shu complex possible. These included an automated pinning 
robot that is capable of performing high-throughput synthetic growth analysis studies in yeast. As 
an example, this machine is able to generate growth analysis for a deletion of a Shu complex gene 
combined with every single non-essential gene in the yeast genome in approximately two weeks. 
Furthermore, our lab contained a state-of-the-art fluorescent microscope specifically set up to 
visualize fluorescent yeast strains that was invaluable in generating data for this dissertation (see 
chapter 3). Finally, yeast have multiple intrinsic benefits compared to other model systems that 
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were important for this study. Yeast grows incredibly quickly and in inexpensive media, allowing 
rapid experimentation. Additionally, yeast is a genetic model system, allowing the combination of 
gene deletions and genetic assays (e.g. recombination or mutagenesis assays) into a single strain. 
This kind of genetic analysis is incredibly powerful when determining where genes function in a 
specific pathway and for analyzing the interplay between different DNA repair pathways.  
1.6 MAJOR HYPOTHESES 
At the start of this dissertation, there were several essential, unanswered questions remaining about 
the Shu complex that formed the basis of this body of work. The first asked how well the Shu 
complex was conserved from budding yeast to humans, and served to confirm the budding yeast 
Shu complex would serve as a useful model system for studying the more inaccessible human Shu 
complex. The second hypothesis dealt with which portions of the HR machinery the Shu complex 
was interacting with, and helped place the Shu complex in an early step of HR. Finally, the third 
hypothesis was about the mechanistic function of the Shu complex in HR. Each hypothesis is 
discussed in detail below with a summary of the pertinent background information that supported 
the hypothesis. 
1.6.1 The Shu complex is well conserved from budding yeast to humans 
The budding yeast system has been extensively studied because many genes in yeast have clear 
homologues and orthologues in humans. Many genes are so well conserved that a recent study 
looking at essential yeast genes found that half could be replaced with their human counterpart and 
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still produce viable cells (84). At the start of this work, several lines of evidence supported the first 
hypothesis discussed in this work, that the Shu complex is well conserved from budding yeast to 
humans. The first, crucial observation was that Shu2 has a potential homologue in fission yeast, 
and that this homologue seemed to perform an analogous function to promote HR (64). Additional 
work revealed that Shu2 likely also has a potential homologue in humans, Sws1 (64,66). However, 
two critical questions remained from these studies. Importantly, these studies had not determined 
if the SWS1 proteins in humans and fission yeast were truly orthologous to the budding yeast 
Shu2, or if these proteins had arisen separately in these organisms through parallel evolutionary 
pressures. Additionally, due to the study of HR across numerous other model organisms, it was 
necessary to determine if Shu2/SWS1 was conserved in other eukaryotic model systems, such as 
in C. elegans or D. melanogaster.  
The second set of data supporting the hypothesis that the Shu complex is conserved 
throughout eukaryotes came from the two crystallization papers published in 2012 (67,68) that 
discovered that Csm2 and Psy3, two members of the Shu complex, were in fact structurally Rad51 
paralogues. Combined with the findings in fission yeast that Sws1 interacts with the Rad51 
paralogues Rlp1 and Rdl1, and the observation that human SWS1 is an obligate heterodimer with 
the divergent Rad51 paralogue SWSAP1, this supported the hypothesis that the Shu complex is 
conserved from yeast to humans, where it is comprised of a Shu2/SWS1 protein interacting with 
divergent Rad51 paralogues (64,66). However, in order to further support this hypothesis, potential 
Shu complexes in other species would need to be catalogued and screened for any evidence that 
they may also be comprised of Rad51 paralogues.  
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Chapter two of this dissertation provides evidence in support of the hypothesis that the Shu 
complex is well conserved throughout all eukaryotic lineages, where it is comprised of a 
Shu2/SWS1 orthologue physically associating with novel Rad51 paralogues. 
1.6.2 The Shu complex interacts with the HR machinery and promotes Rad51-dependent 
HR 
At the start of this dissertation, two manuscripts crystallizing the Shu complex proteins Csm2 and 
Psy3 had recently been published (67,68). Their findings that Csm2 and Psy3 are structurally 
Rad51 paralogues with a DNA binding activity was highly informative for the different hypotheses 
tested in this dissertation, and in particular chapter 3. In all cases we are aware of, proteins that 
look like Rad51 tend to associate with one another or with Rad51 itself, and to regulate 
homologous recombination (24). With this in mind, we hypothesized that the Shu complex would 
also associate with Rad51 or the Rad51 paralogues, Rad55-Rad57. Additionally, the finding in 
fission yeast that Sws1 acts to promote Rad51-dependent gene conversion strongly supported the 
additional hypothesis that the Shu complex would function to promote HR, which is the focus of 
the end of chapter 3 (64). Finally, several lines of evidence led us to hypothesize that the Shu 
complex would also preferentially interact with the kinds of structured DNA utilized during HR. 
First, the crystallization studies discovered that the Csm2-Psy3 dimer, even without Shu1-Shu2, 
contained a DNA binding activity. Second, some of the only published work on the purified human 
Rad51 paralogues found that the BCDX2 complex, which is comprised of Rad51 paralogues, 
preferentially binds to forked DNA like that at a replication fork or double Holliday junction (85). 
Finally, the Shu complex itself only seems to function in the repair of stalled or broken replication 
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forks, which would likely also contain structured DNA substrates such as forked DNA that would 
act as a substrate for the initiation of HR.  
Together, these lines of evidence supported the hypothesis that the Shu complex would 
interact with the HR machinery, including both the protein regulators of HR and the DNA 
substrates used during HR, and promote Rad51-dependent HR, which is the focus of chapter 3. 
1.6.3 The mechanistic function of the Shu complex is to stimulate Rad51 filament 
formation 
The final hypothesis of this dissertation, that the Shu complex stimulates Rad51 filament 
formation, was conceived after most of the data in chapter 3 had been generated, which is briefly 
summarized here. In our study of the Shu complex, we found that Csm2, but not other members 
of the Shu complex, physically associates with the Rad51 paralogues, Rad55-Rad57, whose 
function is to stimulate Rad51 filament formation in vitro and in vivo (24). Importantly, we also 
found that the Shu complex’s function in vivo depended upon the presence of Rad55, suggesting 
the Shu complex acted at the same step as, or downstream of, Rad55. Additionally, in agreement 
with fission yeast, we found that the Shu complex stimulates Rad51-dependent HR, and we also 
discovered that the Shu complex could bind to the kinds of DNA substrates where HR would 
initiate. Combined with other genetic data suggesting the Shu complex acts upstream of double 
Holliday junction formation (Suppressing sgs1∆ and top3∆ cells) and upstream of Rad54 in 
rad54∆ cells, this essentially placed the Shu complex at the Rad51 filament formation step with 
Rad55 (65). 
With these data strongly suggesting the Shu complex acts at the Rad51 filament formation 
step, we hypothesized that the Shu complex, like its binding partner Rad55-Rad57, would also 
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stimulate Rad51 filament formation. The data supporting this hypothesis is presented in chapter 4, 
and strongly suggests that the mechanistic function of the Shu complex is to stimulate Rad51 
filament formation in vitro and in vivo.   
 28 
2.0  EVOLUTIONARY AND FUNCTIONAL ANALYSIS OF THE INVARIANT 
SWIM DOMAIN IN SHU2/SWS1 PROTEIN FAMILY FROM SACCHAROMYCES 
CEREVISIAE TO HOMO SAPIENS 
There are many proteins that both promote Rad51-filament formation as well as disassemble 
inappropriate filaments. Interestingly, in many organisms the proteins that stabilize Rad51-
filaments themselves share structural homology with Rad51 and evolved from the archaeal 
RADB homologue (86). In humans these RAD51 paralogues include RAD51B, RAD51C, 
RAD51D, XRCC2, XRCC3 and SWSAP1 while in the budding yeast they include RAD55, 
RAD57, CSM2, and PSY3 (64,67,68,87-90). It has been proposed that SHU1 is also a Rad51 
paralogue (64). A great deal of work has been done to characterize these proteins in vitro, in 
vivo, as well as phylogenetically (2,86,91,92). Importantly, many human RAD51 paralogues are 
mutated in cancers and associated with cancer pre-disposition (92-98).  Consistent with a critical 
role in genome maintenance, disruption of the yeast Rad51 paralogues results in a mutator 
phenotype and in some cases increased chromosomal rearrangements, which are often observed 
in tumor cells (62,99). In budding yeast, Shu1 and the Rad51 paralogues Csm2 and Psy3 form an 
obligate heterotetramer called the Shu complex (also referred to as the PCSS complex) with a 
fourth member, Shu2, whose major defining feature is a SWIM domain (62,64). The association 
of divergent Rad51 paralogues with a SWIM domain-containing protein is conserved in fission 
yeast Schizosaccharomyces pombe, where the Rad51 paralogues, Rlp1 and Rdl1, interact with a 
Shu2-homologue Sws1 (64). Similarly, the human homologue of Shu2, hSWS1, interacts with 
the RAD51 paralogues RAD51D and XRCC2 (64,66). Importantly, hSWS1 functions as an 
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obligate heterodimer with hSWSAP1, which itself resembles a previously unidentified, highly 
divergent hRAD51 paralogue (66).   
The conserved association between Shu2-like proteins and the Rad51 paralogues promote 
Rad51-dependent HR through a largely undetermined mechanism (89). In all species where 
Shu2-like proteins have been described, their disruption results in a reduction in Rad51 filament 
formation and a corresponding decrease in HR (62,64,66,90). Strikingly, these defects are similar 
to disruption of the Rad51 paralogues (90). It remains to be determined what the functional 
significance of the SWIM domain is, or why Rad51 paralogues associate with SWIM domain 
containing proteins to promote HR throughout several eukaryotic lineages. 
To further our understanding of the Shu2/SWS1 protein family we characterized its 
evolution across taxonomic groups with a special focus on the conservation of the defining SWIM 
domain. During this process we confirmed the orthologous relationship of Shu2 and hSWS1 and 
discovered previously unknown SWS1 orthologues in multiple species, including Caenorhabditis 
elegans and Drosophila melanogaster. Interestingly, evolutionary analysis implicates yeast Shu2 
and its fly orthologue CG34314 in meiosis, as they show strong rate covariation with meiotic 
proteins – specifically with those that contribute to HR. Through analysis of eukaryotic 
Shu2/SWS1 orthologues, we find that the SWIM domain is invariant and can be expanded to 
include an invariant alanine residue after the canonical SWIM domain. Furthermore, we identified 
in the literature a cancer patient from the COSMIC database, who harbors a mutation in this 
invariant alanine (100). In vivo disruption of the invariant SWIM domain residues likely results in 
protein instability and loss of function. Together, our work indicates that the SHU2 gene is found 
in all major eukaryotic lineages where it promotes HR in both mitosis and meiosis. 
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2.1 RESULTS 
2.1.1 Characterization of shu2∆ recombination phenotype and its physical interactions 
with other Shu complex members 
The Rad51 paralogues have a number of defining features, which are related to promoting Rad51 
filament formation such as decreased rates of Rad51-mediated gene conversion upon disruption 
(24,89,101). Consistently, we previously found that deleting either CSM2 or PSY3 results in a 
decrease in gene conversion and a subsequent increase in Rad51-independent repair (89). To 
determine if Shu1 or Shu2 have similar roles in promoting Rad51-dependent repair, we performed 
a heteroallelic recombination assay in wild-type (WT), shu1∆, or shu2∆ cells (Figure 3A). In this 
assay a recombination event between two leu2 heteroalleles with an intervening URA3+ gene can 
generate a LEU2+ prototroph through repair by Rad51-dependent sister chromatid gene 
conversion (GC; LEU2+ URA3+) or Rad51-independent intrachromosomal single-strand 
annealing (SSA; LEU2+ URA3-). Similar to csm2∆ or psy3∆ cells (89), we find that shu1∆ or 
shu2∆ cells significantly decrease rates of Rad51-dependent GC (p ≤ 0.02 and p ≤ 0.005 
respectively) with a corresponding increase in rates of error-prone SSA (Figure 3A). These results 
demonstrate that although Shu2 is not a Rad51 paralogue, it exhibits many of the same phenotypes 
as the other Shu complex members. 
The human Shu2 homologue, hSWS1, interacts with multiple RAD51 paralogues either 
directly or indirectly through hSWSAP1 (64,66). We asked if other yeast Shu members similarly 
bridge the protein-protein interactions between Shu2 and Shu1 or Psy3 (60,62). To address this 
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question, we performed yeast-2-hybrid (Y2H) analysis of yeast expressing SHU2 in the GAL4 
DNA binding domain (pGBK-SHU2) and tested its interaction with either SHU1 or PSY3 
expressed in the GAL4 DNA activating domain (pGAD-SHU1, pGAD-PSY3) in a genetic 
background where one of the four SHU genes is disrupted (Figure 3B and data not shown). We 
find that loss of SHU1 disrupts the Shu2-Psy3 Y2H interaction (Figure 3B). Therefore, similar to 
hSWS1, which interacts with the other hRAD51 paralogues through hSWSAP1, Shu2’s interaction 
with the Rad51 paralogue Psy3 is likely stabilized by Shu1. 
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Figure 3. SHU2 mutants have phenotypes similar to the Rad51 paralogues.  
A. Disruption of SHU1 or SHU2 leads to decreased rates of Rad51-dependent repair. Diagram of direct repeat 
recombination assay (leu2-∆EcoRI::URA3::leu2-∆BstEII) used to measure rates of direct repeat 
recombination by Rad51-dependent GC (right side of diagram, Ura+Leu+ colonies) or Rad51-independent 
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SSA (left side of diagram, Ura-Leu+ colonies). The rates of GC and SSA events in shu1∆ or shu2∆ cells 
were compared to WT and standard deviations shown. B. Shu1 bridges the interaction between Shu2 and 
Psy3. Yeast-2-hybrid analysis of pGBK-SHU2 (containing a GAL4-binding domain) with pGAD-SHU1, 
pGAD-CSM2, pGAD-PSY3, and pGAD-C1 empty plasmid (containing a GAL4-activating domain) in the 
presence or absence of the endogenous SHU1 gene. Interaction is indicated by growth on medium lacking 
histidine. Growth on medium lacking leucine and tryptophan selects for the individual plasmids and serves 
as a loading control. 
2.1.2 Shu2 orthologues are conserved across eukaryotes 
While Shu2 homologues were identified in fission yeast and humans (62,64), their phylogenetic 
orthology with budding yeast Shu2 has not been demonstrated, nor have Shu2 orthologues been 
identified in other major eukaryotic lineages, including important model organisms. To produce 
a complete picture of the SWS1 family we searched for Shu2 homologues across eukaryotic and 
outgroup archaeal lineages.  PSI-BLAST queried with yeast Shu2 yielded hits across fungal 
species and metazoans. PSI-BLAST queried with human SWS1 (ZSWIM7) led to hits across 
eukaryotes, including plants, and to archaeal proteins containing a SWIM domain. In addition, 
we identified putative SWS1 orthologues in several early-branching eukaryote lineages including 
Diplomonadida (Giardia lamblia), Euglenozoa (Leishmania, Phytomonas), green algae 
(Coccomyxa, Bathycoccus), Stramenopiles (Aphanomyces, Albugo, Phaeodactylum, Ectocarpus), 
Alveolata (Paramecium, Plasmodium, Oxytricha), and Ichthyosporea (Capsaspora). These 
sequences clustered with known SWS1 orthologues in phylogenetic trees, separated from 
archaea outgroup sequences.  This deep diversity in addition to known fungal, metazoan, and 
plant orthologues suggests an ancient origin of the SWS1 protein family. PSI-BLAST recovered 
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a single protein sequence from each species, suggesting that there were few or no Shu2/SWS1 
family duplications and that these orthologues are well conserved. 
To define a comprehensive Shu2/SWS1 protein family, we constructed a phylogeny 
using Shu2 homologues from major eukaryotic and archaeal lineages (Figure 4A). In the 
resulting phylogeny, eukaryotic sequences were cleanly separated from the archaeal sequences 
with high branch support (aLRT = 0.98). Moving forward from the archaeal root, the well-
supported branches between eukaryotic sequences were in agreement with accepted speciation 
events, thus supporting the orthology of these Shu2/SWS1 sequences. Although the short 
alignment (219 amino acids) of Shu2/SWS1 did not provide sufficient power to infer all branch 
nodes with strong support, these sequences appear to be true orthologues. Notably, this tree 
revealed Shu2 orthologues in Drosophila melanogaster and Caenorhabditis elegans, which we 
will refer to as dmSws1 and ceSws-1 hereafter, as well as an Arabidopsis thaliana orthologue 
AT4G33925. The archaeal SWIM domain-containing proteins served only to root the tree, and 
we are not able to comment on the orthology or specific function of those sequences. 
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Figure 4. The SWS1 protein family extends across eukaryotes.  
A. A phylogeny based on amino acid sequences shows the deep conservation of the SWS1 protein from 
Giardia lamblia, an early branching eukaryote lineage, to plants, fungi and metazoans. The short sequence 
length did not allow resolution of some interior branches; however, all well supported nodes support the 
orthology of these sequences. B. A partial multiple alignment shows the highly conserved SWIM domain. 
Absolutely conserved residues (*) include the defining CXC  Xn  CXH motif. Double gap columns (--) 
indicate trimmed regions of low sequence identity. C. The Shu2-SWS1 protein family is a monophyletic 
clade in this phylogeny of all proteins with SWIM domains from humans, Drosophila melanogaster, C. 
elegans, and yeast. The alignment for this phylogeny contained only the 30 most highly conserved residues 
in the SWIM domain. These relationships further support the newly discovered Shu2-SWS1 orthologues. 
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A defining feature of the Shu2/SWS1 protein is the SWIM domain, a zinc-binding feature 
(Figure 4B) (64). To further ensure orthology between yeast Shu2 and human SWS1 (also known 
as ZSWIM7) in exclusion of other SWIM-domain containing proteins in humans (ZSWIM1 – 6, 
and ZSWIM8), C. elegans (pqn-55) and D. melanogaster (CG34401), we constructed a phylogeny 
with all SWIM domain proteins from these species and all putative eukaryotic SWS1 orthologues 
(Figure 4C). Homology between these proteins is limited to the SWIM domain so their alignment 
is limited to a region of 30 highly conserved amino acids. As is expected for a small alignment, 
many branching nodes were not well resolved; however, the branching pattern cleanly separates 
the SWS1 orthologues from the other SWIM domain proteins with moderate support (aLRT = 
0.70). This topology further supports the putative orthology of the sequences in Figure 4A (i.e. 
they descended from a single common ancestor). 
2.1.3 Shu2 and its ortholgs have evolutionary histories strongly correlated with 
recombination and meiosis-related proteins 
To better define the biological function of the Shu complex we performed co-evolutionary analysis 
in both budding yeast and Drosophila. This analysis exploits the observation that functionally 
related proteins tend to have co-varying rates of evolution, because they experience shared 
evolutionary pressures. This property can be quantified as evolutionary rate covariation (ERC), 
reflecting the degree to which two proteins have rates of sequence evolution that covary between 
species (102-104). ERC for a protein pair is quantified as a correlation coefficient (ranging 
between -1 and 1) for which higher values reflect stronger rate covariation. ERC values are 
typically elevated between functionally related proteins genome-wide in yeasts, Drosophila, and 
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also between meiosis and DNA repair proteins in mammals (102,105,106). Hence, elevated ERC 
for a protein pair suggests co-functionality between them. 
We first demonstrated that members of the yeast Shu complex have significantly co-
varying rates with each other, as we might predict given their co-functionality (Figure 5A); their 
pairwise ERC values were highly elevated as a group (mean ERC = 0.52, permutation test P < 
0.00001), while the expected mean ERC for a random gene set is zero. These ERC values were 
calculated across a phylogeny of 18 fungal species, including S. cerevisiae. We also found elevated 
ERC values between the Shu complex members and Srs2 (Figure 5A), consistent with a conserved 
physical and/or genetic interaction between Shu2 and Srs2 (a DNA helicase that disassembles 
Rad51 filaments) in both budding and fission yeast (63,64,107).  
 
Figure 5. Co-evolutionary signatures indicate Shu2/SWS1 has highly conserved functional relationships with 
Rad51 paralogues and meiosis proteins. 
A. Evolutionary Rate Covariation (ERC) values between members of the Shu complex are highly elevated 
(P < 1x10-5). The degree of red shading in a cell indicates higher ERC for that protein pair compared to the 
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null expectation of zero. B. Violin plots depict the distributions of ERC values between Shu2 and proteins 
from various functional classes. Violin width is proportional to density at that ERC value. The genome-wide 
distribution (all genes) of ERC with Shu2 is centered at zero, as is Shu2 with mitosis genes (N=107 genes). 
Meiosis (N=126) and Shu complex genes (N=4) show a strong enrichment of high ERC values with Shu2, 
consistent with co-functionality between them. P-values (horizontal bars) strongly reject similarity between 
those distributions and the genome-wide distribution. Each of the 4 values in the Shu complex are also plotted 
with an ‘X’. C. Drosophila Sws1 (dmSws1), orthologue of fungal Shu2, similarly shows elevated ERC values 
with Rad51 paralogues. D. DmSws1 also has high ERC values with meiosis proteins (N=116) and Rad51 
paralogues (N=4), but not with mitosis proteins (N=129). 
To determine the co-evolutionary relationship of the Shu complex with broader functional 
groups within fungi, we studied Shu2’s ERC values with mitotic and meiotic proteins. Shu2 did 
not show significant rate covariation with mitotic proteins; however, ERC values between Shu2 
and meiotic proteins were significantly elevated, suggesting strong co-evolution between them (P 
= 1.1 x 10-8) (Figure 5B). Importantly, these results were unchanged when recombination-related 
genes and genes shared by the 2 sets were removed from analysis and so the association is not 
limited to HR proteins (mitosis P = 0.27; meiosis P = 1.1 x 10-6). Similar to Shu2, Psy3 also exhibits 
significantly increased ERC values with meiotic, but not mitotic, proteins (Figure 21A). In contrast 
to Shu2 and Psy3, both Shu1 and Csm2 show significant rate covariation with both mitotic and 
meiotic proteins (Figure 21B and 21C). In addition, the D. melanogaster Shu2 orthologue dmSws1 
(CG34314) also showed rate covariation with meiotic proteins (P = 0.013) and with Rad51 
paralogues (P = 0.0066), but not with mitotic proteins as a class (Figure 5D). The Drosophila 
dmSws1 results also remained unchanged after removing recombination-related and shared genes 
(mitosis P = 0.62; meiosis P = 0.0238). Most notably, Rad51C and Rad51D showed extremely 
high rate covariation while the other two Rad51 paralogues Spn-A and Spn-B showed modestly 
elevated levels (Figure 5C). Finally, we tested for co-evolutionary associations of meiotic and 
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mitotic genes with the mammalian Shu2 orthologue, SWS1 (ZSWIM7). Contrary to results in 
fungi and Drosophila, ERC values between mammalian SWS1 and meiotic and mitotic genes were 
not generally elevated. Overall, results from fungi and D. melanogaster suggest that the Shu 
complex has conserved meiotic and mitotic roles in eukaryotic species. 
 
2.1.4 Expansion of the SWIM domain to include an invariant alanine three amino acids 
down-stream of the canonical CXC…Xn…CXC motif 
The SWIM motif was originally defined as a zinc binding motif that contains the canonical 
CXC...Xn...CXH sequence (108-110). However, upon analysis of our evolutionarily deep 
alignment we identified an invariant alanine located three amino acids downstream from the 
CXH motif (Figure 6A, Figure 21).  Interestingly in humans, this invariant alanine in hSWS1 is 
mutated to a threonine (A108T) in a cancer patient from the COSMIC database (100). To 
determine if alanine 108 may be functionally important, we constructed a Y2H vector containing 
hSWS1 mutagenized to include this mutation, SWS1-A108T, and as well as mutations in the 
canonical SWIM domain residues (C85S, C87S, C103S, and H105A)(Figure 6B).  Suggesting 
that these residues are functionally important, disruption of the canonical SWIM domain or the 
invariant alanine (A108) results in a reduced Y2H interaction with hSWS1's obligate binding 
partner hSWSAP1 (Figure 6B). Interestingly, another highly conserved residue F90, does not 
result in reduced Y2H interaction when mutated to an alanine (Figure 6B, SWS1-F90A).  These 
results suggest that the SWIM domain in hSWS1 including the invariant alanine are likely 
important for the hSWS1 function. 
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Figure 6. Analysis of the highly conserved SWIM domain residues in the human SWS1 protein. 
A. Sequence logo of the SWIM domain reveals a highly conserved phenylalanine two residues after the 
CXC motif and an invariant alanine two residues after the CXH motif. B. Mutating the SWIM domain in 
human SWS1 impairs its interaction with hSWSAP1. Y2H analysis of pGAD-hSWS1 with mutations in the 
SWIM domain (C85, C87, C103, H105) as well as F90 and A108 were assayed for interaction with human 
SWSAP1 (pGBD-SWSAP1) as described in Figure 3B. 
2.1.5 The SWIM domain is important for Shu2’s functionality in vivo 
To investigate the role of the SWIM domain and the invariant alanine, we created Y2H vectors 
harboring the analogous mutations in budding yeast SHU2 SWIM domain (Figure 7A).  By Y2H, 
we find that mutating the canonical SWIM domain residues (C114S, C116S, C176S, H178S) in 
shu2 results in an undetectable Y2H interaction with Shu2's binding partners Shu1 and Psy3 
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(Figure 7A).  Interestingly, mutating alanine 181 to a threonine leads to a reduced Y2H 
interaction with Psy3 but not Shu1.  Furthermore, while the hSWS1-F90A mutant maintains its 
Y2H interaction with hSWSAP1, we find that the corresponding mutation in yeast shu2, F119A, 
results in a reduced Y2H interaction with Psy3 but not Shu1 (Figure 7A).  These results suggest 
that the canonical SWIM domain in yeast Shu2 is likely important for function and that the 
conserved alanine and phenylalanine may also be components of this domain. 
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Figure 7. The SWIM domain is important for Shu2’s function. 
A. Mutating the SWIM domain in SHU2 impairs its interaction with SHU1 and/or PSY3. Y2H analysis of 
pGBK-SHU2 or pGBK-shu2 mutant interactions with pGAD-SHU1 or pGAD-PSY3 as described in Figure 
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3B. B. Canonical SWIM domain mutants are non-functional. shu2∆ cells harboring the indicated pGBK 
plasmids were 5-fold serially diluted onto YPD medium or YPD medium containing 0.02% MMS and 
incubated at 30˚C for 2 days. C. Disruption of the canonical SWIM domain suppresses sgs1∆ DNA damage 
sensitivity. WT, sgs1∆, sgs1∆ shu2∆, sgs1∆ shu2-C114S, sgs1∆ shu2-C116S, sgs1∆ shu2-F119A, sgs1∆ 
shu2-C176S, sgs1∆ shu2-H178A cells were 5-fold serially diluted onto YPD medium or YPD medium 
containing 50mM HU or 0.006% MMS and incubated at 30˚C for 2 days. D. Loss of the Shu complex 
results in reduced spore viability. Diploid yeast with the indicated mutations were sporulated and individual 
spores were tetrad dissected onto rich medium. Viable spore colonies from twenty-two individual tetrads 
were quantitated and the average number of viable meiotic progeny was calculated. Standard deviations are 
shown from three experiments and significance determined by t-test (p < 0.05). E. Same as D except that 
shu2 SWIM domain containing mutants were analyzed. 
 To determine if the impaired Y2H interactions of the SWIM domain mutants result in 
diminished DNA damage tolerance in yeast, we complemented shu2∆ cells with a wild-type 
SHU2 or a mutant shu2 expressing plasmid. We find that the wild-type SHU2 plasmid 
complements the MMS sensitivity of shu2∆ cells while mutations in the canonical SWIM 
domain (C114S, C116S, C176S, and H178A) do not (Figure 7B). Interestingly, despite the 
altered protein-protein interactions observed in both shu2-F119A and shu2-A181T, both these 
mutant plasmids complement the MMS sensitivity of a shu2∆ cell (Figure 7B). These results 
indicate that the interaction between Shu2 and Psy3 may be dispensable for Shu2’s mitotic 
function. These findings were confirmed when we stably integrated the canonical SWIM domain 
mutants (C114S, C116S, C176S, and H178A) as well as F119A at the endogenous SHU2 locus 
(Figure 21).  Unfortunately, we were unable to integrate A181T into our yeast strains.  Since the 
Shu genes were originally characterized for their ability to suppress a top3∆ or sgs1∆ strain’s 
sensitivity to MMS or HU treatment, we also examined if the integrated SWIM domain alleles 
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would also rescue sgs1∆ DNA damage sensitivity like disruption of SHU2, and find that the 
canonical SWIM domain mutants do (Figure 7C). Similar findings are also observed with a 
SWIM-domain mutation in the fission yeast gene sws1-C152S (64). Thus, our analysis of the 
four canonical SWIM domain mutants demonstrate that the conserved SWIM domain is 
important for this protein family’s function in the repair of MMS-induced DNA lesions. 
 Given the conserved nature of the Shu complex in meiotically dividing yeast, we asked 
how disruption of the SWIM domain would affect meiotic outcome in S. cerevisiae. To test this, 
we sporulated diploids homozygous for deletion of a single Shu complex member and screened 
for viability of the resulting offspring. In agreement with two recent reports (90,111), we find that 
loss of any member of the Shu complex causes a marked decrease in spore viability, with Csm2 
and Psy3 resulting in a more severe defect (Figure 7D, p ≤ 0.02 for all). Next we tested if mutations 
of the SWIM domain would similarly lead to decreased meiotic progeny. We find that the SWIM 
domain mutants C114S, C116S, C176S, and H178A, are also defective for spore viability 
compared to WT (Figure 7E; p ≤ 0.05 for all). In contrast, the shu2-F119A allele spore viability 
was similar to WT (Figure 7E). These results demonstrate that the canonical SWIM domain is 
necessary for Shu2’s role during meiosis. 
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2.2 DISCUSSION 
Here we describe how the SWS1 protein family has evolved throughout major eukaryotic 
lineages to interact with the Rad51 paralogues to promote HR. One defining feature of the SWS1 
protein family is its invariable SWIM domain (consisting of CXC…Xn…CXH motif where X is 
any amino acid and n is a variable number of amino acids) and we show that this domain is 
important for protein functionality. Furthermore, our analysis indicates that the SWIM domain 
contains an invariant alanine two residues after the CXH motif, which would expand the domain 
to CXC…Xn…CXHXXA. Specifically, in budding yeast, mutation of the canonical SWIM 
domain residues reduces Rad51-dependent repair, meiotic viability, and protein-protein Y2H 
interactions. Additionally, we show further evidence that the Shu complex has an important 
meiotic function and that this function is evolutionarily conserved. We demonstrate that the 
SWS1 family is found across eukaryotes and are the first to identify orthologues of SWS1 in 
important model organisms such as D. melanogaster and C. elegans as well as in additional 
fungal and ancient eukaryotic lineages.  
Regulation of meiotic recombination is critical for maintenance of chromosome copy 
number and genetic diversity. Consistent with a central role for the yeast Shu complex during 
meiosis, loss of Shu2 or its binding partners reduces the viability of meiotic offspring, 
implicating this complex as a critical meiotic regulator (Figures 7D and 7E). It was recently 
demonstrated that the Shu complex has an important function in the recruitment of Rad51 to 
meiotic DSB sites and that Shu1 promotes homologue bias (90,111). In agreement with these 
findings, patterns of co-evolution also highlight the importance of the Shu complex in meiosis as 
we find that all the Shu complex members, including Shu2, are co-evolving with other meiotic 
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proteins as shown by elevated ERC values (Figure 5, Figure 20). Importantly, we do not observe 
elevated ERC values between Shu2 or Csm2 with mitotic proteins unlike the other Shu complex 
members, Shu1 or Psy3 (Figure 5, Figure 20). 
Upon further analysis we identified the D. melanogaster SWS1 orthologue, which is also 
likely to function during meiosis. dmSws1 is primarily expressed in the ovaries which are the site 
of meiotic crossing over in flies (112,113). In contrast, dmSws1 is not significantly expressed in 
other adult tissues including the testes, which do not produce recombinant gametes in 
Drosophila. Consistent with dmSws1’s ovarian expression, we find that dmSws1 also exhibits 
strong co-evolutionary signatures (ERC) with meiotic proteins, just as observed for its budding 
yeast orthologue Shu2 (Figure 5B and 5D). Also similar to Shu2, which physically interacts with 
the Rad51 paralogues, we find dmSws1 strongly co-evolves with the Rad51 paralogues 
dmRad51D and dmRad51C (Figure 5A and 5C), which are also primarily expressed in the 
ovaries. Despite this conserved evolutionary pattern, we were unable to detect a physical Y2H 
interaction between dmSws1 and dmRad51D, or between ceSws-1 and Rfs-1. However, this may 
be due to the lack of a third unidentified binding partner as is required for Y2H interaction 
between the human SWS1 and its hRAD51 paralogues. For example, we only detect a Y2H 
interaction between hSWS1 with its obligate binding partner hSWSAP1 despite hSWS1’s 
physical interaction with other RAD51 paralogues (64,66). Alternatively, the strong ERC values 
between dmSws1 and the Rad51 paralogues may be explained by a conserved genetic, but not 
physical interaction. Together, our work implicates that the SWS1 protein family are likely 
conserved pro-recombinogenic factors for meiotic HR in multiple eukaryotic lineages.  In the 
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future, direct experimental evidence to examine dmSws1 role in meiotic and mitotic Rad51 
filament formation will be necessary to confirm this hypothesis. 
While our work indicates that the SWS1 family of proteins functions in meiosis, it is 
clearly evident that these proteins also promote mitotic HR (60-62,65,89,107). Multiple groups 
including our own have demonstrated that loss of SHU2 confers sensitivity to replication fork-
damaging MMS in various budding yeast strains, and, consistent with these findings, previous 
reports have indicated that loss of SWS1 results in a sensitivity to replication fork-blocking 
agents in both fission yeast and human HeLa cells (64,66). Furthermore, we show here that the 
SWIM domain in Shu2 is important for the Shu complex resistance to MMS-induced DNA 
damage. The role and importance of Shu2 and the Shu complex in promoting mitotic HR is not 
completely understood, although it appears to act in part by regulating the activity of Srs2. 
 Srs2 is a DNA helicase that destabilizes Rad51 filaments in vitro which in turn regulates 
HR in vivo (33,34,114,115). Previous reports have shown that Shu2 physically interacts with 
Srs2 (63,64) and that loss of Shu1 results in increased Srs2 occupancy at DSB sites (107). 
Together these findings support a model where the Shu complex may promote Rad51 filament 
formation by inhibiting Srs2 in mitosis. However, a new report indicates Srs2 has an additional 
important function in regulating Rad51-dependent repair during meiosis (90,111). In contrast to 
its role in mitosis, Srs2’s function in meiosis is pro-recombinogenic. Furthermore, disruption of 
SRS2 does not rescue or alter the meiotic defect observed in a Shu complex mutant suggesting 
that the genetic interaction between the Shu complex and Srs2 is different during mitosis and 
meiosis (90). Despite the differing mitotic and meiotic roles of Srs2, the conserved physical 
interaction between Shu2 and Srs2 and the strong evolutionary covariation clearly indicate that 
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these proteins have a functionally important relationship (Figure 5A). In the future, the strong 
ERC observed between Shu complex members could be exploited to identify additional protein 
modifiers of its HR function, as demonstrated in a recent ERC study (106). Moreover, it remains 
uninvestigated if hSWS1 or its binding partner hSWSAP1 retains this physical interaction with 
the putative Srs2 homologues such as PARI or RTEL or if they promote meiotic HR. In 
conclusion, the SWS1 protein family is an important factor in both mitotic and meiotic HR 
where future work will shed light on its unique regulatory mechanisms for RAD51. 
2.3 MATERIALS AND METHODS 
2.3.1 Yeast strains, plasmids, and media 
The strains used in this study are listed in Table 2 and are isogenic to RAD5+ W303, except for 
the PJ69-4A and PJ69-4α yeast-2-hybrid strains (116-118). The primers used are listed in Table 
3.  Standard protocols were used for yeast culturing, transformation (LiOAc method), 
sporulation, and tetrad dissection. The media was prepared as previously described with twice 
the amount of leucine (119). The Y2H plasmid for hSWS1 was created by PCR amplification 
using pJ636 (pcDNA3-3HA-hSWS1) from Paul Russell as a template with oligonucleotides 
hSWS1.F and h.SWS1.R and sub-cloned into the EcoRI and SalI restriction sites of pGBD-C1 
(64). hSWSAP1 was PCR amplified from the MYC–SWSAP1 vector from Jun Huang with 
oligonucleotides SWSAP1.F and SWSAP1.R and sub-cloned into the EcoRI and SalI restriction 
sites of pGAD-C1(66). Creation of pGBK-shu2-C114S (Shu2.C114S.F and Shu2.C114S.R), 
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pGBK-shu2-C116S (Shu2.C116S.F and Shu2.C116S.R), pGBK-shu2-F119A (Shu2.F119A.F 
and Shu2.F119A.R), pGBK-shu2-C176S (Shu2.C176S.F and Shu2.C176S.R), pGBK-shu2-
H178A (Shu2.H178A.F and Shu2.H178A.R), pGBK-shu2-A181T (Shu2.A181T.F and 
Shu2.A181T.R), pGBD-SWS1-C85S (hSWS1.C85S.F and hSWS1.C85S.R), pGBD-SWS1-C87S 
(hSWS1.C87S.F and hSWS1.C87S.R), pGBD-SWS1-F90A (hSWS1.F90A.F and 
hSWS1.F90A.R), pGBD-SWS1-C103S (hSWS1.C103S.F and hSWS1.C103S.R), pGBD-SWS1-
H105A (hSWS1.H105A.F and hSWS1.H105A.R), and pGBD-SWS1-A108T (hSWS1.A108T.F 
and hSWS1.A108T.R) were created using site-directed mutagenesis of the pGBK-SHU2 or 
pGBD-SWS1 plasmids. 
Integration of C114S mutation at the endogenous SHU2 locus was done by creating an 
integration vector by subcloning with EcoRI and PstI from pGBK-shu2-C114S in the 
yiPLAC211 integration vector. WT yiPLAC-SHU2 was made by reversing the C114S mutation 
by site directed mutagenesis using Shu2.S114C.F and Shu2.S114C.R. yiPLAC211 was 
subsequently mutagenized to C116S, F119A, C176S, H178A, and A181T with the primers listed 
in Table 3. The WT and mutant versions of yiPLAC211-shu2 was linearized with BamHI and 
transformed into W9100-2D. Pop-outs were screened on 5-Fluorooritic acid and PCR verified. 
All inserts were verified by DNA sequence analysis. 
2.3.2 Serial dilutions 
The indicated strains were grown to an OD600 of 0.5 and then 5-fold serially diluted onto rich 
medium (YPD) or YPD with either 0.006, 0.012, 0.02% methyl methanesulfonate (MMS) or 50 
mM hydroxyurea (HU). For strains harboring pGBK-shu2 vectors, serial dilutions were 
performed as above with the exception that cells were grown up in SC-TRP medium prior to 
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plating onto YPD medium or YPD with 0.02% MMS. Plates were incubated for 2 days at 30˚C 
prior to imaging.  
2.3.3 Yeast-2-Hybrids 
The GAL4 DNA activating domain (pGAD) expressing plasmids were transformed into PJ69-4A 
and the GAL4 DNA binding domain (pGBK or pGBD) expressing plasmids were transformed into 
PJ69-4α. The SHU1 gene was disrupted with NatNT2 using pFA6A-NatNT2 as described in (47) 
in both the PJ-694A or PJ69-4α strain backgrounds where indicated. The plasmid containing PJ69-
4A and PJ69-4α haploid yeast cells were mated and diploids selected by growth on SC-LEU-TRP 
solid medium. Individual colonies were grown to early log phase to OD600 0.2 and then 5 µl were 
spotted onto medium to select for the plasmids (SC-LEU-TRP) or onto medium to select for 
expression of the reporter HIS3 gene (SC-LEU-TRP-HIS) indicating an interaction. Plates were 
incubated for two days at 30˚C and photographed. The experiments were done in triplicate. 
2.3.4 Homology searching and phylogenetics 
Yeast Shu2 homologues from fungi were retrieved from the non-redundant amino acid sequence 
database at NCBI using PSI-BLAST. Hits with E-values below 0.005 were used for subsequent 
iterations. An additional PSI-BLAST search beginning with the human SWS1 (ZSWIM7) protein 
led to hits across many eukaryotic taxa and in archaea after 3 iterations. While Shu2-homologues 
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were found in hundreds of species, a selection representing major lineages and model organisms 
is shown in Figure 4. Protein sequence phylogenies were inferred in PhyML using the LG 
substitution model with 4 rate classes (120). Branch support values were generated with the 
approximate likelihood ratio test (aLRT).   
2.3.5 Evolutionary rate covariation of Shu2 and fly SWS1 with meiotic and mitotic 
proteins 
Values of evolutionary rate covariation (ERC) were calculated using previously described 
methods (102). Briefly, orthologous protein sequences were collected from species with 
sequenced genomes and aligned in muscle (18 fungal species and 12 Drosophila species for their 
corresponding datasets) (102,106,121). For each protein we then estimated amino acid branch 
lengths using a fixed tree topology and the aaml program of the PAML package. Branch lengths 
were then transformed to relative rates using a projection operator (122,123). The ERC value 
between any two proteins was calculated as the correlation coefficient between their evolutionary 
rates.   
 The elevation of Shu complex ERC values as a group was tested by comparison to 
100,000 random sets of genes of the same size (N = 4 proteins). A p-value was estimated from 
the number of random protein sets with mean ERC values equal to or greater than the mean ERC 
between Shu complex proteins. Sets of mitotic, meiotic, and “recombinase activity” proteins were 
obtained from Gene Ontology annotation through the Yeast Mine and FlyBase Query Builder 
web tools for yeast and Drosophila, respectively (124,125). Statistical significance for ERC 
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between Shu2 and these functional groups was performed by comparing their ERC distributions 
to the whole-proteome background (all genes) through Wilcoxon rank sum tests. 
 
2.3.6 Spore viability assay 
Diploid yeast strains where both copies of the indicated genotype had been disrupted or mutated 
at their endogenous locus were sporulated at 30˚C. The individual spores were tetrad dissected 
onto rich medium and spore viability ascertained. A plate of twenty-two individual tetrads was 
analyzed in triplicate with standard deviations calculated. 
2.3.7 Mitotic recombination assays 
Mitotic recombination rates were calculated from WT, shu1∆, and shu2∆ cells containing the leu2-
∆EcoRI::URA3::leu2-∆BstEII direct repeat recombination assay as described in (101). Gene 
conversion (GC) events are measured by Leu+ Ura+ colonies and single-strand annealing (SSA) 
recombinants are measured by Leu+ Ura- colonies. Nine individual colonies were analyzed of each 
genotype and the experiment was performed in triplicate. The mitotic recombination rate and 
standard deviation was calculated as described (126). 
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3.0  THE SHU COMPLEX INTERACTS WITH THE RAD51 NUCLEOPROTEIN 
FILAMENT TO MEDIATE ERROR-FREE RECOMBINATION 
3.1 INTRODUCTION 
DNA double-strand breaks (DSBs) are cytotoxic lesions whose improper repair can lead to 
mutations, genomic rearrangements, or cell death. Faced with a DSB, eukaryotic cells can 
differentially utilize non-homologous end joining (NHEJ) or homologous recombination (HR) to 
repair the lesion. Misregulation of these pathways is both a hallmark of, and a driving force behind, 
cancer development. Recent work in the budding yeast Saccharomyces cerevisiae has 
characterized a novel regulator of HR, the Shu complex, which is also conserved in humans 
(62,64,66). Loss of the Shu complex leads to misregulation of HR resulting in a higher mutation 
rate and increased genome rearrangements (62,64,66,99). Therefore, the Shu complex is likely an 
important regulator to suppress the chromosomal rearrangements and mutations observed in tumor 
cells although the mechanism is largely unknown. 
In budding yeast, the primary method of repairing a DSB is through Rad51-mediated HR 
[Reviewed in (2,127)]. Following recognition of a DSB break by the cell, the 5 end of the break 
is resected leading to 3′ single-stranded DNA (ssDNA) overhangs that are coated by the ssDNA 
binding complex RPA. RPA on the nucleoprotein filament is displaced by Rad51 in a Rad52-
dependent fashion. Formation of the Rad51 nucleoprotein filament is required for the homology 
search and strand invasion steps of HR. Resolution of the HR intermediates can be achieved 
through a multistep process leading to either crossover or non-crossover products. 
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Since formation of the Rad51 filament is essential for all recombination events that require 
strand invasion, Rad51 loading onto the DNA is tightly regulated. Srs2 is a DNA helicase referred 
to as an “anti-recombinase” since it functions to destabilize Rad51 filaments by translocating along 
ssDNA mediating Rad51 removal from DNA ends (33,34). Additional proteins promote Rad51 
filament formation, for example Rad52, which displaces RPA to facilitate Rad51 loading 
(128,129). At the same time, the Rad51 paralogues, the heterodimer Rad55-Rad57, integrate into 
and stabilize the Rad51 filament, block the progression of Srs2, and allow improved Rad51 
nucleation and elongation (24,35,130-132). Failure to form Rad51 filaments shifts repair of DSBs 
away from HR towards Rad51-independent repair pathways such as single-strand annealing (SSA) 
(133-135). In SSA the ends of a break are resected to reveal distal homologous stretches of DNA 
that base pair to one another, a process that can result in the loss of the intervening genetic 
sequences.  
The Shu complex, comprised of Shu1, Shu2, Csm2, and Psy3 was previously identified in 
a genetic screen to identify mutants that suppress the slow growth phenotype of top3 mutants 
(62). Further analysis revealed that the Shu complex promotes Rad51-dependent HR (65,107). 
Subsequently, it was found in Schizosaccharomyces pombe that the Shu2 homologue, Sws1, 
physically interacts with Srs2, and that loss of the Shu complex suppresses the camptothecin-
sensitivity of srs2∆ cells (64). More recently, it was demonstrated in S. cerevisiae that the Shu 
complex suppresses Srs2 recruitment to DSBs (107). This suggests a model whereby the Shu 
complex promotes Rad51-dependent HR by inhibiting the anti-recombinase Srs2.  
Sequence homology between the Shu complex proteins, Shu1 and Psy3, and the human 
RAD51 paralogues, XRCC2 and RAD51D, respectively, has suggested that this yeast complex is 
composed of additional Rad51 paralogues (64). Consistent with this hypothesis, recent structural 
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information has revealed that both Psy3 and Csm2 adopt a similar alpha-beta sandwich fold 
structurally homologous to the ATPase core domain of Rad51 and RecA (67,68). Two independent 
crystallization studies demonstrate that the Shu complex is able to bind to DNA through the 
activity of the L2 loops in Psy3 and Csm2 (67,68). Importantly, Shu1 and Shu2 are dispensable 
for DNA binding in vitro, suggesting that recruitment of the Shu complex to DNA is mediated by 
Psy3 and Csm2 under endogenous conditions (68). However, both studies analyzed the DNA-
binding capability of the Shu complex for either ssDNA or dsDNA substrates, both of which are 
not the DNA structures typically used during HR, therefore the biological substrates for these 
proteins are currently unclear. Additionally, it remains unknown if the Shu complex functions 
similarly to the other Rad51 paralogues, Rad55 and Rad57, which are incorporated into the Rad51 
filament to mediate Rad51 filament nucleation and elongation. 
Here we show that the Shu complex acts during DSB repair, shifting the balance towards 
error-free DNA repair through gene conversion and away from other error-prone repair pathways, 
such as SSA. We report that similar to the other Rad51 paralogues, Csm2 interacts with Rad51 as 
well as Rad55 and Rad57, and functions epistatically to Rad55-Rad57. Interestingly, we show by 
fluorescent microscopy that loss of the Shu complex results in impaired Rad55 focus formation 
indicating that Csm2 and Psy3 are needed for efficient recruitment of Rad55 to DSB sites. Finally, 
we find that the loss of the Shu complex alters the balance of HR outcomes away from the Rad51-
dependent gene conversion and towards the Rad51-independent SSA pathway. Together our work 
describes a model whereby the Shu complex, controlled by the DNA-binding activity of the Csm2 
and Psy3 heterodimer, interacts with the Rad51 filament to stabilize it. 
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3.2 RESULTS 
3.2.1 Csm2 and Psy2 preferentially bind forked and 3' overhang DNA substrates 
Recently the co-structure of two Shu complex members, Csm2 and Psy3, has been solved and 
biochemical analysis has revealed that the heterodimer of Csm2 and Psy3 is responsible for 
binding of the Shu complex to DNA in vitro (67,68). However, the preferred physiological DNA 
substrates for these proteins has yet to be identified. To understand the function of the Shu complex 
during HR, we sought to characterize the preferred DNA substrates for these proteins. First, we 
co-purified Csm2 and Psy3 as a 1:1 heterodimer to homogeneity (Figure 8A). Since the Shu 
complex was previously found to function during post-replicative repair (60), we first examined 
the ability of a Csm2-Psy3 complex to bind a forked DNA substrate. Csm2-Psy3 complex was 
titrated against a fluorescein labeled forked DNA substrate and binding measured by fluorescence 
anisotropy (Figure 8B). 
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Figure 8. The Csm2 and Psy3 heterodimer preferentially bind forked and 3 overhang DNA substrates.  
A. Csm2-Psy3 was purified using the schematic presented in conditions outlined in the MATERIALS AND 
METHODS section. Coomasie stained Csm2-Psy3 heterodimer (2.4 micrograms) is shown. Csm2 is 25 kDa 
and Psy3 is 28 kDa.  B. The Csm2-Psy3 heterodimer was assayed for DNA binding. Increasing concentrations 
of Csm2-Psy3 was added to a reaction mixture containing 25 nM fluorescein-labeled DNA fork in a 
fluorescence spectrophotometer. The experiment was done in triplicate and the standard deviation is plotted. 
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An estimate of the equilibrium dissociation constant, Kd, is 200 nM. C. Fluorescein-labeled fork (25 nM) 
was allowed to bind to 546.6 nMol of Psy3-Csm2 and then competed off with increasing concentrations of 
unlabeled DNA substrates in a fluorescence spectrophotometer.  Compared to the fluorescein labeled fork, 
the 3’ overhang, 5’ overhang, dsDNA, and ssDNA require a greater than 1.5, 2, 3, and 26-fold higher 
concentration, respectively, to exhibit 50% competition. The experiment was done in triplicate and the 
standard deviation is plotted. 
To define the best binding substrate for the Csm2-Psy3 heterodimer, we added sufficient 
protein to obtain ~80% binding to the fluorescently labeled fork substrate and then added unlabeled 
DNA competitors, such single-stranded DNA (ssDNA), short double-stranded DNA (dsDNA), 5′ 
DNA overhang, 3′ DNA overhang, or a forked DNA substrate (Table 3; Figure 8C). Our results 
show that the forked DNA substrate and to a lesser extent the 3′ DNA overhang, effectively 
compete for Csm2-Psy3 binding, while 5′-overhang DNA, dsDNA, and ssDNA requires a greater 
than 2, 3, and 26-fold higher concentration, respectively, than forked DNA to show 50% inhibition 
(Figure 8C). Importantly, forked DNA and 3′ overhangs are DNA structures utilized by the 
homologous recombination pathway. We then verified these results by performing electrophoretic 
mobility shift assays (EMSA) using the substrates illustrated in Table 3.  In this assay, a mobility 
shift in the DNA substrate would be observed if the competing DNA substrate bound to Csm2-
Psy3 heterodimer. We find that the forked DNA and, to a lesser extent the 3′ overhang substrates, 
are the best DNA binding competitors for Csm2-Psy3 (Figure 23). Together our results show that 
the Csm2-Psy3 complex can specifically recognize and bind DNA substrates used by the 
homologous recombination pathway. 
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3.2.2 Csm2 interacts with Rad51 and the Rad51 paralogues Rad55-Rad57 
Two of the human components of the Shu complex, XRCC2 and RAD51D, are RAD51 
paralogues, which are proteins that have structural similarity to RAD51 (64,92). Consistent with 
this finding, the crystal structure of the yeast Shu proteins, Csm2 and Psy3, also reveal structural 
similarity to Rad51 (67,68). These results strongly suggest that, like the mammalian Shu complex, 
Csm2 and Psy3 are also Rad51 paralogues. Other Rad51 paralogues in yeast, such as the Rad55-
Rad57 heterodimer, are incorporated into the Rad51 filament, thus stabilizing and promoting 
Rad51 filament formation and elongation (35,130,131). Since Csm2 and Psy3 bind to similar DNA 
substrates utilized by Rad51 during HR, we assessed whether they could interact with Rad51 or 
the other Rad51 paralogues, Rad55 or Rad57, by yeast-two-hybrid (Y2H). We obtained plasmids 
harboring fusions of the GAL4 activation domain with RAD51, RAD55, or RAD57 (pGAD) or  of 
the  GAL4-DNA binding domain with PSY3 or CSM2 (pGBD) (Figure 9). Growth of yeast cells 
transformed with the respective combination of plasmids was assessed on medium lacking leucine 
and tryptophan (Control) or additionally lacking histidine (Interaction). Using this assay, we 
observe that Csm2 interacts with both Rad51 and Rad55 as well as weakly with Rad57 (Figure 9). 
In contrast, Psy3 does not interact with Rad51, Rad55, or Rad57 (Figure 9). These results are 
consistent with the model that Csm2 mediates binding of the Shu complex to DNA perhaps through 
its physical interaction with Rad51 or the other Rad51 paralogues. 
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Figure 9. Csm2 physically interacts with Rad51, Rad55, and Rad57 by yeast-2-hybrid.  
Csm2 or Psy3 cloned into the pGAD (containing a GAL4-activating domain) plasmid were assayed for 
interaction with Rad55, Rad57 or Rad51, which were individually cloned into the pGBD plasmid (containing 
a GAL4-binding domain), by yeast-two-hybrid. Growth on minimal medium lacking histidine indicates a 
yeast-two-hybrid interaction as HIS3 is the downstream reporter gene activated by interaction between the 
queried plasmids (Interaction). Equal cell plating was determined by growth on minimal media lacking 
leucine and tryptophan, which selects for the two plasmids (Loading Control). 
 
3.2.3 The Shu complex and Rad55-Rad57 function in the same epistasis group 
Similar to other Rad51 paralogues, we find that Csm2 interacts with Rad51. Therefore, we asked 
whether Csm2 functions in the same epistasis group as Rad55-Rad57. To address this question, 
we compared csm2∆ and rad55∆ single and double mutants for sensitivity to DNA damaging 
agents such as methyl methanesulfonate (MMS, a DNA alkalating agent) or ionizing radiation (IR, 
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which induces DSBs) (Figure 10A). Since rad55∆ cells were previously found to be cold sensitive, 
we analyzed these mutants for growth at both 23˚C and 30˚C (24,136,137) (Figure 10A). We 
observe that both a rad55∆ single mutant and rad55∆ csm2∆ double mutants are equally sensitive 
to both MMS and IR treatments when compared to the wild-type (WT) or a csm2∆ single mutant, 
suggesting that Rad55 is epistatic to Csm2 with respect for DNA damage (Figure 10A). These 
results show that Rad55 and Csm2 likely function in the same epistasis group. Interestingly, csm2∆ 
cells were only sensitive to 0.006% MMS at lower temperatures (Figure 10A; 23˚C panel) 
suggesting that like Rad55-Rad57, the Shu complex is likely involved in formation or stabilization 
of a larger complex. 
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Figure 10. Csm2 is in the same epistasis group as Rad55 and regulated Rad55 recruitment to DNA damage 
sites. 
A. WT, csm2∆, rad55∆, and rad55∆ csm2∆ cells were five-fold serially diluted onto YPD medium or YPD 
medium containing 0.006% MMS or exposed to 60 Gy IR and incubated at 23˚C or 30˚C for two days. B. 
YFP-Rad55 expressing strains were analyzed for the percentage of cells with nuclear Rad55 foci before 
(untreated) or after IR (40 Gy). Images of Rad55 are shown and a fluorescent Rad55 focus is indicated with 
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a white arrowhead. Each experiment was done in triplicate with a total of 400-800 total cells analyzed with 
standard errors plotted. 
3.2.4 Csm2 is necessary for the recruitment of Rad55 to DNA damage sites 
Since Csm2 and Rad55 function in the same epistasis group in response to DNA damaging agents, 
we wondered if Csm2 or Psy3 would be necessary for Rad55 recruitment to DSB sites. We 
analyzed cells with fluorescently tagged Rad55 (YFP-Rad55) for formation of fluorescent foci, 
which indicates their redistribution to a DNA damage site, before and after exposure to IR (Figure 
10B and 10C). In WT cells, we observe a Rad55 focus in approximately 4% of cells before DNA 
damage (untreated) and this percentage increases to 8% following IR exposure, suggesting that 
Rad55 is redistributed to DNA damage sites (Figure 10B and 10C). In contrast, in cells where 
either CSM2 or PSY3 are deleted, we do not see an increase in Rad55 recruitment into DNA repair 
foci, and we observe fewer cells with a Rad55 focus after IR (Figure 10C). Therefore, Csm2 and 
Psy3 are needed for efficient recruitment of Rad55 to DNA damage sites caused by IR. 
3.2.5 Unlike rad55∆, the cold sensitivity of csm2∆ cells exposed to MMS is not suppressed 
by over-expression of Rad55-Rad57 or Rad51 
Previously it was reported that the cold-sensitivity of rad55∆ cells exposed to IR could be 
suppressed by either over-expressing Rad55, Rad55-Rad57 together, or Rad51 using a CEN or 2µ 
plasmid (132,138,139). Therefore we asked if the slow growth of csm2∆ cells exposed to MMS 
would similarly be suppressed by Rad55-Rad57 or Rad51 over-expression. Akin to what was 
previously observed with IR, the cold sensitivity of rad55∆ cells exposed to MMS could be 
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partially suppressed by expressing Rad55-Rad57 or Rad51 from a CEN plasmid (Figure 11). In 
contrast, the slow growth of csm2∆ upon MMS exposure was not suppressed by either Rad55-
Rad57 co-expression or Rad51 at 23˚C (Figure 11). Therefore, it is possible that Csm2 and Rad55 
have different roles with respect to their function during repair of MMS induced lesions. 
Alternatively, greater expression levels of Rad51 might be needed in order to observe suppression 
of this phenotype. 
 
 
Figure 11. Over-expression of Rad55-Rad57 or Rad51 does not suppress the MMS sensitivity of csm2∆ cells 
at 23˚C.  
WT, csm2∆, and rad55∆ cells were either co-transformed with both a Rad55 and Rad57 plasmid, a Rad51 
plasmid, or their respective empty vectors. Cells were grown to early log phase in minimal medium with 
selection for the plasmids and then five-fold serially diluted onto YPD or YPD with 0.006% MMS. After 
three or four days of growth at 23˚C, the plates were photographed. 
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3.2.6 The Shu complex promotes Rad51-dependent recombination events 
Previously, we hypothesized that the Shu complex promotes Rad51 filament formation since fewer 
spontaneous Rad51 fluorescent foci are observed when the Shu complex is disrupted in yeast or 
mammalian cells (64,107). Since Rad51 filaments are essential for HR, we asked whether 
disruption of the Shu complex might alter repair pathway choice if Rad51 filament formation is 
limited. To address this question, we utilized a heteroallelic recombination assay that can 
distinguish between direct repeat recombination mediated by sister chromatid gene conversion 
(GC, a Rad51-mediated event) and intrachromosomal single-strand annealing (SSA, a Rad51-
independent event) (Figure 12A). In this assay a recombination event can generate a functional 
LEU2 allele between two leu2 heteroalleles. The intervening URA3 marker between the leu2 
alleles enables us to differentiate between sister chromatid GC (Leu+ Ura+) and SSA (Leu+ Ura-
) recombinants (Figure 12A). Using this assay, wild-type PSY3 cells exhibit similar rates of GC 
and SSA (Figure 12B). In contrast, disruption of PSY3 or CSM2 results in significantly more SSA 
events (p ≤ 0.05 and p ≤ 0.01, respectively) where GC events are modestly, but significantly, 
reduced (p ≤ 0.001) (Figure 12B). Since more SSA recombinants are observed with PSY3 or CSM2 
disruption, these results are consistent with the model where inhibiting the Shu complex shifts the 
repair of spontaneous DSBs towards a Rad51-independent repair process.  
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Figure 12. Disruption of CSM2 or PSY3 leads to more Rad51-independent recombination events. 
A. Strains harboring a direct repeat recombination assay (leu2-∆EcoRI::URA3::leu2-∆BstEII) were used to 
simultaneously measure rates of direct repeat recombination by gene conversion or intra-chromosomal 
single-strand annealing that result in a LEU2+ allele. Generation of a function LEU2 gene can occur either 
through a gene conversion event in which the other leu2 allele is used as a template for repair (Rad51-
dependent, left side of cartoon) resulting in Leu+Ura+ colonies. Alternatively, repair can also occur by single-
strand annealing where the intervening regions are resected until a region of homology is exposed and 
religated (Rad51-independent, right side of cartoon) resulting in Leu+Ura- colonies. B. The rates of gene 
conversion and single-strand annealing events in psy3∆, csm2∆, rad55∆, or rad55∆ csm2∆ strains were 
compared to control cells (PSY3 or RAD55 CSM2) where equal rates of gene conversion and single-strand 
annealing events are observed. The dashed line indicates that these strains were analyzed independently. 
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Since Rad55 interacts with Csm2 and functions in the same epistasis group in response to 
DNA damage, we furthermore assessed whether disrupting Rad55 would have a similar effect on 
recombination rates using this assay. We assayed csm2∆ and rad55∆ single mutants and compared 
their recombination rates to the double rad55∆ csm2∆ mutant or RAD55 CSM2 cells (Figure 12B). 
As expected, disruption of RAD55 resulted in very few detectable GC events (recombination rate 
less than 6.7 x 10-7) and SSA rates were increased to a level similar to a csm2∆ single mutant 
(Figure 12B). These results show that Rad55 has a more prominent role in mediating gene 
conversion when compared to disruption of either PSY3 or CSM2. Furthermore, the increased SSA 
event observed in either a rad55∆ or csm2∆ single or double mutants were similar, again 
suggesting that Rad55 and Csm2 are epistatic. 
3.3 DISCUSSION 
After a DSB occurs, cells can commit to multiple repair pathways to repair the lesion. An important 
complex in committing the cell to error-free DNA repair is the Shu complex. Recently the crystal 
structures of two components of the Shu complex, Csm2 and Psy3, have been solved (67,68). 
These proteins bind DNA and are structural paralogues of Rad51. With this in mind, we examined 
the preferred binding substrates of purified Csm2-Psy3 heterodimer and find that these proteins 
preferentially bind to forked DNA and, to a lesser extent, 3 over-hang DNA substrates (Figure 8 
and Figure 23. Importantly these DNA structures are utilized by the HR pathway and are coated 
by Rad51 nucleoprotein filaments to perform the essential homology search and strand invasion 
HR steps. Since Csm2 and Psy3 exhibit structural similarity to Rad51, we examined whether they 
interact with Rad51 or the other known Rad51 paralogues in yeast, Rad55-Rad57. Importantly, by 
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yeast-2-hybrid we detected an interaction between Csm2 and Rad51 as well as Rad55-Rad57 
(Figure 9). Subsequently, we found that Csm2 is epistatic to Rad55, suggesting that they function 
in the same pathway (Figure 10). Importantly, by fluorescent microscopy we find that Csm2 and 
Psy3 are necessary for Rad55 recruitment to DSB sites induced by ionizing radiation (Figure 11). 
Finally, we discovered, using recombination assays, that both Csm2 and Psy3 are important in 
Rad51-mediated repair at the expense of error-prone DNA repair mechanisms such as SSA (Figure 
12). Together our results point to a model where the Shu complex, which consists of Rad51 
paralogues, is likely recruited to HR substrates through its DNA binding activity where it can 
interact with Rad51 and Rad55-Rad57 to mediate Rad51 filament formation and commitment to 
error-free DNA repair (Figure 13). 
 
 
Figure 13. Schematic of the role of the Shu complex during error-free HR. 
After a double-strand DNA break occurs, Csm2-Psy3 heterodimer recruits the Shu complex to the break-site 
which can either be at a replication fork or a 3 DNA overhang.  At the break-site, Csm2-Psy3 can promote 
Rad51 filament formation and stabilization; 1) through a direct interaction with Rad51 and Rad55-Rad57 
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and/or 2) by inhibiting Srs2 recruitment to DSB sites.  Stabilization of Rad51 filaments promotes DSB repair 
by error-free HR pathway while inhibiting other error-prone DNA repair mechanisms such as SSA. 
One of the key steps in HR is the formation of Rad51 filaments. Importantly, there are 
proteins that mediate Rad51 filament formation, such as Rad52 and its epistasis group of proteins 
including the Rad51 paralogues, Rad55-Rad57 (24,129,137,140-142). How do the Rad51 
paralogues promote Rad51 nucleofilament formation? Both Rad55-Rad57 are RecA-like proteins 
with structural similarity to Rad51 (130,131) and are needed for Rad51 mediated recombination 
events (24). Since disruption of either RAD55 or RAD57 leads to slower and reduced recruitment 
of Rad51 to DSB sites and dimmer Rad51 foci (23,143,144), it has been proposed that Rad55-
Rad57 nucleate Rad51 filaments where they stabilize Rad51 on the ssDNA end leading to longer 
Rad51 filament tracks (24,145). In support of this model, the IR sensitivity of rad55∆ or rad57∆ 
can be suppressed by over-expressing Rad51 (132,138,139). Furthermore, the cold sensitivity of 
rad55∆ and rad57∆ suggests that they are important for stabilization of larger complexes such as 
the Rad51 presynaptic filament (136,137).  
There are several lines of evidence that suggest that the Shu complex also consists of Rad51 
paralogues. First, like the other Rad51 paralogues, the structure of Csm2 and Psy3 shows similarity 
to Rad51 (67,68). Secondly, similar to Rad55 and Rad57, the Shu genes are also needed for Rad51 
recruitment to DNA damage sites in both yeast and human cells (64,66,107). Additionally, Csm2 
interacts with Rad51 and the other Rad51 paralogues (Figure 9) and its disruption leads to 
decreases in Rad51-mediated DNA repair processes (Figure 12). Finally, Csm2 is in the same 
epistasis group as Rad55 in response to DNA damaging agents MMS and IR (Figure 10A). 
Together, we provide further genetic evidence that the Shu complex consists of Rad51 paralogues 
that is consistent with the structural homology observed by She et al and Tao et al (67,68). 
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In addition to the Rad51 paralogues stabilizing Rad51 on the DNA, there are also factors 
that mediate Rad51 filament disassembly such as the DNA helicase Srs2. ATP-bound Rad51 
frequently binds ssDNA, although with limited extension. In contrast, ADP-bound Rad51 can be 
readily disassociated from DNA (127,145,146). Srs2 promotes ATP hydrolysis of DNA bound 
Rad51 and then subsequently uses its helicase activity to translocate along the DNA filament 
where it can interact with the next available Rad51-ATP substrate (147-149). In humans there are 
multiple proteins that have overlapping functions to Srs2 such as RECQL5, PARI, and RTEL (150-
153). Recently, the Rad51 paralogues Rad55-Rad57 have been shown to physically interact with 
Srs2 in a 1:1 ratio (35). Further biochemical analysis has revealed that Rad55-Rad57 has an 
additional function in mediating Rad51 filament formation through its interaction with Srs2 where 
it inhibits Srs2 translocation activity and thus prevents removal of Rad51 from ssDNA substrates 
(35). 
The Shu complex also has a role in regulating Srs2. Shu2 physically interacts with Srs2 in 
both budding and fission yeast (63,64). Disruption of either SHU1 or SHU2 results in more 
fluorescently tagged Srs2 recruited into spontaneous DNA repair foci and increased recruitment 
of Srs2 to inducible DSB sites (107). Therefore, it is possible that the interaction between Rad51 
paralogues in promoting Rad51 filament assembly by inhibiting Srs2 may be a shared function. 
However, it remains unknown if the Shu complex is incorporated into the Rad51 filament like the 
other paralogues. 
One puzzling observation made here is that Csm2 and Psy3 both promote Rad55 focus 
formation after IR but are not IR sensitive when disrupted (Figure 10).  This is consistent with a 
reduction in Rad51 foci observed in shu1∆ cells (107). Although fewer Rad55 foci are observed, 
perhaps enough Rad55 is recruited to these lesions to enable cell viability after IR treatment in the 
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absence of PSY3 or CSM2. Alternatively, there may be a delay in the kinetics of Rad55 focus 
assembly at DNA repair sites that would not result in a growth defect in IR exposed csm2∆ cells. 
 
How are the roles of the Shu complex different from Rad55-Rad57 during HR?  Previously 
we proposed a model where the function of the Shu complex was to inhibit Srs2 recruitment to 
DNA repair sites, thus promoting error-free Rad51 mediated recombination. We find that 
disruption of either RAD55 or RAD57 leads to a more pronounced defect in HR and increased 
sensitivity to a broader range of DNA damaging agents. Furthermore, unlike Rad55-Rad57, the 
Shu genes likely have a more specialized function with respect to HR, perhaps a more dominant 
role at the replication fork or in response to specific types of DNA lesions. Consistent with this 
idea, the Shu complex was shown to have a role in post-replicative repair and to influence use of 
error-free DNA polymerases in response to MMS induced lesions (60,62). Furthermore, disruption 
of the Shu complex members leads to sensitivity to MMS specifically but not other DNA damaging 
agents (i.e. IR, UV, HU, etc.) (60,62,64,65). Unlike the other Rad51 paralogues, csm2∆ cold 
sensitivity upon exposure to MMS is not suppressed by Rad51 over-expression (Figure 11). These 
results may explain why csm2∆ or psy3∆ cells do not have a more dramatic effect on gene 
conversion rates like those observed in rad55∆ cells. Regardless, the interaction between the Shu 
complex and the other key players in mediating HR (such as Rad51, Rad55, Rad57, Srs2), 
underscore the importance of understanding the unique roles these proteins play during Rad51 
filament formation. 
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3.4 MATERIALS AND METHODS 
3.4.1 Strains, plasmids and media 
The strains used in this study are listed in Table 4 and are isogenic with W303 and derived from 
the RAD5+ strains W1588-4C and W5909-1B (116,117) except for PJ69-4A and PJ69-4α strains 
used during the yeast-2-hybrid experiments (118). Standard protocols were used for crosses, tetrad 
dissection, and yeast transformation (LiOAc method) (119). The media was prepared as described, 
except with twice the amount of leucine (119). 
3.4.2 Purification of Csm2 and Psy3 
Full length S. cerevisiae Csm2 and Psy3 were amplified from genomic DNA by PCR and cloned 
into the bacterial co-expression plasmid pCDF Duet-1 (cloning described in Table 4; EMD 
Millipore). Protein expression was performed in E.coli BL21 (DE3) Codon+(pRIL) via IPTG 
induction. Cells were harvested by centrifugation, lysed in 20 mM Tris (pH 8.0), 300 mM NaCl, 
10% glycerol, 5 mM imidazole, 1 mM β-mercaptoethanol, and the lysates cleared by centrifugation 
at 30,000xg. Csm2 and Psy3 were co-purified by nickel affinity chromatography (Qiagen) via the 
His6 tag on Csm2, followed by an overnight digestion with TEV. The Csm2-Psy3 complex was 
then further purified using HiTrap Heparin HP (GE Healthcare) affinity chromatography and size 
exclusion chromatography using a Sephacryl S-200 column (GE Healthcare) with peak fractions 
eluting as an apparent heterodimer verified by SDS-PAGE. The peak fractions were dialyzed into 
a buffer containing 20 mM Tris (pH 8.0), 300 mM NaCl, 8% glycerol, and 1 mM dithiothreitol 
and concentrated to 1.6 mg/ml using a Vivaspin concentrator (Millipore).  
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3.4.3 Competition electrophoretic mobility shift assay (EMSA) 
Fluorescein-labeled DNA fork (260 nM), detailed in Table 5, with or without an unlabeled 
competitor DNA oligonucleotide (1300 nM), was incubated on ice for 30 minutes with purified 
Csm2-Psy3 complex (3.0 µM) in EMSA reaction buffer (10 mM Tris pH 8.0, 50 mM NaCl, 2 mM 
DTT, 4 mM MgCl2) in a reaction volume of 10 µl. Equilibrated samples were loaded on a pre-
cooled and pre-run 5% native polyacrylamide gel containing 0.5X TBE and run at 200 volts for 2 
hours at 4ºC. The resulting gel was visualized by fluorescence using a FLA-5100 Fluorescent 
Image Analyzer (FujiFilm). 
3.4.4 Fluorescence anisotropy assays for DNA binding 
The basic protocol and mathematical rationale for this technique is outlined in Hey et al (154). All 
experiments were performed using a Cary Eclipse Fluorescence Spectrophotometer (Varian) fitted 
with a peltier thermostatted multicell holder and automated polarizer. Fluorescent 
anisotropy/polarization measurements were collected with the excitation wavelength of 498 nm 
(slit-width 5 nm) and the emission wavelength at 520 nm (slit-width 5 nm), with a photomultiplier 
tube (PMT) voltage of 780V. Reactions were carried out at 30˚C in a standard reaction buffer (20 
mM Tris pH 8, 100 mM NaCl) with a total volume of 400 µL. A fluorescein-labeled DNA fork 
substrate (Table 5) was used in each of the experiments. For the DNA binding isotherms, 
anisotropy measurements were collected using three fluorescein-labeled fork concentrations (25 
nM). Purified Csm2-Psy3 was titrated into the reaction volume to the indicated concentration and 
allowed 7.5 minutes of equilibration prior to the anisotropy measurement. Protein was titrated until 
the anisotropy signal plateaued, indicating saturation of the labeled probe. For the competition 
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curves, fluorescence experiments were carried out with 25 nM fluorescein-labeled DNA fork and 
546.6 nM Csm2-Psy3. The different unlabeled competitors (Table 5) were added at increasing 
concentrations and allowed 7.5 minutes equilibration time before each measurement. Unlabeled 
DNA probe was added until polarized fluorescence stabilized, indicating saturation of the reaction 
with unlabeled DNA probe. Experiments were done in triplicate. 
3.4.5 Yeast-2-Hybrids 
The yeast-two-hybrid plasmid pGAD was used to express a fusion of GAL4 activation domain 
and pGBD was used to express a fusion of the GAL4 DNA binding domain.  pGAD expressing 
plasmids (Csm2, Psy3, and empty vector) were transformed into PJ69-4A (118) and positive 
colonies were selected on SC-LEU medium. pGBD expressing plasmids (Rad55, Rad57, Rad51) 
were transformed in PJ69-4α (118) and recombinants were selected on SC-TRP medium. PJ69-
4A and PJ69-4α haploid yeast cells harboring their respective plasmids were mated and diploids 
were selected on SC-LEU-TRP solid medium. Individual diploid cells were grown to early log 
phase OD600 0.2 and then 5 µl were spotted onto medium to select for the plasmids (SC-LEU-TRP) 
or onto medium to select for expression of the reporter HIS3 gene (SC-LEU-TRP-HIS) indicating 
a yeast-2-hybrid interaction. Plates were incubated for two days at 30˚C and subsequently 
photographed. Each experiment was done in triplicate. 
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3.4.6 Serial dilutions 
The indicated strains were grown to early log phase, diluted to an OD600 of 0.2 and subsequently 
five-fold serially diluted onto rich medium or rich medium exposed to 70 Gy or 0.006% methyl 
methanesulfonate (MMS) and incubated for two days at either 23˚C or 30˚C. 
3.4.7 Fluorescent microscopy 
Cells were grown overnight at 30°C in 3 ml cultures of SC with adenine (100 mg/ml) and harvested 
for microscopy as previously described (155). A YFP-Rad55 integrated at its endogenous locus 
was introduced by mating into WT, csm2∆, and psy3∆ cells and was visualized before and after 
40 Gy of ionizing radiation using a Nikon TiE inverted live cell system with a 100X oil immersion 
objective (1.45 numerical aperture) with a Photometrics HQ2 camera and motorized Prior Z-stage. 
Stacks of 11 0.3µm sections were captured using the following exposure times: differential 
interference contrast (60 ms) and YFP-Rad55 (4000 ms). The images were deconvolved using 
Elements imaging software (Nikon). All images were processed and enhanced identically and 
experiments were performed in triplicate with 400-800 total cells analyzed. 
3.4.8 Mitotic recombination assays 
Mitotic recombination rates were calculated from haploid cells with the indicated mutations and 
the leu2-∆EcoRI::URA3::leu2-∆BstEII direct repeat recombination assay as described in (101). 
Single-strand annealing (SSA) recombinants were measured as Leu+ Ura- colonies and gene 
conversion (GC) events were measured as Leu+ Ura+ colonies. For each genotype, nine individual 
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colonies were analyzed and the experiment was performed in triplicate. The average mitotic 
recombination rate and standard deviation was calculated as described by (126). 
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4.0  PROMOTION OF RAD51 PRESYNAPTIC FILAMENT ASSEMBLY BY THE 
ENSEMBLE OF S. CEREVISIAE RAD51 PARALOGUES WITH RAD52 
4.1 INTRODUCTION 
HR represents a major tool for repairing injured replication forks, chromosomes with DNA 
double-strand breaks (DSBs), telomere lengthening, and ensuring the accurate disjunction of 
homologous chromosomes in meiosis I (156,157). Defective HR underlies human diseases 
including cancer and Fanconi anemia (71,92-94,98). An important conserved HR step is the 
formation of a Rad51-ssDNA nucleoprotein filament, also called the presynaptic filament, at 
DNA damage. In yeast, Rad51 presynaptic filament assembly on ssDNA pre-occupied by RPA, 
the ubiquitous single-strand DNA binding protein, is facilitated by Rad52 (or by BRCA2 in 
humans) and a heterodimeric complex of the Rad51 paralogues Rad55 and Rad57 (150,157). In 
conjunction with the DNA motor protein Rad54, the presynaptic filament mediates homology 
search and strand invasion, and the resultant DNA joint, the D-loop, is resolved through 
mechanistically distinct pathways to a crossover or non-crossover product.  
Recent studies identified the yeast Shu complex as a novel factor that promotes Rad51-
dependent repair through an undefined mechanism (60,62,64,65,107). The Shu complex consists 
of four subunits that include two Rad51 paralogues (Csm2 and Psy3), Shu1, and Shu2 (62) and is 
conserved in humans (64,66,158). The Shu complex was originally identified during a screen for 
mutants that suppress the slow growth of top3∆ cells and it was shown to act in the RAD52 epistasis 
group to promote HR (62,65). The Shu complex similarly suppresses the HU and MMS sensitivity 
of sgs1∆ cells, placing it at an early step of HR (62). Here we present the first biochemical evidence 
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for a synergistic role of the Shu complex with Rad55-Rad57 and Rad52 to promote Rad51 
presynaptic filament formation on RPA-coated ssDNA. Our data support a model wherein Csm2 
and Rad55 bridge interactions among the Rad55-Rad57 heterodimer, the Shu complex, and Rad52 
to promote Rad51-dependent homology-directed DNA repair. 
4.2 RESULTS 
4.2.1 The Shu complex interacts with the regulators of Rad51 filament formation and acts 
upstream of Rad51 filament formation 
We first focused on the purified Csm2-Psy3 heterodimer (Figure 24), as the known protein 
interaction and DNA binding activities occur through these subunits, including our previous 
findings that Csm2 associates with Rad55 in the yeast two-hybrid (Y2H) system (89). Indeed, we 
found by affinity pull-down that Csm2-Psy3 interacts with Rad55-Rad57 (Figure 14A and Figure 
25A). Similarly, the Shu complex (Csm2-Psy3-Shu1-Shu2) interacts with Rad55-Rad57 by pull-
down (data not shown). We next asked whether Csm2 would interact with Rad52 by Y2H 
analysis (Figure 14B). As shown before, association of Csm2 with Rad55 and self-interaction of 
Rad52 were seen (61,89,159), and, importantly, Csm2 and Rad55 interacted with Rad52 (Figure 
14B). While the Csm2-Rad52 interaction was abolished in rad55∆ cells, the Rad52-Rad55 
interaction remained without CSM2 (Figure 14C, D). We employed biochemical pull-down to 
validate these interactions and found that, consistent with the Y2H results above, while GST-
tagged Rad52 could interact with Rad55-Rad57 (Figure 14E), its interaction with the Shu 
complex was negligible. We attempted to validate that Rad55-Rad57 bridges Rad52 to Shu 
 80 
complex by performing the GST pull-down on a mixture of GST-Rad52, Rad55-Rad57, and Shu 
complex. However, the degree to which Shu complex is pulled down by Rad52 is either not 
affected or only modestly affected by the presence of Rad55-Rad57 (data not shown), perhaps 
because the associations are too labile for the tripartite assembly to persist through washing 
steps. In agreement with prior Y2H results (61,89), pull-down analysis revealed that Rad55-
Rad57 interacts with Rad51 while Csm2-Psy3 does so only weakly (Figure 25B). Addition of 
Csm2-Psy3 does not attenuate Rad55-Rad57 interaction with Rad51, suggesting the interactions 
are non-competitive (data not shown). We have additionally tested RPA in pull-downs and find 
that it may interact weakly with Rad55-Rad57 (data not shown). 
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Figure 14. Interactions of Rad55-Rad57 with the Shu complex and Rad52. 
A. Rad55-Rad57 was incubated with Csm2-Psy3 and the protein complex was captured through the (His)6 
tag on Rad55 using Ni2+ resin. S, supernatant containing unbound proteins; W, wash of the resin; E, eluate 
from the resin. B. Rad52 was tested for Y2H interaction with the indicated proteins. C. The Y2H 
interaction between Rad52 and Csm2 was examined in wild type or rad55∆ cells. D. The Y2H interaction 
between Rad52 and Rad55 was examined in wild type or csm2∆ cells. E. GST-tagged Rad52 was mixed 
with Rad55-Rad57 or Shu complex, and protein complexes were captured on glutathione resin. 
Immunoblotting for the FLAG tag on Rad57 and Psy3 was used to identify Rad55-Rad57 and Shu complex 
retained on the resin. 
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It has been proposed that the Shu complex and Rad55-Rad57 act to promote Rad51 
presynaptic filament formation by antagonizing the Srs2 helicase (35), which negatively 
regulates HR by disrupting the presynaptic filament (33,34). Cells lacking Srs2 therefore 
accumulate ssDNA-bound Rad51. Since Rad54 enhances the ability of the Rad51 presynaptic 
filament to catalyze DNA strand invasion (40), srs2∆ rad54∆ double mutants are inviable, likely 
because they accumulate long-lived presynaptic filaments. Thus, srs2∆ rad54∆ inviability is 
suppressed by disruption of RAD52, which limits presynaptic filament formation (160). 
Similarly, disruption of RAD55 or CSM2 suppresses srs2∆ rad54∆ inviability (161). To expand 
upon these findings, we asked whether disruption of RAD55 or CSM2 suppresses srs2∆ rad54∆ 
inviability to the same extent as RAD52 deletion by tetrad dissection and spore analysis, and 
indeed it does (Figure 26, p-value < 0.05). Thus, the Shu complex and Rad55-Rad57 do not act 
solely as negative regulators of Srs2 and can function independently of Rad54. 
4.2.2 The Shu complex acts with Rad55-Rad57 and Rad52 to stimulate Rad51 filament 
formation 
We used several complementary approaches to assess the role of the Shu complex in Rad51 
presynaptic filament assembly (Figure 15A, B, Figure 27). Specifically, we monitored Rad51 
loading onto RPA-coated ssDNA bound to magnetic beads (Figure 15A) and also examined 
homologous DNA strand exchange activity (Figure 15B). In the absence of RPA, Rad51 readily 
gained access to the bead-immobilized ssDNA and efficiently catalyzed the exchange of 
homologous DNA strands (Figure 15A, B, lane 2). However, RPA on ssDNA strongly attenuated 
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Rad51 loading efficiency and DNA strand exchange (Figure 15A, B, lane 3). Under the reaction 
conditions, the Shu complex and Rad55-Rad57 alone or together were insufficient to overcome 
the inhibitory effect of RPA (Figure 15A, B, lanes 4-6). The addition of Rad52 permitted Rad51 
loading onto RPA-coated ssDNA, but, because of the limiting conditions employed, the amount 
of ssDNA-associated Rad51 was only a fraction of that achieved when RPA was absent (Figure 
15A, B, lane 7 compared to 2). Rad51 loading in the presence of Rad52 was stimulated by the 
addition of Rad55-Rad57 but not the Shu complex (Figure 15A, B, lanes 7 compared to 8 and 9). 
Importantly, adding Shu complex together with Rad52 and Rad55-Rad57 led to a marked 
stimulation of Rad51 loading and DNA strand exchange activity (Figure 15A, B, lane 10). The 
enhancement of Rad51 loading by Rad55-Rad57 and the Shu complex is most prominent at both 
18˚C and 23˚C and less pronounced at 30˚C (Figure 15B and Figure 28A, B). This is consistent 
with rad55∆ cells exhibiting a more severe DNA damage sensitivity at lower temperatures 
(35,136). Since we found that Shu complex stimulates Rad51 filament assembly, we next 
visualized the nucleoprotein products of Rad51 loading using electron microscopy (EM).  
Consistent with our biochemical data, we observed a significantly greater number of Rad51 
filaments in reactions where Rad55-Rad57 and Shu complex were added together with Rad52 
(Figure 27). Collectively, these results reveal a synergistic action of Rad52 and the two Rad51 
paralogue complexes in enabling utilization of RPA-coated ssDNA for presynaptic filament 
assembly.  
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Figure 15. Enhancement of Rad51 loading onto RPA-coated ssDNA by the Shu complex and Rad55-
Rad57. 
A. (i) Schematic of the Rad51 loading assay. A. (ii) Magnetic bead resin with immobilized ssDNA was pre-
incubated with RPA, then Rad51 was added along with combinations of Rad52, Shu complex, and Rad55-
Rad57. The amount of Rad51 retained on the ssDNA was determined by immunoblotting. B. (i) Schematic 
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of the DNA strand exchange assay. B. (ii) RPA-coated ssDNA was incubated with Rad51 and 
combinations of Rad52, Shu complex, and Rad55-Rad57, mixed with radiolabeled homologous dsDNA 
and Rad54, and then analyzed. S, dsDNA substrate; P, DNA strand exchange product. Standard deviations 
are plotted and (*) indicates significance. 
 
We found that the Csm2-Psy3 heterodimer is just as adept as the full Shu complex in the 
enhancement of presynaptic filament assembly in the presence of Rad55-Rad57, suggesting that 
Shu1 and Shu2, which are not Rad51 paralogues, may not be directly involved in presynaptic 
filament assembly (Figure 29A). The DNA strand exchange reactions performed in Figure 15B 
contained Rad54 to accelerate the rate of product formation (162), but similar results were 
obtained without Rad54 (Figure 29B). Rad55-Rad57 and the Shu complex do not appear to 
directly enhance the activities of Rad51 or Rad54 since DNA strand exchange reactions lacking 
RPA are not stimulated by addition of Rad55-Rad57 and Shu complex (Figure 29C). When 
Rad51 loading incubations were shortened to 45 min, similar results were obtained (data not 
shown). 
4.2.3 Csm2’s interaction with Rad55-Rad57 is essential for its function in vitro and in vivo 
By X-ray crystallography, several groups have determined the structure of Csm2-Psy3 
(67,68,90). We searched for solvent exposed residues that could participate in interaction with a 
partner molecule such as Rad55. We applied surface triplet propensity analysis (163) to this 
structure (68) to reveal a potential protein interaction surface on Csm2 (Figure 30A), which is 
highly conserved in numerous fungal homologues (Figure 30B). The phenylalanine 46 to alanine 
(F46A) (Figure 16A and Figure 30) mutation was made, as changing this surface residue is 
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unlikely to affect the stability or folding of Csm2. Importantly, we found that the F46A mutation 
disrupts the Y2H interaction of Csm2 with Rad55 but not Psy3 (Figure 16B). 
 
Figure 16. Impairment of physical interaction and functional synergy of the Shu complex with Rad55-
Rad57 by the csm2-F46A mutation. 
A. Cartoon view of the Csm2-Psy3 heterodimer(68), with Csm2 in blue and Psy3 in green. Csm2-F46 is 
highlighted in red. B. Y2H analysis for interaction of Csm2 and csm2-F46A with Rad55, Rad51, Rad52, 
and Psy3. C. Pull-down assay (as in Fig. 1a) to examine interaction of (His)6-Rad55-Rad57 with Csm2-
Psy3 harboring csm2-F46A. D. Analysis of the DNA binding activity of Shu complex harboring csm2-
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F46A. E. Rad51 loading and F. DNA strand exchange assays were carried out as in Figure 15 to evaluate 
the efficacy of Shu complex harboring csm2-F46A in the promotion of presynaptic filament assembly. 
Standard deviations are plotted and (*) indicates significance. 
 
We purified Csm2-Psy3 containing the csm2-F46A mutant and verified that it is impaired 
for Rad55-Rad57 interaction (Figure 16C) but is proficient in DNA binding (Shu-F46A; Figure 
16D) and complex formation with Shu1-Shu2 (Figure 24). Consistent with Rad55 bridging the 
interactions between Csm2 with Rad51 and Rad52, we found that the mutant Csm2 does not 
interact with Rad51 or Rad52 (Figure 16B), and, importantly, that Shu-F46A is unable to 
enhance Rad51 presynaptic filament assembly in the bead-based Rad51 loading assay or DNA 
strand exchange reaction (Figure 16E, F, compare lane 6 to 7). These results provide the first 
evidence that the physical interaction between Csm2 and Rad55-Rad57 is functionally 
significant and are congruent with our finding that the Shu complex synergizes with Rad55-
Rad57 in Rad51 presynaptic filament assembly. 
To determine if the Csm2-Rad55 interaction is important for HR, we integrated csm2-F46A 
into the endogenous CSM2 locus and found that the mutant cells are almost as sensitive to MMS 
as csm2∆ cells (Figure 17A). Furthermore, since previous studies demonstrated that the Shu 
complex acts upstream of Sgs1, we tested if the csm2-F46A mutation suppresses the MMS and 
HU sensitivity of an sgs1∆ mutant like csm2∆ and found that it does (Figure 17B). We next 
employed a direct repeat recombination assay (89,164) to reveal that csm2-F46A cells are as 
impaired as the csm2∆ mutant in Rad51-mediated gene conversion (Figure 17C), with a 
corresponding increase in Rad51-independent single-strand annealing events (Figure 17C; (89), p-
value < 0.02). Consistent with disruption of other HR factors (99), using a canavanine mutagenesis 
assay we found that csm2-F46A cells accumulate spontaneous mutations like csm2∆ (60,62) 
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(Figure 17D). Together, our results demonstrate that the interaction between Csm2 and Rad55 is 
indispensable for the biological efficacy of the Shu complex. 
 
 
Figure 17. Impairment of homologous recombination by the csm2-F46A mutation.  
A. csm2-F46A cells are as sensitive to MMS as a csm2∆ mutant. Cultures were five-fold serially diluted onto 
YPD medium with the indicated dose of MMS and incubated for 2 days at 30˚C. B. Similar to csm2∆, csm2-
F46A alleviates the MMS and HU sensitivity of an sgs1∆ mutant. Cells of the indicated genotypes were five-
fold serially diluted and tested for sensitivity to 0.012% MMS or 100 mM HU. C. WT, csm2∆, or csm2-F64A 
cells harboring a direct repeat HR reporter (leu2-ΔEcoRI::URA3::leu2-ΔBstEII) were tested for spontaneous 
rates of Rad51-dependent gene conversion (GC) and Rad51-independent single-strand annealing (SSA) as 
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described (89). The rates of GC are significantly decreased in both csm2-F46A and csm2∆ strains (p < 0.01) 
with a corresponding increase in SSA relative to WT strains (p < 0.02). Standard deviations are plotted and 
(*) indicates significance. D. Like csm2∆ cells, csm2-F46A cells exhibit an elevated mutation rate in a 
canavanine mutagenesis assay. Standard deviations are plotted and (*) indicates significance. 
 
4.3 DISCUSSION 
Regulation of Rad51 presynaptic filament formation is essential for HR-mediated repair of 
damaged DNA and stalled replication forks. Mutations in human mediators of Rad51 presynaptic 
filament assembly, viz, the hRAD51 paralogues (RAD51B, RAD51C, RAD51D, XRCC2, 
XRCC3) or BRCA2, can result in a predisposition to numerous cancers (71,92-94,98). Whether 
the Rad51 mediators function independently or in a cooperative fashion has remained unknown 
(27,165,166). In budding yeast, Rad52 and the Rad55-Rad57 complex have been shown 
biochemically to promote presynaptic filament formation in isolation. We have furnished 
evidence that while the Shu complex is devoid of recombination mediator activity, it synergizes 
with Rad55-Rad57 and Rad52 to mediate the assembly of Rad51 on RPA-coated ssDNA (Figure 
18, see chapter 5 discussion). Our work supports a model in which Rad55-Rad57 bridges an 
interaction between Rad52 and the Shu complex (Figure 14) that is functionally important for 
Rad51 presynaptic filament assembly (Figure 15, Figures 27 and 29). Our study represents the 
first in vitro reconstitution of Rad51 presynaptic filament assembly being mediated by an 
ensemble of seven proteins (Rad52, Rad55-Rad57, and Shu1-Shu2-Csm2-Psy3). Furthermore, 
we have revealed the importance of the Csm2-Rad55 interaction in promoting HR in cells 
(Figure 17) and in the facilitation of Rad51 presynaptic filament assembly and homologous DNA 
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pairing and strand exchange in vitro (Figure 16). Genetic evidence suggests that the Shu complex 
acts primarily in the repair of stalled replication forks (60), and while Shu1 and Shu2 are 
required for efficient fork repair in vivo, they are dispensable for Rad51 loading in vitro (Figure 
29A). One possibility is that the Shu complex interaction with Rad55-Rad57 enables its 
association with replication fork derived DNA intermediates and subsequently Shu1 and Shu2 
would be necessary for DNA repair progression. Although the function of Shu1-Shu2 remains 
elusive, previous work suggested that they may regulate Shu complex binding to complex DNA 
structures produced during HR (68), or Shu complex interactions with other HR regulators, such 
as Srs2 (35,63,150). Intriguingly, the arrangement of the human BCDX2 RAD51 paralogue 
complex is similar to the Shu complex with Rad55-Rad57 (Figure 31). Given the conservation of 
the HR machinery, mechanistic insights into the yeast Rad51 paralogues will provide a model for 
understanding how the human paralogues promote HR. For example, the human RAD51 
paralogues may work with BRCA2, the functional equivalent of yeast Rad52, in presynaptic 
filament assembly (167). This postulated function of the human RAD51 paralogues is likely 
important for cancer avoidance (71,92-94,98). 
4.4 MATERIALS AND METHODS 
4.4.1 Strains, plasmids, and media 
The strains used are listed in Table 6. Yeast crosses, transformations, tetrad dissections, and 
media preparation were carried out as described (89). The csm2-F46A mutation was introduced 
into integration, Y2H, and expression vectors by site-directed mutagenesis using primers 
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Csm2.F46A.Forward (GATGCCACAAGCTCAGCTCCGCTAAGTCAATTCC) and 
Csm2.F46A.Reverse (GGAATTGACTTAGCGGAGCTGAGCTTGTGGCATC). The 
integration vector was made using primers Csm2.Integration.HindIII 
(CCCAAGCTTAACAATTCCTCTCTGAGTTGAAA) and Csm2.Integration.MfeI 
(CCCCAATTGTATCCTTTAAATAAAACCTGTTTTTCCC) to amplify CSM2 with promoter 
and terminator from genomic DNA. The amplified DNA was cut with HindIII and MfeI and 
ligated into yiPLAC211 cut with HindIII and EcoRI. 
4.4.2 Yeast-2-Hybrid analysis 
Y2H experiments were carried out as described in chapters 2 and 3. 
4.4.3 Serial dilutions 
Five-fold serial dilutions were performed with a starting OD600 of 0.5, as described in 
chapters 2 and 3.  
4.4.4 Mitotic recombination assay 
Mitotic recombination assays were performed as described in chapters 2 and 3 (164) and 
recombination rates and standard deviations calculated (126). Each experiment was 
performed in quadruplicate with standard deviations plotted and significance determined 
by t-test. 
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4.4.5 Canavanine mutagenesis assay 
For each trial, individual CAN1 colonies from WT, csm2∆, and csm2-F46A cells were grown 
in 5 ml YPD medium overnight at 30˚C, diluted 1:10, and 250 µl were plated onto SC-
ARG+CAN plates. To determine the number of cells plated, the culture was further diluted 
1:10,000 and 120 µl were plated onto YPD plates. The plates were incubated at 30˚C for 
two days before colonies were counted. The relative rate of CAN1 inactivation for each 
strain is reported as an average of five experiments with standard deviations plotted.  
4.4.6 Suppression of rad54∆ srs2∆ synthetic lethality 
To analyze the suppression of rad54∆ srs2∆ synthetic lethality, a diploid yeast strain 
heterozygous for the indicated genes was sporulated for 72 hrs and tetrad dissected onto 
rich medium and incubated for two days at 30˚C. Three hundred and sixty one tetrads were 
genotyped and assessed for viability. Chi squared analysis was used to determine 
significance for which genotypes were associated with inviability.  
4.4.7 Protein expression and purification 
Rad51, Rad52, RPA, and Rad54 proteins were prepared as previously described (168-170). 
The Rad55-Rad57 complex was expressed in S. cerevisiae strain JEL1 (171) by using the pESC-
URA vector (Agilent) harboring (His)6-tagged RAD55 and FLAG-tagged RAD57 genes; the 
affinity tags are fused to the N-termini of Rad55 and Rad57 proteins. Cells were grown at 30°C 
until OD660 of 0.7 then induced for protein expression by the addition of galactose to 2%, cultured 
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for an additional 18 hrs, and harvested by centrifugation. All the subsequent steps were carried out 
at 4°C in Buffer T (25 mM Tris-HCl, pH 7.4, 10% glycerol, 0.5 mM EDTA, 0.01% IGEPAL CA-
630 (Sigma), 1 mM DTT) was used throughout protein purification. Importantly, the inclusion of 
ATP and Mg2+ during lysis (with 5 mM ATP and 2 mM Mg2+) and purification steps (with 2 mM 
of each) helps minimize the aggregation of Rad55-Rad57 and precipitation. To prepare cell lysate, 
a 40 g cell pellet was resuspended in 160 ml of buffer with 500 mM KCl, 10% sucrose, 0.1% 
IGEPAL, and protease inhibitors (1 mM phenylmethylsulfonyl fluoride and 5 µg/ml each of 
aprotinin, chymostatin, leupeptin, and pepstatin) then lysed by grinding with dry ice followed by 
sonication. After ultracentrifugation (100,000 X g for 1 hr), the clarified lysate was incubated with 
2 ml of Ni2+-NTA affinity resin (Qiagen) for 30 min with gentle mixing. The resin was poured into 
a column and washed using buffer with 500 mM KCl and 20 mM imidazole, followed by elution 
using wash buffer supplemented with 250 mM imidazole. The eluate was then mixed with 0.5 ml 
anti-FLAG affinity resin (Sigma) for 2 hrs with gentle mixing. The resin was poured into a column 
and washed using buffer with 200 mM KCl, followed by elution using wash buffer supplemented 
with 0.3 mg/ml FLAG peptide. The protein pool was diluted with an equal volume of buffer T and 
fractionated in a 1 ml Mono Q column with a 30 ml gradient of 100-700 mM KCl, collecting 0.5 
ml fractions. The peak fractions of Rad55-Rad57 (eluting at ~290 mM KCl) were pooled, 
concentrated in an Amicon Ultra micro-concentrator (Millipore) to 0.6 ml, and fractionated in a 
24 ml SuperDex 200 size exclusion column (GE Healthcare) in buffer with 300 mM KCl, 
collecting 0.5 ml fractions. The peak fractions of Rad55-Rad57 (eluting at appropriate position for 
monodisperse, heterodimeric complex) were pooled, concentrated in an Amicon Ultra micro-
concentrator to 150 µl, snap-frozen in liquid nitrogen, and stored at -80°C. The yield of highly 
purified Rad55-Rad57 was ~150 µg. 
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The Shu complex was expressed in E. coli (Rosetta [DE3]) by co-transforming cells 
with the pET-Duet vector harboring (His)6-tagged Shu1 and MBP-tagged Shu2 and the 
pRSF-Duet vector harboring Strep-tagged Csm2 and FLAG-tagged Psy3. All the affinity tags 
are fused to the N-terminus of proteins. Cells were grown in 2xLB broth supplemented with 
0.1 mM ZnCl2 at 37°C until OD600 of 0.8 and protein expression was induced by the addition 
of IPTG to 0.2 mM and shifted to growth at 16°C for 16 hrs. Cells were harvested by 
centrifugation. All the subsequent steps were conducted at 4°C in buffer T. For lysate 
preparation, a 40 g cell pellet was resuspended in 200 ml of buffer with 300 mM KCl and 
protease inhibitors as above then lysed by sonication. After ultracentrifugation (100,000 X 
g for 1 hr), the clarified lysate was incubated with 2 ml of Ni2+-NTA affinity resin (Qiagen) 
for 30 min with gentle mixing. The resin was poured into a column and washed using 
buffer with 150 mM KCl and 10 mM imidazole, followed by elution using wash buffer 
supplemented with 200 mM imidazole. The eluate was then mixed with 2 ml amylose 
affinity resin (NEB) for 2 hrs with gentle mixing. The resin was poured into a column and 
washed with buffer with 150 mM KCl. Tobacco etch virus (TEV) protease (10 µg) was 
mixed with the resin to cleave at the linker between MBP and Shu2 and thus permit release 
of the Shu complex from the amylose resin; this incubation was performed overnight at 
4°C. The released Shu complex was mixed with 0.7 ml anti-FLAG affinity resin (Sigma) for 2 
hrs with gentle mixing. The resin was poured into a column and washed using buffer with 
150 mM KCl, followed by elution using wash buffer supplemented with 0.3 mg/ml FLAG 
peptide. The eluate was concentrated in an Amicon Ultra micro-concentrator to 0.6 ml and 
fractionated in a 24 ml SuperDex 200 column in buffer with 150 mM KCl, collecting 0.5 ml 
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fractions. For both WT and F46A forms, Shu complex eluted at the position for 
monodisperse tetrameric protein complex. The peak fractions were pooled, concentrated 
in an Amicon Ultra micro-concentrator to 100 µl, snap-frozen in liquid nitrogen, and stored 
at -80°C. The yield of highly purified Shu complex was 65 µg. 
 
4.4.8 Affinity pull-down assays 
Csm2-Psy3 (0.5 µg) was incubated with or without His-tagged Rad55-Rad57 (0.5 µg) in 30 
µl of buffer C (20 mM MOPS, pH 7.2, 150 mM KCl, 10% glycerol, 0.01% IGEPAL, 1 mM DTT, 
1 mM ATP, 2 mM MgCl2, 15 mM imidazole) for 60 min at 4°C. The reactions were mixed 
with 4 µl of Ni2+-NTA resin for 30 min at 4°C. After washing the resin five times with 150 µl 
of buffer C with 200 mM KCl, bound proteins were eluted with 2% SDS. The supernatant 
(S), elution (E), and wash (W) fractions were analyzed by 15% SDS-PAGE followed by 
Coomassie Blue staining. For pull-down via GST-Rad52, proteins were captured on 
glutathione resin using the same procedure as above but using buffer with 100 mM KCl and 
no imidazole, then the various fractions were immunoblotted with α-FLAG antibody (Sigma 
Aldrich, catalog # A8592) to detect the FLAG-tagged Shu complex and Rad55-Rad57. The 
input samples shown represent 1/30th of the total input. 
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4.4.9 Rad51 loading onto ssDNA immobilized on magnetic beads 
RPA (0.4 µM) was added to biotinylated dT 83-mer ssDNA (1.4 µM nucleotides) coupled to 
magnetic streptavidin beads (Roche) in 10 µl of buffer A (35 mM MOPS, pH 7.2, 50 mM KCl, 
1 mM DTT, 2 mM ATP, 5 mM MgCl2, 100 µg/ml BSA) at 37°C for 10 min. Excess RPA was 
removed by magnetic separation. Then, a mixture consisting of the indicated combination 
of Rad51, Rad52, Rad55-Rad57, and Shu complex was added to the RPA-coated ssDNA 
resin in 10 µl buffer A. The protein concentrations used were 0.75 µM Rad51, 0.06 µM 
Rad52, 0.11 µM Rad55-Rad57, and 0.23 µM Shu complex. The reactions were incubated at 
18°C (except where stated otherwise) for 90 min with periodic agitation. The beads were 
briefly washed twice with 10 µl buffer A. Proteins were eluted with 2% SDS and Rad51 
amount was determined by immunoblotting with α-Rad51 antibody (144). 
 
4.4.10 Homologous DNA pairing and strand exchange reaction 
Oligonucleotide-based DNA pairing and strand exchange assay was conducted as described 
previously (172) with slight modifications. The 80-mer ssDNA oligonucleotide (1.6 µM 
nucleotides) was incubated with RPA (0.13 µM) in buffer A at 37°C for 10 min. Then, a mixture 
consisting of the indicated combination of Rad51, Rad52, Rad55-Rad57, and Shu complex was 
incorporated. The protein concentrations used were 0.64 µM Rad51, 0.05 µM Rad52, 0.14 µM 
Rad55-Rad57, and 0.14 µM Shu complex. The reactions were incubated at 18°C (except where 
stated otherwise) for 90 min, then spermidine (4 mM final concentration) and 32P-labeled 
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homologous 40-mer dsDNA (0.8 µM base pairs final concentration) with Rad54 (0.035 µM final 
concentration) and an ATP regenerating system (20 mM creatine phosphate, 30 µg/ml creatine 
kinase) were added to complete the reaction (final volume of 12.5 µl). The reactions were 
incubated for 30 min at 18°C, deproteinized by treatment with 1% SDS and 1 mg/ml proteinase K 
for 5 min at 37°C, and then subjected to electrophoresis in a 10% polyacrylamide gel in TAE 
buffer (40 mM Tris acetate, pH 7.4, 0.5 mM EDTA). Radiolabeled DNA species were visualized 
and quantified by phosphorimaging. 
4.4.11 Electron microscopy 
The reactions were set up similarly to the DNA strand exchange assay for examining Rad51 
loading efficiency, except that a longer ssDNA substrate (150-mer) was used and BSA was 
not included in buffer A. After a 1.5 hr incubation at 18°C, the reaction was applied to a 
glow-discharged, carbon-coated EM grid (Ted Pella, Inc.) and stained with 2% uranyl 
acetate. The EM images were acquired on an FEI Tecnai T12 transmission electron 
microscope at magnification of 30,000 with 20 images sampled per grid. 200 to 400 
nucleoprotein particles were counted for each reaction condition. 
 
4.4.12 DNA binding assay 
The Shu complex (0.05, 0.10, 0.20, and 0.40 µM) was incubated with radiolabeled 83-mer 
ssDNA (1 µM nucleotides) in buffer B (20 mM MOPS, pH 7.2, 1 mM DTT, 150 mM KCl, 5 mM 
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MgCl2, 2.5 mM ATP) for 10 min at 30°C. DNA species were resolved by electrophoresis in an 
8% polyacrylamide gel run in TA buffer (40 mM Tris acetate, pH 7.4) and then visualized 
and quantified by phosphorimaging. 
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5.0  DISCUSSION 
Here we describe how the Shu complex has been conserved from budding yeast to humans, and 
provide evidence that it functions primarily to stimulate Rad51 filament formation during DNA 
damage as summarized in Figure 18. These findings have important implications for the study of 
homologous recombination and for understanding cancer development and treatment, as described 
in the preceding chapters. As the field turns its attention to the function of the human Rad51 
paralogues, we believe the findings we have outlined here for the budding yeast Shu complex will 
serve as a framework for understanding the mechanistic function of the human Shu complex.  
 
Figure 18. Model for Shu complex function in presynaptic filament assembly. 
Rad52 and Rad55-Rad57 together promote the nucleation of Rad51 onto RPA-coated DNA to seed the 
assembly of the Rad51 presynaptic filament. Our results have revealed that the Shu complex, via its 
interaction with Rad55-Rad57, enhances the efficiency of the filament assembly process.  
 
The observation a decade ago that Shu2 is well conserved from budding yeast to humans 
indicated that a mechanistic understanding of the Shu complex in yeast might be functionally 
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relevant to humans. Other groups have found physical interactions between Shu2/SWS1 with 
Rad51 paralogues in budding yeast, fission yeast, and humans, but no group had conclusively 
determined whether the Shu complex has an orthologous complex in higher eukaryotes. Our 
finding that every eukaryotic lineage has a clear Shu2 orthologue, and that this orthologue shows 
strong co-evolutionary signatures with Rad51 paralogues, strongly supports the idea that every 
eukaryotic lineage contains a Shu complex comprised of a Shu2/SWS1 orthologue interacting with 
Rad51 paralogues. Indeed, after identifying the Shu2 orthologue in C. elegans, other members of 
the laboratory were able to detect physical interactions between C. elegans Sws-1 and the C. 
elegans Rad51 paralogues Rip-1 and Rfs-1 ((173), McClendon and Sullivan et al, unpublished 
work). This conservation of a Shu complex throughout eukaryotes means that moving forward, 
our understanding of the in vivo and in vitro functionality of the Shu complex in lower eukaryotes, 
such as budding yeast and C. elegans, will provide a framework for studying the human Shu 
complex and its role in human health.  
The fact that the Shu complex responds only to specific forms of replication fork damage 
makes the Shu complex a compelling target for selective therapies. While inhibition of HR, such 
as in patients with mutations in BRCA2, dramatically sensitizes cells to different chemotherapeutic 
interventions, such as PARP inhibitors, chemical inhibition of central HR proteins such as BRCA2 
or RAD51 are likely to cause serious side effects and be poorly tolerated in patients. The Shu 
complex, with its more specialized function and less severe phenotype when deleted when 
compared to the Rad51 paralogues Rad55-Rad57, may prove to be an effective target in the 
treatment of human disease. Why deletion of the Shu complex gives a minor phenotype relative to 
its binding partners Rad55-Rad57 remains unknown, but likely stems from its more specialized 
response to specific lesions and the possibility of Shu complex-independent HR pathways as 
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discussed below. Given the conservation of Shu2/SWS1 and its relatively minor phenotype 
compared to disruption of the Rad51 paralogues, inhibition of SWS1, perhaps by blocking its 
association with its obligate binding partner SWSAP1, may be an effective chemotherapeutic 
target. Disruption of the Shu complex will likely be effective at sensitizing tumors to alkylating 
agents, but not to other chemotherapeutics or endogenous damage, likely minimizing unwanted 
side effects compared to other targets in the HR pathway. Similarly, chemical inhibition of the Shu 
complex may prove useful for treating patients with Bloom, Werner, and Rothmund-Thomson 
syndromes. The Shu complex was originally characterized as mutants which rescue the defects 
created by Top3 and its binding partner, Sgs1, the homologue of the proteins mutated in Bloom, 
Werner, and Rothmund-Thomson syndromes (62). Disruption of the Shu complex rescues the 
severe hyper-recombination and mutation rates of cells without SGS1, and it will be important to 
determine if disruption of the human Shu complex will be able to rescue the phenotypes of cells 
without the Sgs1 homologues, indicating that the Shu complex could be a potent clinical target for 
these patients. 
We feel that this study provides a reasonable framework in which to evaluate the function 
of the human Shu complex, but this work also raises numerous questions that should be addressed 
in budding yeast to more fully characterize the Shu complex. What follows are several of the major 
questions that these studies have generated, and several experimental approaches that will help to 
clarify the role of the budding yeast Shu complex in HR.  
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5.1 DOES THE SHU COMPLEX REMAIN ASSOCIATED WITH THE RAD51 
FILAMENT? 
The finding that the Shu complex acts to stimulate Rad51 filament formation, accounting for half 
of the total Rad51 filament formation in vitro, raises several questions about its function in vivo 
(chapter 4). For instance, how the Shu complex associates with the Rad51 filament remains 
unknown. The Shu complex could be integrated throughout the Rad51 filament, or it could bind 
to the surface of the filament as has been proposed for Rad52 (Summarized in Figure 19 and (27)). 
Alternatively, the Shu complex could act to “cap” a Rad51 filament, and direct Rad51 filaments 
to expand unidirectionally, as was suggested in a paper investigating the meiotic function of the 
Shu complex (90). Given these unanswered questions, it will be essential to look directly at Rad51 
filaments by electron microscopy or dual atomic force microscopy in the presence or absence of 
the Shu complex, Rad55-Rad57, and Rad52 to determine if/how these proteins are interacting with 
the Rad51 filament. If the Shu complex remains associated with the Rad51 filament, it will be 
important to determine if it can impact downstream steps of HR, such as the recruitment of strand 
invasion factors, e.g. Rad54, Rdh54, or the inhibition of Srs2 during Rad51 filament formation. 
 103 
 
Figure 19. Models of how the Shu complex and Rad55-Rad57 may interact with the Rad51 filament. 
The first, critical experiment to determine if the Shu complex remains bound to Rad51 
filaments would be to directly visualize these filaments, such as by EM, AFM or as recently 
demonstrated in Claire Wyman’s laboratory, using combined total internal reflection fluorescence 
and scanning force microscopy (TIRF-SFM, (36)). In general, during these kinds of experiments 
Rad51 coated ssDNA is placed onto a thin piece of mica or glass and visualized as a clearly visible 
nucleoprotein filament, similar to the EM images of Rad51 in chapter 4. Depending on the type of 
assay being used, proteins such as the Shu complex would be labeled by quantum-dot, gold 
particle, or fluorescent tags and co-incubated with the Rad51 filament and visualized for their 
ability to interact with the filament. A clear possibility in this assay is that the Shu complex would 
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need as its binding partners, Rad55-Rad57 and Rad52, to effectively or efficiently integrate into 
and/or interact with the Rad51 filament (Figures 18 and 19). Alternatively, the Shu complex may 
simply dissociate from the DNA as Rad51 filaments form (Figure 19, left). In an opposing model, 
the Shu complex may coat the Rad51 filament like its binding partner Rad52 (Figure 19, right). 
To investigate these models, the easiest approach would be to use the TIRF-SFM set up. In this 
assay, different fluorophores could be conjugated to Rad55, Rad52, and Csm2 to allow 
simultaneous visualization of each protein’s localization patterns on Rad51 filaments. 
Alternatively, in an AFM or EM system, a single protein such as Csm2 could be labeled with a 
gold particle or quantum dot and evaluated for integration into the Rad51 filament with and without 
either Rad55 or Rad52. These experiments would likely provide exciting data on whether Csm2, 
as well as Rad55 and Rad52, could integrate into the Rad51 filament, and if that integration, or the 
location of the integration in the filament, depended upon the other proteins being evaluated.  
Data from these kinds of experiments would likely be invaluable to our understanding of 
both the structure and contents of the Rad51 filament, as well the mechanistic function of the Shu 
complex itself. For instance, formation of Rad51 filaments on structured DNA, such as a forked 
DNA, may alter integration of the Shu complex into the filament, which could help inform the role 
of the Shu complex at MMS-induced replication damage (Discussed further in section 5.2). If the 
Shu complex integrates into the Rad51 filament, it may change the localization of other proteins 
known to interact with the filament, such as Rdh54, a potential binding partner for the Shu 
complex, which is discussed more in section 5.4. Additionally, the Shu complex is known to 
physical interact with Srs2 in both budding and fission yeast (63,64), and if the Shu complex was 
present inside the filament it may provide mechanistic clues to the significance of this interaction, 
which is the focus of section 5.3. Finally, the Shu complex has also been found to have an 
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important function in meiotic HR, so understanding how the Shu complex may differentially 
interact with a Rad51 filament, a filament of Dmc1, the meiosis-specific Rad51 homologue, or a 
co-filament of Rad51 and Dmc1 could yield functionally useful insights into the Shu complex’s 
meiotic role which is discussed further in section 5.6. 
5.2 WHAT UNDERLIES THE SPECIFIC ROLE OF THE SHU COMPLEX IN THE 
REPAIR OF MMS-INDUCED DNA DAMAGE? 
With such a central function in HR as stimulating 50-70% of the total amount of Rad51 filament 
formation in vitro (chapter 4), an important question in the field is why the Shu complex mutants 
are only sensitive to such a discrete set of damaging agents, e.g. MMS and cisplatin induced 
replication damage, while the Shu complex’s binding partners Rad52, Rad55, and Rad51 have 
much broader DNA damage sensitivities, including other replicative blocking agents such as UV 
or hydroxyurea (HU) treatment (Godin et al unpublished).  
5.2.1 Lesion specificity of the Shu complex 
One possible explanation is that the Shu complex may respond only to discrete lesions at a 
replication fork, such as methylated DNA, abasic sites, or ssDNA breaks. However, by blocking 
the repair of methylated DNA by base excision repair at different steps so that cells would 
accumulate different levels of these lesions, we were unable to see any lesion specificity for the 
Shu complex in the repair of MMS-induced damage (Godin et al, unpublished). In fact, this 
analysis broadened the substrate specificity for the Shu complex to include methylated DNA, 
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ssDNA breaks, abasic sites, and the intermediates produced by rad27∆ cells, which may include 
both the replication intermediates (e.g. unprocessed okazaki fragments) or the unrepaired 5'-dRPs 
normally processed by Rad27 during BER (Godin et al, unpublished). Together, this analysis 
suggests that the Shu complex is responding to many types of lesions that challenge replication 
forks and thus lesion-specificity may not fully explain the modest phenotype of a Shu complex 
mutant. Alternatively, these data may support a model wherein the Shu complex promotes a 
specific pathway in HR, e.g. replication fork protection as discussed in section 5.3. 
This analysis raised even further questions about the Shu complex’s specificity for DNA 
damage beyond MMS. We found that disruption of any member of the Shu complex results in 
sensitivity to cisplatin, which can induce replication fork blocking lesions. These include intra-
strand DNA crosslinks and protein-DNA crosslinks, in addition to the more severe ICLs that block 
DNA unwinding. Because of the broad spectrum of lesions produced during cisplatin treatment, it 
will be important to determine if the Shu complex has a direct role in ICL repair. Moving forward, 
this should be addressed by testing the Shu complex mutants for sensitivity to other crosslinking 
agents, such as psoralen or mitomycin C. If the Shu mutants are sensitive to other sources of ICLs, 
genetic analysis with other components of ICL repair, e.g. Rad1-Rad10 in NER, or Rev3 in TLS, 
will be informative. Our unpublished data has demonstrated that the Shu complex mutants are not 
normally sensitive to UV, and that deletion of Rad1 does not significantly sensitize Shu complex 
mutants to MMS. If the Shu complex mutants display no synthetic sickness with Rad1 upon UV 
treatment or MMS treatment, but do display synthetic sickness with Rad1 upon psoralen or 
cisplatin treatment, it would strongly implicate the Shu complex in ICL repair.  
Studying the potential role for the Shu complex in ICL repair will also generate useful data 
for another unanswered question about the Shu complex’s lesion specificity, which is why the Shu 
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complex is not sensitive to UV radiation. Our unpublished data, as well as other groups, have 
clearly implicated other HR proteins such as Rad55 in the repair and/or bypass of UV damage 
(61). However, the Shu complex mutants display no sensitivity beyond WT, even at doses of UV 
near the lethal range for WT cells. In order to verify that the Shu complex has no role in the 
replication fork blocking lesions produced by UV, several experiments would be highly 
informative. An obvious hypothesis is that, in the absence of the Shu complex, the cell is able to 
reliably use TLS polymerases to efficiently bypass these photoproducts. To determine if the Shu 
complex functions only in a back-up capacity, single and double mutants between Shu complex 
mutants, such as csm2∆, and TLS mutants, such as rev3∆, should be evaluated for UV sensitivity. 
Excitingly, a recent report has used this kind of analysis and found that the double mutants exhibit 
synergistic UV sensitivity, suggesting a role for the Shu complex in the bypass of UV 
photoproducts when TLS polymerases are inhibited (61). Building off of these findings, it would 
be straightforward to perform mutagenesis and recombination assays in WT, rev3∆, csm2∆, and 
rad55∆ combination cells to determine the importance of the Shu complex in promoting 
repair/tolerance of these lesions by HR. For example, treatment with UV would be predicted to 
induce either recombination (Bypass by HR) or bypass by TLS polymerases. Looking at the 
balance of repair by mutation vs. recombination in each single, double, and triple mutant would 
be informative for determining the preferred repair pathways in a WT cell, and for learning why 
the Shu complex mutants are only sensitive to UV when TLS polymerases are disrupted. 
Additionally, determining the difference between a rad55∆ mutant, which is sensitive to UV even 
when TLS polymerases are functional, and a csm2 mutant, which is not sensitive to UV when TLS 
polymerases are present, may shed light on the differences between Shu complex-dependent and 
independent HR. 
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5.2.2 Regulation of the Shu complex activity by post-translational modifications 
One explanation for the differences in Shu complex-dependent and independent HR is that post-
translational modifications of some components of the HR machinery may be necessary for 
recruitment of the Shu complex to sites of damage. There are several promising, non-exclusive 
possibilities as to what these post-translation modifications may be. For example, Rad55 is 
phosphorylated in response to DNA damage, specifically after treatment with MMS (29), and, 
interestingly mutations in Rad55 that prevent Rad55 phosphorylation give a hypomorphic 
phenotype. These Rad55-phosphoryation mutants are primarily sensitive to MMS, but not IR, and 
display a reduced MMS sensitivity when compared to a full deletion of RAD55. This phenotype is 
remarkably similar to the deletion of any member of the Shu complex, raising the possibility that 
Rad55 phosphorylation is required to stimulate its interaction with the Shu complex. In order to 
test this hypothesis, several experiments would be important. First, Y2H analysis comparing the 
Rad55 phosphorylation-null mutant’s interaction with Csm2 to the WT Rad55 would be highly 
informative, where loss of this interaction would support the hypothesis that Rad55 
phosphorylation regulates binding to the Shu complex. Additionally, since all in vitro work on 
Rad55-Rad57 uses proteins purified from yeast, it is possible that a fraction of the Rad55-Rad57 
being used are phosphorylated and they may be responsible for the interaction levels observed 
(chapter 4). These in vitro pull down assays should be repeated in the presence or absence of a 
phosphatase, which will remove the endogenous phosphorylation of Rad55-Rad57, or the kinase 
Rad53, which phosphorylates Rad55-Rad57, to determine if phosphorylation is important for this 
interaction. Finally, evaluating the epistatic relationship between a Rad55 phosphorylation-null 
mutant and CSM2 for MMS resistance or ability to perform HR would determine if the Shu 
complex requires Rad55’s phosphorylation in order to exert its function.  
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Beyond Rad55, posttranslational modifications of other factors, such as SUMOylation of 
Rad52, could also regulate the Shu complex. Previous reports find that deletion of SHU1 can 
inhibit Rad52-dependent HR at rDNA (32), but this inhibition largely depends on the ability of 
Rad52 to be SUMOylated. One possible explanation for this finding is that SUMOylated Rad52 
triggers a Shu complex-dependent form of HR, but non-SUMOylatable Rad52 is incapable of 
effectively initiating Shu complex-dependent HR. These experiments that found this relation with 
SUMO status of Rad52 were performed exclusively on rDNA, so it would be informative to 
determine if non-SUMOylatable Rad52 has any other HR defects outside of the rDNA. These 
could include impaired HR, as measured by the direct repeat recombination assay, or sensitivity 
to MMS. Both potential phenotypes could be due to reduced Shu complex functionality. 
Alternatively, the non-SUMOylatable form of Rad52 may actually suppress a Shu complex 
mutant’s MMS sensitivity if an alternative form of HR is being reliably initiated. Determining if 
the SUMO status of Rad52 alters a Shu complex mutant’s phenotype would clarify the role of 
post-translational modifications on regulating the function of the Shu complex.  
5.3 WHAT DIFFERENTIATES THE ROLE OF THE SHU COMPLEX AT AN HU-
INDUCED STALLED FORK FROM AN MMS-INDUCED STALLED FORK 
One of the major questions regarding the Shu (Suppresses HU sensitivity) complex is why deletion 
of the Shu complex is able to rescue both the severe MMS and HU sensitivity of an sgs1∆ cell, 
while disruption of the Shu complex itself only leads to increased sensitivity to MMS but not HU. 
The fact that loss of the Shu complex rescues an HU-treated sgs1∆ cell strongly suggests that a 
major function of the Shu complex is to generate the kinds of toxic DNA intermediates, e.g. double 
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Holliday junctions, that are normally processed by Sgs1 following HU exposure. However, the 
observation that Shu complex mutants display no HU sensitivity, whereas other HR mutants such 
as rad55∆ cells are sensitive to HU, suggest there is a Shu complex-independent role for HR 
proteins at the replication fork that does not necessitate the formation of complex, HR 
intermediates that are toxic in sgs1∆ cells (61,62). Excitingly, several recent reports suggest 
possible clues as to what these Shu complex independent roles might be as well as methods to test 
these models. 
 In humans, RAD51 has functions independent of HR in regulating HU-stalled replication 
forks (84). This work found that RAD51 interacts with FANCD2 and RAD18 to ensure mono-
ubiquitination of PCNA. Mono-ubiquitinated PCNA results in Pol eta recruitment to HU-stalled 
replication forks, which promotes survival of HU-treated cells through an as yet undetermined 
mechanism. Critically, this function for RAD51 persisted when RAD51 was pharmacologically 
inhibited from performing HR or in cells lacking BRCA2, a critical factor for HR, which suggests 
RAD51’s function at HU-treated forks is independent of HR. One hypothesis for why Shu complex 
mutants are not HU sensitive is that in the absence of Shu complex-dependent HR, cells can readily 
utilize a similar kind of pathway where TLS polymerases are able to promote viability in HU 
treated cells. In support of this model, previous work has uncovered that simultaneous disruption 
of REV3, yeast pol zeta, with the Shu complex can uncover a previously unobserved role for the 
Shu complex at UV-damaged replication forks, so a similar phenomena may occur in HU-treated 
cells (61). However, in the absence of Rad51-stabilizing proteins such as Rad55, this Rad51-
dependent recruitment of TLS polymerases may not occur as readily, giving rise to the HU 
sensitivity seen in rad55∆ cells. Moving forwards, it will be informative to evaluate the 
recruitment and function of the TLS polymerases at HU-stalled replication forks in the presence 
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or absence of the Shu complex or other members of the HR machinery using chromatin 
immunoprecipitations and the kinds of genetic assays described in chapters 3 and 4.  
While evaluating the genetic dependencies for the Shu complex at HU-stalled forks will be 
informative, recent work has generated a new method to directly evaluate the role of the Shu 
complex at purified, HU-stalled forks. A recent paper from Dana Branzei’s group purified the HR 
intermediates produced at an MMS-damaged replication fork and directly evaluated these structure 
by EM (59). They found these cells generate multiple kinds of structures proposed to form during 
HR at a replication fork (Figure 2). These intermediates include double Holliday junctions, single 
Holliday junctions, and hemi-catenanes formed by Sgs1-mediated dissolution of double Holliday 
junctions. Critically, they also found that the lesion at a fork that initiates HR are likely gaps of 
ssDNA and not free ssDNA ends (Figure 2). Using this system, sgs1∆ cells accumulated more 
intermediates, as predicted. In order to determine why the Shu complex mutants display MMS but 
not HU sensitivity, use of this assay will be highly informative. In this assay, will there be 
differences in the kinds of replication fork intermediates that occur in HU vs. MMS treated cells? 
Or, will the different types of damage result in a similar kind of repair by HR? If the Shu complex 
is disrupted in these HU and MMS-treated cells, how are the kinds of DNA intermediates formed 
after each damaging agent different? Finally, will replication forks form different repair 
intermediates in an HU-treated Shu complex mutant compared to an HR mutant that is HU 
sensitive, such as a rad55∆ cell? The ability to now directly visualize stalled and broken replication 
forks by EM clearly has wide-ranging implications in the study of the Shu complex and its 
differential response to different sources of replication fork stress.  
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5.4 WHAT IS THE IMPORTANCE OF THE PHYSICAL ASSOCIATION BETWEEN 
SHU2 AND SRS2? 
One of the enduring questions about the Shu complex centers on the function of Shu2’s conserved 
interaction with Srs2. Before the Shu complex was characterized in 2005, it was identified in a 
high-throughput Y2H screen as a protein that physically interacts with Srs2, whose mechanistic 
function in vitro is to disassemble Rad51 filaments and to regulate polymerase interactions with 
PCNA during replication (33,34,62,63). In 2006, when the fission yeast Shu complex was 
characterized, Shu2’s orthologue Sws1 was also found to interact with Srs2 (64). However, the 
function of this conserved interaction has remained elusive. An obvious hypothesis is that the Shu 
complex, like Rad55-Rad57, could act to inhibit Srs2’s ability to destabilize Rad51 filaments (35). 
In support of this model, previous work has suggested that disruption of the Shu complex causes 
an elevation in Srs2 foci by fluorescent microscopy (107). In addition, unpublished work from our 
laboratory finds that, in regards to MMS treatment, Srs2 is epistatic to the Shu complex, suggesting 
the Shu complex’s primary role may relate to Srs2. Arguing against this model, however, is the 
finding that the Shu complex contains at least some Srs2-independent roles in HR since we find 
that the lethality of an srs2∆ rad54∆ cell is fully suppressed by further deletion of Csm2 (Chapter 
4). As an alternative, Srs2 is known to interact with PCNA and prevent polymerases from 
interacting with PCNA. Thus the Shu complex’s interaction with Srs2 may reflect a previously 
unknown role for the Shu complex in replication fork stability. In order to fully determine the 
mechanistic function of the interaction between Srs2 and Shu2, significantly more work is 
required. 
The first step in understanding the significance of the interaction between Srs2 and Shu2 
is to verify this interaction, originally found by Y2H, through several different approaches such as 
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Co-IP or by in vitro pull downs using purified proteins. It is entirely plausible that these two 
proteins may only interact in the presence of DNA as both are avid DNA binding proteins, and 
any Co-IP interaction observed with these proteins should be tested in the presence and absence 
of a DNAse such as benzonase to determine the importance of DNA for this interaction. 
Additionally, since the Shu complex has been found to require its binding partner Rad55-Rad57 
for essentially all of its mitotic functionality (chapter 4), it is possible the Shu complex may only 
interact with Srs2 via Rad55. This hypothesis could be tested by repeating the Y2H analysis 
between Srs2 and Shu2 using strains in which the endogenous Rad55 has been disrupted. If Shu2’s 
interaction with Srs2 is dependent upon Rad55, the likely function of the Shu complex may be to 
further stimulate or regulate the observed ability of Rad55 to inhibit Srs2, which can readily be 
tested in vitro by repeating the experiments performed in (35) to include the Shu complex, or by 
modifying the in vitro assays in chapter 4 to include Srs2. 
If, however, Shu2’s interaction with Srs2 is independent of Rad55, use of separation-of-
interaction alleles will likely prove to be the most useful way to study this interaction. Using site-
directed mutagenesis in Shu2, it should be possible to perform a Y2H screen to find mutations that 
block or reduce the binding of Shu2 to Srs2. Shu2 likely represents an easier candidate in which 
to find mutations, as it is a significantly smaller protein (223 vs. 1174 amino acids) to mutagenize. 
Alternatively, if the Y2H screen fails, the analysis could be repeated with the well-conserved 
fission yeast proteins Srs2 and Sws1, which may give a stronger Y2H signal. Alternatively the 
interaction domain between Srs2 and Shu2 can be identified using in vitro pull-downs of one full-
length protein with different domains of the other protein, e.g. full length Shu2 with the Rad51-
interacting domain of Srs2. Finding the specific regions of each protein that physically interact 
with one another will enable a more directed mutagenesis screen to determine how mutations in 
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each domain alter this interaction. Regardless of the method used, identification of Shu2 alleles 
that block the interaction with Srs2 will be essential for determining the Srs2-specific functions of 
the Shu complex in promoting resistance to MMS, reducing mutations, and promoting 
recombination as determined using the kinds of genetic and in vitro assays outlined in chapters 3 
and 4.  
5.5 DOES THE SHU COMPLEX HAVE A ROLE DOWNSTREAM OF RAD51 
FILAMENT FORMATION? 
In addition to Shu2’s observed interaction with Srs2, we have also found that every member of the 
Shu complex will strongly interact with Rdh54 by Y2H (Godin et al. unpublished), which suggests 
a role for the Shu complex in the later steps of HR where Rdh54 (human RAD54B) acts to 
stimulate strand invasion of Rad51 nucleoprotein filaments into homologous dsDNA. 
Unfortunately, if the Shu complex does act at later steps of HR, these functions would likely be 
masked in a full deletion of the Shu complex due to its early function in Rad51 filament formation. 
To determine a potential function of the Shu complex at these later steps, specific mutations in the 
Shu complex and/or its binding partner Rdh54 will need to be made to block this interaction. Using 
these mutants, Rad51 filaments should form normally, but the downstream roles of the Shu 
complex should be apparent and could be screened for by MMS sensitivity and HR pathway choice 
using different recombination assays.  
There are, however, practical difficulties in studying the interaction between Rdh54 and 
the Shu complex. Rdh54 appears to interact with multiple components of the Shu complex, which 
is supported by Y2H analysis finding these interactions persist in cells where SHU1, SHU2, CSM2, 
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or PSY3 have been individually deleted (Godin et al. unpublished). Thus, generating a strain where 
the interactions between the Shu complex and Rdh54 are fully ablated may be difficult. In an ideal 
scenario, Rdh54 may interact with all of the Shu complex members through the same interface, 
such that identification of a mutant in Rdh54 that blocks an interaction with one member of the 
Shu complex will block interactions with the other members of the Shu complex. However, if each 
member of the Shu complex interacts with Rdh54 through a separate domain, a Y2H screen of 
each member of the Shu complex for disruptions in the Rdh54 interaction will be necessary, and 
subsequent analysis of this interaction will necessitate combining multiple separation-of-
interaction mutations for the four Shu complex members into one strain to completely inhibit this 
interaction. 
If the practical limitations of these studies are overcome, however, there are several 
approaches to take to study the function of the interaction with Rdh54. First, using whichever 
separation-of-interaction approach proved viable, those strains could be evaluated for MMS 
resistance, mutagenesis, and HR levels as described in chapters 3 and 4. Defects in the recruitment 
of Rdh54 to a Rad51 filament could manifest as impaired recombination and reduced gene 
conversion, or it could cause persistent Rad51 filaments in vivo as measured by fluorescent 
microscopy. Alternatively, as Rdh54 has previously been implicated in regulating Rad51-
independent BIR (55), perhaps use of these alleles in a BIR recombination assay, such as that 
developed by Lorraine Symington (54), would uncover a novel role for the Shu complex in 
preventing the use of this alternative HR pathway. Use of these alleles would also enable 
informative chromatin immunoprecipitation experiments (ChIP) to determine if the interaction 
between Rdh54 and the Shu complex is essential for Rdh54’s recruitment to DSBs or stalled 
replication forks. Additionally, in each case described above, a powerful control would be to repeat 
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the experiments in a strain containing a form of Rad51 developed in Doug Bishop’s laboratory 
that is entirely defective for strand invasion and that is epistatic to all defects in the recruitment of 
downstream factors such as Rdh54 (174).  
5.6 HOW DOES THE FUNCTION OF THE SHU COMPLEX IN MEIOSIS DIFFER 
FROM MITOSIS? 
An important aspect of the Shu complex that was not the central focus of this dissertation 
is its critical role in promoting HR during meiosis. Our work raises many questions about the 
mechanistic function of the Shu complex in meiosis, and how that function may differ from its 
role in mitotically cycling cells. Previous work from Akira Shinohara’s group has determined that 
disruption of any member of the Shu complex causes a significant decrease in viable spores 
produced during meiosis (90). Critically, disruption of Shu1 or Shu2 gives a more modest 
phenotype (~75% viability) compared to disruption of Csm2 or Psy3 (~40% viability), suggesting 
the Shu complex in meiosis may not be functioning as an obligate heterotetramer as in mitosis 
((90,175) and chapter 2). Importantly, Csm2 and Psy3 are epistatic to Shu1 and Shu2 in all 
experiments tested in meiotic cells. In meiosis, loss of the Shu complex results in reduced inter-
homologue bias, and poor chromosomal segregation, all consistent with a role for the Shu complex 
in promoting Rad51 filament formation. However, disruption of the interaction between Csm2 and 
Rad55 by csm2-F46A as reported in chapter 4 does not cause a meiotic defect (Godin et al. 
unpublished data), suggesting the Shu complex may have a function independent of Rad55, and 
perhaps even Rad51, during meiosis. 
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To more fully explore the role of the Shu complex in meiosis, it is important to first verify 
that the defect caused by disruption of the Shu complex is due to impaired Rad51 filament 
formation. In meiosis, Rad51’s recombinase activity is inhibited by Hed1, which allows the 
meiosis-specific Rad51 homologue Dmc1 to carry out the recombinase activity during the repair 
of Spo11-induced DSBs (176,177). If the defects in the Shu complex mutants are caused by 
impaired Rad51 filament formation, and not by any defects in Dmc1, then deletion of HED1 will 
not be predicted to rescue the Shu complex mutants. If, however, HED1 disruption rescues the 
phenotype of Shu complex disrupted meiotic cells, it would argue the Shu complex has a role 
beyond Rad51 filament formation, which is supported by the lack of a defect in the csm2-F46A 
cells. The likely role of the Shu complex would then be regulation of Dmc1, which is functionally 
and structurally very similar to Rad51. To test this hypothesis, it would be necessary to screen for 
interactions between the Shu complex and Dmc1 and its regulators, Mei5-Sae3 which excitingly 
interact with forked DNA structures and Rad51 filaments, just like the Shu complex ((178) 
chapters 3 and 4)), and additionally stimulate Dmc1 filament formation. If the Shu complex is 
capable of interacting with any of these proteins, it will be important to use similar in vitro assays 
discussed in chapter 4 to look for a role of the Shu complex in promoting Dmc1 filament formation.  
Additionally, when investigating the function of the Shu complex in meiosis, it is important 
to note that essentially all interacting partners of the Shu complex have roles in meiosis. As a 
genetic interaction partner, Sgs1 is known to function in crossover regulation in meiosis, but 
whether the Shu complex has a role in regulating Sgs1 during meiosis is unknown. Similarly, 
Srs2’s role in meiosis has only recently been investigated, but it seems to function to promote HR 
in potentially the same pathway as the Shu complex (175). Due to the potentially new role for Srs2 
in promoting HR in meiosis, it is possible that the interaction observed between Srs2 and Shu2, 
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discussed in section 5.3, may indicate a cooperative role for these two proteins in meiosis, rather 
than the Shu complex inhibiting Srs2 as has been hypothesized in mitotic cells. Finally, even if the 
Shu complex’s function in meiosis is to promote Rad51 filament formation, new models will need 
to be drawn to address why the interaction between the Shu complex and Rad55 seems dispensable 
for this function in meiotic but not mitotic cells.  
5.7 CONCLUDING REMARKS 
Together, this thesis helps to establish that the Shu complex is a conserved regulator of HR 
at specific kinds of replication fork damage and that the Shu complex primarily functions to 
promote Rad51 filament formation. While there are many open questions regarding the function 
of the Shu complex, it is our hope that the models and data presented in this work will provide a 
framework for the study of both the human and budding yeast Shu complexes moving forwards, 
and will contribute significantly to our understanding of the role of the Shu complex in human 
health and disease.  
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APPENDIX A 
CHAPTER 2 SUPPLEMENTAL DATA 
 
Figure 20. Distributions of ERC with Shu complex members PSY3. 
A., SHU1 B., and CSM2 C. Violin plots show the median (dot) and upper and lower quartiles (black box) of 
ERC values of meiosis and mitosis proteins versus Shu complex members. Similarly, the violin curves depict 
the density of observed values. Both mitosis and meiosis groups were tested for their departure from the null 
(all genes) distribution. For these tests “***” indicates a P-value less than 0.001. 
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Figure 21. A deep evolutionary alignment of Shu2/SWS1 orthologues clearly reveals conserved residues of 
the SWIM domain. 
The first block contains the invariant and canonical CXC motif and the highly conserved F/Y residue just 
upstream. The second block contains the expanded CXHXXA motif. 
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Figure 22. The SWIM domain is important for Shu2’s function. 
Canonical SWIM domain mutants are non-functional. The indicated mutants were stably integrated into the 
endogenous SHU2 locus and 5-fold serially diluted onto YPD medium or YPD medium containing 0.02% 
MMS and incubated at 30˚C for 2 days. 
Table 2. Chapter 2 Strains and Plasmids 
Name Description 
W9100-2D MATα ADE2 leu2-3,112 his3-11,15 ura3-1 TRP1 lys2∆ RAD5 
KBY159-1C MATα LYS2 shu1::HphNT1 
KBY162-7C MATα trp1-1 lys2∆ shu2::NatNT2 
KBY107-5C MATa leu2-3,112 trp1-1 LYS2 csm2::KanMX4 
KBY108-1C MATa bar1::LEU2 trp1-1 LYS2 psy3::KanMX4 
KBY213-2A MATα rad55::NatMX 
PJ69-4A MATa trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ GAL2-
ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ 
PJ69-4 MATα  trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ GAL2-
ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ 
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KBY403 
KBY475 
MATa trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ GAL2-
ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ shu1::natMX4 
MATα trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ GAL2-
ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ shu1::natMX4 
W3770-4D MATa leu2-∆EcoRI::URA3::leu2-∆BstEII 
KBY13-2C MATa leu2-∆EcoRI::URA3-HO::leu2-∆BstEII shu1::HIS3 
KBY90 MATa leu2-∆EcoRI::URA3-HO::leu2-∆BstEII shu2::TRP1 
KBY469 MATα  shu2-C114S 
KBY834-6A MATα  shu2-C116S trp1-1 LYS2 sgs1::HIS3 
KBY835-3B MATα  shu2-F119A trp1-1 lys2∆ sgs1::HIS3 
KBY836-5C MATα  shu2-C176S sgs1::HIS3 trp1-1 LYS2 
KBY856-1C MATα  shu2-H178A sgs1::HIS3 trp1-1 LYS2 
KBY161-2A 
KBY51-3B 
KBY484-2B 
KBY483-1B 
KBY138 
W9100-11B 
W9100-12C 
KBY457 
KBY21-3D 
MATa trp1-1 LYS2 shu2::HphNT1 
MATa sgs1::HIS3 trp1-1 LYS2 MET22 
MATα sgs1::HIS3 shu2::NatMX4
MATa sgs1::HIS3 trp1-1 shu2-C114S 
MATa/MATα ade2-1/ADE2 TRP1/trp1-1 lys2∆/LYS2 
MATa ade2-1 
MATα ADE2 trp1-1 LYS2 
MATa/MATα ade2-n/ade2-I-SceI shu1::HIS3/shu1::HIS3 
met22::KLURA3/MET22 his3::NatMX4/his3::hphMX4 
LYS2/lys2::GAL-IsceI 
MATa ade2-n shu1::HIS3 LYS2 met22::KLURA3 his3::NatMX4 RAD5 
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KBY24-13A 
KBY341 
KBY92-1A 
KBY488 
KBY474-1B 
KBY474-1A 
KBY342 
KBY107-2C 
KBY38-6D 
KBY343 
KBY57-1B 
KBY106-12B 
MATα ade2-IsceI shu1::HIS3 lys2::GAL-IsceI ura3-1 MET22 
his3::hphMX4  
MATa/MATα shu2::TRP1/shu2::TRP1 leu2∆EcoRI::URA3-
HO::leu2∆BstEII/ura3-1 LYS2/LYS2 trp1-1/trp1-1 ade2/ADE2 
MATα shu2::TRP1 LYS2 trp1-1 
MATa/mat α ade2-1/ADE2 trp1-1/TRP1 LYS2/lys2∆
leu2∆EcoRI::URA3-HO::leu2∆BstEII/ura3-1 shu2-C114S/shu2-
C114S 
MATa ade2-1 trp1-1 LYS2 leu2∆EcoRI::URA3-HO::leu2∆BstEII 
shu2-C114S 
MATα ADE2 TRP1 lys2∆ ura3-1 shu2-C114S 
MATa ADE2/ade2-1 bar1::LEU2/leu2-3,112 TRP1/trp1-1 
csm2::KanMX4/csm2::KanMX4  
ura3-1/leu2∆EcoRI::URA3-HO::leu2∆BstEII 
MATa ADE2 bar1::LEU2 TRP1 csm2::KanMX4 ura3-1  
MATα csm2::KanMX4 leu2∆EcoRI::URA3-HO::leu2∆BstEII his3-11 
trp1-1 ade2-1  
MATa psy3::KanMX4/psy3::KanMX4 leu2∆EcoRI::URA3-
HO::leu2∆BstEII his3-11/ura3-1 ade2-1/ADE2 trp1-1/trp1-1 
LYS2/LYS2 
MATa psy3::KanMX4 leu2∆EcoRI::URA3-HO::leu2∆BstEII ade2-1 
trp1-1 LYS2  
MATα trp1-1 LYS2 psy3::KanMX4 
KBY875 
KBY861-2C 
MATa/α ADE2/ADE2 TRP1/trp1-1 lys2∆/LYS2 shu2-C116S/shu2-
-C116S 
MATa ADE2 TRP1 lys2∆ shu2-C116S 
KBY861-1D MATα ADE2 trp1-1 LYS2 shu2-C116S 
KBY886 MATa/α ADE2/ADE2 trp1-1/trp1-1 lys2∆/LYS2 shu1u2-F119A/shu1-
F119A 
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KBY835-3D 
KBY835-5B 
KBY878 
KBY863-5A 
KBY863-5C 
KBY876 
KBY864-1A 
KBY864-1D 
pWJ1479 
pWJ1474 
pWJ1477 
pWJ1476 
pGAD-C2 
pKB108 
MATa ADE2 trp1-1 lys2∆ shu2-F119A 
MATα trp1-1 LYS2 shu2-F119A 
MATa/α ade2-1/ADE2 TRP1/trp1-1 LYS2/LYS2 shu2-C176S/shu2-
C176S 
MATa ade2-1 TRP1 LYS2 shu2-C176S 
MATα ADE2 trp1-1 LYS2 shu2-C176S
MATa/α ade2-1/ADE2 TRP1/trp1-1 lys2∆/LYS2 shu2-H178A/shu2-
H178A 
MATa ade2-1 TRP1 lys2∆ shu2-H178A 
MATα ade2-1 trp1-1 LYS2 shu2-H178A 
pGBDK-SHU2 (TRP, KANR) 
pGAD-SHU1 (LEU, AMPR) 
pGAD-CSM2 (LEU, AMPR) 
pGAD-PSY3 (LEU, AMPR) 
pGAD-C2 (LEU, AMPR) 
pGBK-Shu2-C114S (TRP, KANR) 
pKB318 pGBK-Shu2-C116S (TRP, KANR) 
pKB330 pGBK-Shu2-F119A (TRP, KANR) 
pKB319 pGBK-Shu2-C176S (TRP, KANR) 
pKB320 pGBK-Shu2-H178A (TRP, KANR) 
pKB321 pGBK-Shu2-A181T (TRP, KANR) 
pKB52 pGAD-SWSAP1 (LEU, AMPR) 
pKB78 pGBD-SWS1 (TRP, AMPR) 
pKB93 pGBD-Sws1-C85S (TRP, AMPR) 
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pKB94 pGBD-Sws1-C87S (TRP, AMPR) 
pKB322 pGBD-Sws1-F90A (TRP, AMPR) 
pKB316 pGBD-Sws1-C103S (TRP, AMPR) 
pKB317 pGBD-Sws1-H105A (TRP, AMPR) 
pKB142 pGBD-Sws1-A108T (TRP, AMPR) 
pGBD-C1 pGBD-C1(TRP, AMPR) 
pKB13 yiPLAC211-Shu2-C114S 
pKB315 yiPLAC211-Shu2 
pKB327 yiPLAC211-Shu2-C116S 
pKB323 yiPLAC211-Shu2-F119A 
pKB328 yiPLAC211-Shu2-C176S 
pKB324 yiPLAC211-Shu2-H178A 
All yeast strains are W303 background derivatives and RAD5 (116) W1588 (117) except 
for PJ69-4A and PJ69-4 (118). The KBY403 and KBY475 strains were constructed in PJ69-4
and PJ69-4A backgrounds, respectively. The strains are listed in the order they appear in the 
figures and text. 
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Table 3. Chapter 2 Primers 
Name Sequence 
hSWS1.F GCGGAATTCATGGCCGTAGTGTTGCCGGCGGTTG 
hSWS1.R GCGGTCGACCTACTTAAAGGTGGACTGCAGCTC 
SWSAP1.F GCGGAATTCATGCCTGCCGCCGGACCGCCTTTG 
SWSAP1.R GCGGTCGACTCAGGGCTGGCCTCCAGAGCTTGAAC 
hSWS1.C85S.F GCTTCTTGTCATTACTCTTCATGTCCTGCATTTG 
hSWS1.C85S.R CAAATGCAGGACATGAAGAGTAATGACAAGAAGC 
hSWS1.C87S.F CTTGTCATTACTGTTCATCTCCTGCATTTGCATTCTC 
hSWS1.C87S.R GAGAATGCAAATGCAGGAGATGAACAGTAATGACAAG 
hSWS1.F90A.F CTGTTCATGTCCTGCAGCCGCATTCTCAGTGCTAC 
hSWS1.F90A.R GTAGCACTGAGAATGCGGCTGCAGGACATGAACAG 
hSWS1.C103S.F GACAGCATCCTGTCCAAGCATCTCTTGG 
hSWS1.C103S.R CCAAGAGATGCTTGGACAGGATGCTGTC 
hSWS1.H105A.F CAGCATCCTGTGCAAGGCCCTCTTGGCAGTTTAC 
hSWS1.H105A GTAAACTGCCAAGAGGGCCTTGCACAGGATGCTG 
hSWS1.A108T.F GCAAGCATCTCTTGACAGTTTACCTGAGTC 
hSWS1.A108T.R GACTCAGGTAAACTGTCAAGAGATGCTTGC 
Shu2.C114S.F CGCACACTGGTTCTCCTCATGTGAAGAG 
Shu2.C114S.R CTCTTCACATGAGGAGAACCAGTGTGCG 
Shu2.S114C.F CGCACACTGGTTCTGCTCATGTGAAGAG 
Shu2.S114C.R CTCTTCACATGAGCAGAACCAGTGTGCG 
Shu2.C116S.F CACACTGGTTCTGCTCATCCGAAGAGTTTTGTAAATAC 
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Shu2.C116S.R 
Shu2.F119A.F 
Shu2.F119A.R 
Shu2.C176S.F 
Shu2.C176S.R 
Shu2.H178A.F 
Shu2.H178A. 
Shu2.A181T.F 
Shu2.A181T.R 
GTATTTACAAAACTCTTCGGATGAGCAGAACCAGTGTG 
GGTTCTGCTCATGTGAAGAGGCCTGTAAATACTTTCATGAAG 
CTTCATGAAAGTATTTACAGGCCTCTTCACATGAGCAGAACC 
CAAATTTGATAAAGTTTGTTCCTCGCATCTACTGGCGTTCTC 
GAGAACGCCAGTAGATGCGAGGAACAAACTTTATCAAATTT  
GTTTGTTGTTCGGCTCTACTGGCGTTC 
GAACGCCAGTAGAGCCGAACAACAAAC 
GTTCGCATCTACTGACGTTCTCCATTTTGC 
GCAAAATGGAGAACGTCAGTAGATGCGAAC 
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APPENDIX B 
CHAPTER 3 SUPPLEMENTAL DATA 
Figure 23. Competition electrophoretic mobility shift assay (EMSA). 
Fluorescein-labeled DNA fork (260 nM), detailed in Table 3, with or without an unlabeled competitor DNA 
oligonucleotide (1300 nM), was incubated on ice for 30 minutes with purified Csm2-Psy3 complex (3.0 µM) 
in EMSA reaction buffer (10 mM Tris pH 8.0, 50 mM NaCl, 2 mM DTT, 4 mM MgCl2) in a reaction volume 
of 10 µl. Equilibrated samples were loaded on a pre-cooled and pre-run 5% native polyacrylamide gel 
containing 0.5X TBE and run at 200 volts for 2 hours at 4ºC. The resulting gel was visualized by fluorescence 
using a FLA-5100 Fluorescent Image Analyzer (FujiFilm). 
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Table 4. Chapter 3 Strains and Plasmids 
Name Description 
W1588-4A MAT ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 
RAD5 
W5909-1B MATa ADE2 TRP1 lys2∆ 
PJ69-4A MATa trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ 
GAL2-ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ 
PJ69-4 MAT trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ 
GAL2-ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ 
KBY 217 MATa trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ 
GAL2-ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ 
rad51::natMX4 
KBY 222 MAT trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ 
GAL2-ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ 
rad51::natMX4 
KBY 212 MATa trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ 
GAL2-ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ 
rad55::natMX4 
KBY 221 MAT trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ 
GAL2-ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ 
rad55::hphMX4 
W3770-4D MATa leu2-∆EcoRI::URA3::leu2-∆BstEII 
KBY57-1B MATa leu2-∆EcoRI::URA3-HO::leu2-∆BstEII psy3::KanMX4 
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KBY38-3B MATa leu2-∆EcoRI::URA3-HO::leu2-∆BstEII csm2::KanMX4 
KBY65-21C MATa leu2-∆EcoRI::URA3-HO::leu2-∆BstEII rad55∆ 
KBY65-1C MATa leu2-∆EcoRI::URA3-HO::leu2-∆BstEII csm2::KanMX4 
rad55∆ 
KBY65-12B MATa csm2::KanMX rad55∆ leu2-∆EcoRI::URA3-HO::leu2-
∆BstEII 
KBY15-2A MATa csm2::KanMX 
KBY89-2B MAT rad51:LEU2 ade2-n::TRP1::ade2-I-SceI lys2::GAL-I-SceI 
W4121-9B MATa rad55∆ bar1::LEU2 
W3791-2B MATa rad57::LEU2 YFP-8ala-RAD55 bar1::LEU2 
KBY107-5C MATa csm2::KanMX 
KBY108-1C MATa psy3::KanMX bar1::LEU2 
W9100-2D MAT ADE2 leu2-3,112 his3-11,15 ura3-1 TRP1 lys2∆ 
W3778-2B MATa YFP-8ala-RAD55 bar1::LEU2 
KBY108-5A MAT  psy3::KanMX4 YFP-8ala-Rad55 
KBY107-4A MAT csm2::KanMX YFP-8ala-Rad55 
pWJ1481 pGBD-CSM2 (TRP, KANR) 
pKBB5 pGBD-PSY3 (TRP, KANR) 
pGBD-C1 pGBD-C1(TRP, KANR) 
pGAD-C2 pGAD-C2 (LEU, AMPR) 
pGAD-RAD51 pGAD-C2-RAD51 (cloned SmaI to SalI; LEU, AMPR) 
pGAD-RAD55 pGAD-RAD55 (LEU, AMPR) 
pGAD-RAD57 pGAD-RAD57 (LEU, AMPR) 
pWJ1921 pCDF-DUET1 with CSM2-TEV in MCS1 (PstI to HindIII) and 
TEV-PSY3 in MCS2 (BglII to Kpn1) 
pRS313-RAD51 pRS313-RAD51 (CEN, HIS, AMPR) 
pRS416 pRS416 (CEN, URA, AMPR) 
pRS413 pRS413 (CEN, HIS, AMPR) 
pRS313-RAD57 pRS313-RAD57 (CEN, HIS, AMPR) 
pRS316-RAD55 pRS316-RAD55 (CEN, URA, AMPR) 
131 
Table 5. Chapter 3 Primers used 
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Figure 24. Purity analysis of Shu complex and Rad55-Rad57. 
(i) SDS-PAGE analysis of purified Shu (SSCP; Shu1-Shu2-Csm2-Psy3) complex and Csm2-Psy3 (CP;
Csm2-Psy3) complex with either wild-type Csm2 or the Csm2-F46A mutant. A. (ii) Schematic depiction 
of the arrangement of subunits within the Shu complex. B. SDS-PAGE analysis of purified Rad55-Rad57 
complex.  
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Figure 25. Interactions of Rad55-Rad57 with the Shu complex and Rad51. 
A. Physical interaction of Csm2-Psy3 with Rad55-Rad57 was revealed by pull-down in which Strep-tagged
Csm2-Psy3 was captured on Steptactin resin. Analysis followed the procedure described. B. Interaction of 
Rad51 with Rad55-Rad57 or Csm2-Psy3 was assessed by pull-down. Complexes were captured on anti-
FLAG resin via the FLAG tag on Psy3 or Rad57. The elution fractions were immunoblotted for Rad51.  
Figure 26. Genetic analyses of csm2∆ for functions independent of RAD54 and SRS2. 
Deletion of CSM2, RAD55, or, RAD52 suppresses the synthetic lethality of srs2∆ rad54∆. 
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Figure 27. Electron microscopy visualization of the nucleoprotein complexes formed via Shu complex and 
Rad55-Rad57 facilitated loading of Rad51. 
A. Representative images of Rad51 (i) and RPA (ii) nucleoprotein complexes with ssDNA as visualized by
negatively stained EM (Scale bars: 50 nm) B. (i) Schematic of the Rad51 loading assay employed for EM 
visualization. B. (ii) RPA-coated ssDNA was incubated with Rad51 and combinations of Rad52, Shu 
complex, and Rad55-Rad57, then analyzed by EM. The graphed values represent the portion of all 
nucleoprotein complex observed (Both Rad51 and RPA) that were identified as Rad51 filaments under each 
condition. Standard deviations are plotted and (*) indicates significance.  
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Figure 28. Analysis of the effect of Rad55-Rad57 and Shu complex on Rad51 loading at 23˚C and 30˚C. 
DNA strand exchange assay was carried out to assess the effect of Rad55-Rad57 and Shu complex on Rad51 
loading at reaction temperatures of A. 23˚C and b, 30˚C.  
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Figure 29. Analysis of Shu complex and Csm2-Psy3 complex in Rad51-mediated DNA strand exchange. 
A. Results showing that Csm2-Psy3 is just as adept as Shu complex in enabling Rad51 to utilize an RPA-
coated ssDNA substrate for DNA strand exchange. Reactions were carried out as in Figure 15 (i.e. at 18˚C 
with Rad54 present). B. Results showing that omission of Rad54 does not affect the ability of Rad55-Rad57 
and Shu complex to promote DNA strand exchange with an RPA-coated ssDNA substrate. The reactions 
were carried out as in Figure 15B, except that Rad54 was omitted and the reaction time upon dsDNA addition 
extended to 10 hrs. C. Results showing that Rad55-Rad57 and Shu complex do not stimulate DNA strand 
exchange activity of Rad51 when free ssDNA is used as substrate. DNA strand exchange activity of Rad51 
when free ssDNA is used as substrate. DNA strand exchange reactions were performed without RPA present. 
In (i) Rad54 was added to the reactions and a reaction time of 30 min was used, similarly to Figure 15B. In 
(ii), Rad54 was omitted and a reaction time of 10 hours was used as in panel B.   
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Figure 30. Analysis of the Csm2-Psy3 structure to identify potential protein-protein interaction surfaces. 
A. Surface triplet propensity mapped onto the surface of the Csm2-Psy3 heterodimer. Values were calculated
as described in (163) and colored as a heat map with residues having a higher predicted score in red. The 
location of Csm2 F46A is indicated. B. Sequence conservation from an alignment of 21 fungal orthologues 
was mapped onto the surface of the Csm2-Psy3 heterodimer. Invariant residues (including Csm2 F46A) are 
shown in red while positions with less than 50% identity are colored white.  
Figure 31. Comparison of human and yeast Rad51 paralogue complexes. 
The RAD51 paralogues form the BCDX2 complex consisting of the RAD51B-RAD51C heterodimer 
associated with the RAD51D-XRCC2 heterodimer. Likewise, we have found that the yeast Rad51 paralogues 
associate in a similar higher order structure. Both human and yeast Rad51 paralogues interact with and 
functionally regulate Rad51. Given that the yeast Rad51 paralogues function with Rad52, it seems likely that 
the human RAD51 paralogues function in a similar manner with human RAD52 and/or BRCA2 in 
presynaptic filament assembly.  
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Table 6. Chapter 4 Strains and Plamids 
Name Description 
PJ69-4A MATa trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ 
GAL2-ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ 
PJ69-4 MAT trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ 
GAL2-ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ 
KBY 212 MATa trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ 
GAL2-ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ 
rad55::natMX4 
KBY 221 MAT trp1-901 leu2-3,112  ura3-52 his3-200  gal4∆  gal80∆ 
GAL2-ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ 
rad55::hphMX4 
W9100-2D MAT ADE2 leu2-3,112 his3-11,15 ura3-1 TRP1 lys2∆ 
KBY619-7C MATcsm2::KanMX4 LYS2 trp1-1 
KBY804-17D MATa LYS2 srs2::HIS3 csm2::kanMX4 rad55::NatNt2 
rad52::URA3 
KBY363-3C MAT trp1-1 LYS2 rad54::LEU2 
KBY107-2D MATa lys2∆ csm2::KanMX4 
KBY551 MAT  csm2-F46A 
KBY51-3B MATa sgs1::HIS3 trp1-1 LYS2 
KBY707-2A MATa sgs1::HIS3 bar1::LEU2 LYS2 csm2::KanMX4 
KBY611-1B MAT  csm2-F46A sgs1::HIS3 LYS2 
KBY225-5B MATa leu2∆EcoRI::URA3-HO::leu2∆BsteII LYS2 trp1-1 
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KBY225-8D MAT α leu2∆EcoRI::URA3-HO::leu2∆BsteII csm2::kanMX LYS2 
trp1-1   
KBY650-5C MATa csm2-F46A trp1-1 LYS2 leu2∆EcoRI::URA3-
HO::leu2∆BstEII  
KBY233-6D MATa trp1-1 CAN1   
KBY614-3D MATa LYS2 trp1-1 csm2::KanMX4 CAN1 
KBY613-1B MATa trp1-1 LYS2 CAN1 Csm2-F46A  
ZOO347 pGAD-RAD52 (LEU, AMPR) 
pWJ1481 pGBK-CSM2 (TRP, KANR) 
pGBD-RAD52 pGBD-RAD52 (TRP, KANR) 
pGBD-C1 pGBD-C1(TRP, KANR) 
pGAD-C2 pGAD-C2 (LEU, AMPR) 
pGAD-RAD51 pGAD-C2-RAD51 (cloned SmaI to SalI; LEU, AMPR) 
pGBD-RAD55 pGAD-RAD55 (LEU, AMPR) 
MH34 ADH-RAD52 (LEU, AMPR) 
pRS424 pRS424 (TRP, AMPR) 
pWJ1476 
pGAD-CSM2 (LEU, AMP
R
) 
pKB212 
pGAD-csm22-F46A (LEU, AMP
R
) 
pKB44 
pGBK-csm2-F46A (TRP, KAN
R
) 
pKB139 yiPLAC211-Csm2-F46A  
pET-DUET-S1S2 
Co-expression of Shu1 and Shu2 (AMP
R
) 
pRSF-DUET-C2P3 
Co-expression of Csm2 and Psy3 (KAN
R
) 
pESC-R55R57 Co-expression of Rad55 and Rad57 (URA) 
140 
BIBLIOGRAPHY 
1. Hoeijmakers, J.H. (2001) Genome maintenance mechanisms for preventing cancer.
Nature, 411, 366-374.
2. Heyer, W.D., Ehmsen, K.T. and Liu, J. (2010) Regulation of homologous recombination
in eukaryotes. Annual review of genetics, 44, 113-139.
3. Ellis, N.A., Groden, J., Ye, T.Z., Straughen, J., Lennon, D.J., Ciocci, S., Proytcheva, M.
and German, J. (1995) The Bloom's syndrome gene product is homologous to RecQ
helicases. Cell, 83, 655-666.
4. Kitao, S., Ohsugi, I., Ichikawa, K., Goto, M., Furuichi, Y. and Shimamoto, A. (1998)
Cloning of two new human helicase genes of the RecQ family: biological significance of
multiple species in higher eukaryotes. Genomics, 54, 443-452.
5. Puranam, K.L. and Blackshear, P.J. (1994) Cloning and characterization of RECQL, a
potential human homologue of the Escherichia coli DNA helicase RecQ. J Biol Chem, 269,
29838-29845.
6. Seki, M., Yanagisawa, J., Kohda, T., Sonoyama, T., Ui, M. and Enomoto, T. (1994)
Purification of two DNA-dependent adenosinetriphosphatases having DNA helicase
activity from HeLa cells and comparison of the properties of the two enzymes. J Biochem,
115, 523-531.
7. Yu, C.E., Oshima, J., Fu, Y.H., Wijsman, E.M., Hisama, F., Alisch, R., Matthews, S.,
Nakura, J., Miki, T., Ouais, S. et al. (1996) Positional cloning of the Werner's syndrome
gene. Science, 272, 258-262.
8. Bernstein, K.A., Gangloff, S. and Rothstein, R. (2010) The RecQ DNA helicases in DNA
repair. Annu Rev Genet, 44, 393-417.
9. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D.A.,
Smith, S., Uziel, T., Sfez, S. et al. (1995) A single ataxia telangiectasia gene with a product
similar to PI-3 kinase. Science, 268, 1749-1753.
10. Shiloh, Y. (1997) Ataxia-telangiectasia and the Nijmegen breakage syndrome: related
disorders but genes apart. Annu Rev Genet, 31, 635-662.
11. Kolodner, R.D., Putnam, C.D. and Myung, K. (2002) Maintenance of genome stability in
Saccharomyces cerevisiae. Science, 297, 552-557.
12. Li, X. and Heyer, W.D. (2008) Homologous recombination in DNA repair and DNA
damage tolerance. Cell Res, 18, 99-113.
 141 
13. Bernstein, K.A. and Rothstein, R. (2009) At loose ends: resecting a double-strand break. 
Cell, 137, 807-810. 
14. Clerici, M., Mantiero, D., Lucchini, G. and Longhese, M.P. (2005) The Saccharomyces 
cerevisiae Sae2 protein promotes resection and bridging of double strand break ends. J Biol 
Chem, 280, 38631-38638. 
15. Kim, H.S., Vijayakumar, S., Reger, M., Harrison, J.C., Haber, J.E., Weil, C. and Petrini, 
J.H. (2008) Functional interactions between Sae2 and the Mre11 complex. Genetics, 178, 
711-723. 
16. Lengsfeld, B.M., Rattray, A.J., Bhaskara, V., Ghirlando, R. and Paull, T.T. (2007) Sae2 is 
an endonuclease that processes hairpin DNA cooperatively with the Mre11/Rad50/Xrs2 
complex. Mol Cell, 28, 638-651. 
17. Fiorentini, P., Huang, K.N., Tishkoff, D.X., Kolodner, R.D. and Symington, L.S. (1997) 
Exonuclease I of Saccharomyces cerevisiae functions in mitotic recombination in vivo and 
in vitro. Mol Cell Biol, 17, 2764-2773. 
18. Huang, K.N. and Symington, L.S. (1993) A 5'-3' exonuclease from Saccharomyces 
cerevisiae is required for in vitro recombination between linear DNA molecules with 
overlapping homology. Mol Cell Biol, 13, 3125-3134. 
19. Mimitou, E.P. and Symington, L.S. (2008) Sae2, Exo1 and Sgs1 collaborate in DNA 
double-strand break processing. Nature, 455, 770-774. 
20. Zhu, Z., Chung, W.H., Shim, E.Y., Lee, S.E. and Ira, G. (2008) Sgs1 helicase and two 
nucleases Dna2 and Exo1 resect DNA double-strand break ends. Cell, 134, 981-994. 
21. Sung, P. and Klein, H. (2006) Mechanism of homologous recombination: mediators and 
helicases take on regulatory functions. Nat Rev Mol Cell Biol, 7, 739-750. 
22. Wold, M.S. (1997) Replication protein A: a heterotrimeric, single-stranded DNA-binding 
protein required for eukaryotic DNA metabolism. Annu Rev Biochem, 66, 61-92. 
23. Lisby, M., Barlow, J.H., Burgess, R.C. and Rothstein, R. (2004) Choreography of the DNA 
damage response: spatiotemporal relationships among checkpoint and repair proteins. Cell, 
118, 699-713. 
24. Sung, P. (1997) Yeast Rad55 and Rad57 proteins form a heterodimer that functions with 
replication protein A to promote DNA strand exchange by Rad51 recombinase. Genes Dev, 
11, 1111-1121. 
25. Krogh, B.O. and Symington, L.S. (2004) Recombination proteins in yeast. Annu Rev 
Genet, 38, 233-271. 
26. West, S.C. (2003) Molecular views of recombination proteins and their control. Nat Rev 
Mol Cell Biol, 4, 435-445. 
 142 
27. Gibb, B., Ye, L.F., Kwon, Y., Niu, H., Sung, P. and Greene, E.C. (2014) Protein dynamics 
during presynaptic-complex assembly on individual single-stranded DNA molecules. Nat 
Struct Mol Biol, 21, 893-900. 
28. Bashkirov, V.I., King, J.S., Bashkirova, E.V., Schmuckli-Maurer, J. and Heyer, W.D. 
(2000) DNA repair protein Rad55 is a terminal substrate of the DNA damage checkpoints. 
Mol Cell Biol, 20, 4393-4404. 
29. Herzberg, K., Bashkirov, V.I., Rolfsmeier, M., Haghnazari, E., McDonald, W.H., 
Anderson, S., Bashkirova, E.V., Yates, J.R., 3rd and Heyer, W.D. (2006) Phosphorylation 
of Rad55 on serines 2, 8, and 14 is required for efficient homologous recombination in the 
recovery of stalled replication forks. Mol Cell Biol, 26, 8396-8409. 
30. Sacher, M., Pfander, B., Hoege, C. and Jentsch, S. (2006) Control of Rad52 recombination 
activity by double-strand break-induced SUMO modification. Nat Cell Biol, 8, 1284-1290. 
31. Torres-Rosell, J., Sunjevaric, I., De Piccoli, G., Sacher, M., Eckert-Boulet, N., Reid, R., 
Jentsch, S., Rothstein, R., Aragon, L. and Lisby, M. (2007) The Smc5-Smc6 complex and 
SUMO modification of Rad52 regulates recombinational repair at the ribosomal gene 
locus. Nat Cell Biol, 9, 923-931. 
32. Bernstein, K.A., Juanchich, A., Sunjevaric, I. and Rothstein, R. (2013) The Shu complex 
regulates Rad52 localization during rDNA repair. DNA Repair (Amst), 12, 786-790. 
33. Krejci, L., Van Komen, S., Li, Y., Villemain, J., Reddy, M.S., Klein, H., Ellenberger, T. 
and Sung, P. (2003) DNA helicase Srs2 disrupts the Rad51 presynaptic filament. Nature, 
423, 305-309. 
34. Veaute, X., Jeusset, J., Soustelle, C., Kowalczykowski, S.C., Le Cam, E. and Fabre, F. 
(2003) The Srs2 helicase prevents recombination by disrupting Rad51 nucleoprotein 
filaments. Nature, 423, 309-312. 
35. Liu, J., Renault, L., Veaute, X., Fabre, F., Stahlberg, H. and Heyer, W.D. (2011) Rad51 
paralogues Rad55-Rad57 balance the antirecombinase Srs2 in Rad51 filament formation. 
Nature, 479, 245-248. 
36. Sanchez, H., Kertokalio, A., van Rossum-Fikkert, S., Kanaar, R. and Wyman, C. (2013) 
Combined optical and topographic imaging reveals different arrangements of human 
RAD54 with presynaptic and postsynaptic RAD51-DNA filaments. Proc Natl Acad Sci U 
S A, 110, 11385-11390. 
37. Santa Maria, S.R., Kwon, Y., Sung, P. and Klein, H.L. (2013) Characterization of the 
interaction between the Saccharomyces cerevisiae Rad51 recombinase and the DNA 
translocase Rdh54. J Biol Chem, 288, 21999-22005. 
38. Klein, H.L. (1997) RDH54, a RAD54 homologue in Saccharomyces cerevisiae, is required 
for mitotic diploid-specific recombination and repair and for meiosis. Genetics, 147, 1533-
1543. 
 143 
39. Heyer, W.D., Li, X., Rolfsmeier, M. and Zhang, X.P. (2006) Rad54: the Swiss Army knife 
of homologous recombination? Nucleic Acids Res, 34, 4115-4125. 
40. Petukhova, G., Stratton, S. and Sung, P. (1998) Catalysis of homologous DNA pairing by 
yeast Rad51 and Rad54 proteins. Nature, 393, 91-94. 
41. Qi, Z., Redding, S., Lee, J.Y., Gibb, B., Kwon, Y., Niu, H., Gaines, W.A., Sung, P. and 
Greene, E.C. (2015) DNA sequence alignment by microhomology sampling during 
homologous recombination. Cell, 160, 856-869. 
42. Wright, W.D. and Heyer, W.D. (2014) Rad54 functions as a heteroduplex DNA pump 
modulated by its DNA substrates and Rad51 during D loop formation. Mol Cell, 53, 420-
432. 
43. Li, X. and Heyer, W.D. (2009) RAD54 controls access to the invading 3'-OH end after 
RAD51-mediated DNA strand invasion in homologous recombination in Saccharomyces 
cerevisiae. Nucleic acids research, 37, 638-646. 
44. Li, X., Zhang, X.P., Solinger, J.A., Kiianitsa, K., Yu, X., Egelman, E.H. and Heyer, W.D. 
(2007) Rad51 and Rad54 ATPase activities are both required to modulate Rad51-dsDNA 
filament dynamics. Nucleic Acids Res, 35, 4124-4140. 
45. Solinger, J.A., Kiianitsa, K. and Heyer, W.D. (2002) Rad54, a Swi2/Snf2-like 
recombinational repair protein, disassembles Rad51:dsDNA filaments. Mol Cell, 10, 1175-
1188. 
46. Lo, Y.C., Paffett, K.S., Amit, O., Clikeman, J.A., Sterk, R., Brenneman, M.A. and 
Nickoloff, J.A. (2006) Sgs1 regulates gene conversion tract lengths and crossovers 
independently of its helicase activity. Mol Cell Biol, 26, 4086-4094. 
47. Janke, C., Magiera, M.M., Rathfelder, N., Taxis, C., Reber, S., Maekawa, H., Moreno-
Borchart, A., Doenges, G., Schwob, E., Schiebel, E. et al. (2004) A versatile toolbox for 
PCR-based tagging of yeast genes: new fluorescent proteins, more markers and promoter 
substitution cassettes. Yeast, 21, 947-962. 
48. Ira, G., Malkova, A., Liberi, G., Foiani, M. and Haber, J.E. (2003) Srs2 and Sgs1-Top3 
suppress crossovers during double-strand break repair in yeast. Cell, 115, 401-411. 
49. Boddy, M.N., Gaillard, P.H., McDonald, W.H., Shanahan, P., Yates, J.R., 3rd and Russell, 
P. (2001) Mus81-Eme1 are essential components of a Holliday junction resolvase. Cell, 
107, 537-548. 
50. Fricke, W.M. and Brill, S.J. (2003) Slx1-Slx4 is a second structure-specific endonuclease 
functionally redundant with Sgs1-Top3. Genes Dev, 17, 1768-1778. 
51. Ip, S.C., Rass, U., Blanco, M.G., Flynn, H.R., Skehel, J.M. and West, S.C. (2008) 
Identification of Holliday junction resolvases from humans and yeast. Nature, 456, 357-
361. 
 144 
52. Schwartz, E.K. and Heyer, W.D. (2011) Processing of joint molecule intermediates by 
structure-selective endonucleases during homologous recombination in eukaryotes. 
Chromosoma, 120, 109-127. 
53. Costantino, L., Sotiriou, S.K., Rantala, J.K., Magin, S., Mladenov, E., Helleday, T., Haber, 
J.E., Iliakis, G., Kallioniemi, O.P. and Halazonetis, T.D. (2014) Break-induced replication 
repair of damaged forks induces genomic duplications in human cells. Science, 343, 88-
91. 
54. Ho, C.K., Mazon, G., Lam, A.F. and Symington, L.S. (2010) Mus81 and Yen1 promote 
reciprocal exchange during mitotic recombination to maintain genome integrity in budding 
yeast. Mol Cell, 40, 988-1000. 
55. Signon, L., Malkova, A., Naylor, M.L., Klein, H. and Haber, J.E. (2001) Genetic 
requirements for RAD51- and RAD54-independent break-induced replication repair of a 
chromosomal double-strand break. Mol Cell Biol, 21, 2048-2056. 
56. Hashimoto, Y., Ray Chaudhuri, A., Lopes, M. and Costanzo, V. (2010) Rad51 protects 
nascent DNA from Mre11-dependent degradation and promotes continuous DNA 
synthesis. Nat Struct Mol Biol, 17, 1305-1311. 
57. Zellweger, R., Dalcher, D., Mutreja, K., Berti, M., Schmid, J.A., Herrador, R., Vindigni, 
A. and Lopes, M. (2015) Rad51-mediated replication fork reversal is a global response to 
genotoxic treatments in human cells. J Cell Biol, 208, 563-579. 
58. Iannascoli, C., Palermo, V., Murfuni, I., Franchitto, A. and Pichierri, P. (2015) The WRN 
exonuclease domain protects nascent strands from pathological MRE11/EXO1-dependent 
degradation. Nucleic Acids Res, 43, 9788-9803. 
59. Giannattasio, M., Zwicky, K., Follonier, C., Foiani, M., Lopes, M. and Branzei, D. (2014) 
Visualization of recombination-mediated damage bypass by template switching. Nat Struct 
Mol Biol, 21, 884-892. 
60. Ball, L.G., Zhang, K., Cobb, J.A., Boone, C. and Xiao, W. (2009) The yeast Shu complex 
couples error-free post-replication repair to homologous recombination. Molecular 
microbiology, 73, 89-102. 
61. Xu, X., Ball, L., Chen, W., Tian, X., Lambrecht, A., Hanna, M. and Xiao, W. (2013) The 
yeast Shu complex utilizes homologous recombination machinery for error-free lesion 
bypass via physical interaction with a Rad51 paralogue. PLoS One, 8, e81371. 
62. Shor, E., Weinstein, J. and Rothstein, R. (2005) A genetic screen for top3 suppressors in 
Saccharomyces cerevisiae identifies SHU1, SHU2, PSY3 and CSM2: four genes involved 
in error-free DNA repair. Genetics, 169, 1275-1289. 
63. Ito, T., Chiba, T., Ozawa, R., Yoshida, M., Hattori, M. and Sakaki, Y. (2001) A 
comprehensive two-hybrid analysis to explore the yeast protein interactome. Proceedings 
of the National Academy of Sciences of the United States of America, 98, 4569-4574. 
 145 
64. Martin, V., Chahwan, C., Gao, H., Blais, V., Wohlschlegel, J., Yates, J.R., 3rd, McGowan, 
C.H. and Russell, P. (2006) Sws1 is a conserved regulator of homologous recombination 
in eukaryotic cells. The EMBO journal, 25, 2564-2574. 
65. Mankouri, H.W., Ngo, H.P. and Hickson, I.D. (2007) Shu proteins promote the formation 
of homologous recombination intermediates that are processed by Sgs1-Rmi1-Top3. 
Molecular biology of the cell, 18, 4062-4073. 
66. Liu, T., Wan, L., Wu, Y., Chen, J. and Huang, J. (2011) hSWS1.SWSAP1 is an 
evolutionarily conserved complex required for efficient homologous recombination repair. 
The Journal of biological chemistry, 286, 41758-41766. 
67. She, Z., Gao, Z.Q., Liu, Y., Wang, W.J., Liu, G.F., Shtykova, E.V., Xu, J.H. and Dong, 
Y.H. (2012) Structural and SAXS analysis of the budding yeast SHU-complex proteins. 
FEBS letters, 586, 2306-2312. 
68. Tao, Y., Li, X., Liu, Y., Ruan, J., Qi, S., Niu, L. and Teng, M. (2012) Structural analysis 
of Shu proteins reveals a DNA binding role essential for resisting damage. The Journal of 
biological chemistry, 287, 20231-20239. 
69. Compton, S.A., Ozgur, S. and Griffith, J.D. (2010) Ring-shaped Rad51 paralog protein 
complexes bind Holliday junctions and replication forks as visualized by electron 
microscopy. The Journal of biological chemistry, 285, 13349-13356. 
70. Meindl, A., Hellebrand, H., Wiek, C., Erven, V., Wappenschmidt, B., Niederacher, D., 
Freund, M., Lichtner, P., Hartmann, L., Schaal, H. et al. (2010) Germline mutations in 
breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility 
gene. Nat Genet, 42, 410-414. 
71. Clague, J., Wilhoite, G., Adamson, A., Bailis, A., Weitzel, J.N. and Neuhausen, S.L. (2011) 
RAD51C germline mutations in breast and ovarian cancer cases from high-risk families. 
PLoS One, 6, e25632. 
72. Osorio, A., Endt, D., Fernandez, F., Eirich, K., de la Hoya, M., Schmutzler, R., Caldes, T., 
Meindl, A., Schindler, D. and Benitez, J. (2012) Predominance of pathogenic missense 
variants in the RAD51C gene occurring in breast and ovarian cancer families. Hum Mol 
Genet, 21, 2889-2898. 
73. Thompson, E.R., Boyle, S.E., Johnson, J., Ryland, G.L., Sawyer, S., Choong, D.Y., 
kConFab, Chenevix-Trench, G., Trainer, A.H., Lindeman, G.J. et al. (2012) Analysis of 
RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian 
cancer patients. Hum Mutat, 33, 95-99. 
74. Blanco, A., Gutierrez-Enriquez, S., Santamarina, M., Montalban, G., Bonache, S., 
Balmana, J., Carracedo, A., Diez, O. and Vega, A. (2014) RAD51C germline mutations 
found in Spanish site-specific breast cancer and breast-ovarian cancer families. Breast 
Cancer Res Treat, 147, 133-143. 
 146 
75. Namazi, A., Abedinzadeh, M., Nourbaksh, P. and Neamatzadeh, H. (2015) Association 
between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta 
analysis of 5,193 cases and 6,645 controls. Asian Pac J Cancer Prev, 16, 2263-2268. 
76. Vaz, F., Hanenberg, H., Schuster, B., Barker, K., Wiek, C., Erven, V., Neveling, K., Endt, 
D., Kesterton, I., Autore, F. et al. (2010) Mutation of the RAD51C gene in a Fanconi 
anemia-like disorder. Nat Genet, 42, 406-409. 
77. Shu, Z., Smith, S., Wang, L., Rice, M.C. and Kmiec, E.B. (1999) Disruption of 
muREC2/RAD51L1 in mice results in early embryonic lethality which can Be partially 
rescued in a p53(-/-) background. Mol Cell Biol, 19, 8686-8693. 
78. Deans, B., Griffin, C.S., Maconochie, M. and Thacker, J. (2000) Xrcc2 is required for 
genetic stability, embryonic neurogenesis and viability in mice. EMBO J, 19, 6675-6685. 
79. Pittman, D.L. and Schimenti, J.C. (2000) Midgestation lethality in mice deficient for the 
RecA-related gene, Rad51d/Rad51l3. Genesis, 26, 167-173. 
80. Kuznetsov, S.G., Haines, D.C., Martin, B.K. and Sharan, S.K. (2009) Loss of Rad51c leads 
to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice. Cancer 
Res, 69, 863-872. 
81. Miller, K.A., Yoshikawa, D.M., McConnell, I.R., Clark, R., Schild, D. and Albala, J.S. 
(2002) RAD51C interacts with RAD51B and is central to a larger protein complex in vivo 
exclusive of RAD51. J Biol Chem, 277, 8406-8411. 
82. Wiese, C., Collins, D.W., Albala, J.S., Thompson, L.H., Kronenberg, A. and Schild, D. 
(2002) Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells. 
Nucleic Acids Res, 30, 1001-1008. 
83. Masson, J.Y., Tarsounas, M.C., Stasiak, A.Z., Stasiak, A., Shah, R., McIlwraith, M.J., 
Benson, F.E. and West, S.C. (2001) Identification and purification of two distinct 
complexes containing the five RAD51 paralogs. Genes Dev, 15, 3296-3307. 
84. Kachroo, A.H., Laurent, J.M., Yellman, C.M., Meyer, A.G., Wilke, C.O. and Marcotte, 
E.M. (2015) Evolution. Systematic humanization of yeast genes reveals conserved 
functions and genetic modularity. Science, 348, 921-925. 
85. Yokoyama, H., Sarai, N., Kagawa, W., Enomoto, R., Shibata, T., Kurumizaka, H. and 
Yokoyama, S. (2004) Preferential binding to branched DNA strands and strand-annealing 
activity of the human Rad51B, Rad51C, Rad51D and Xrcc2 protein complex. Nucleic 
Acids Res, 32, 2556-2565. 
86. Lin, Z., Kong, H., Nei, M. and Ma, H. (2006) Origins and evolution of the recA/RAD51 
gene family: evidence for ancient gene duplication and endosymbiotic gene transfer. Proc 
Natl Acad Sci U S A, 103, 10328-10333. 
 147 
87. Schild, D., Lio, Y.C., Collins, D.W., Tsomondo, T. and Chen, D.J. (2000) Evidence for 
simultaneous protein interactions between human Rad51 paralogs. J. Biol. Chem., 275, 
16443-16449. 
88. Takata, M., Sasaki, M.S., Tachiiri, S., Fukushima, T., Sonoda, E., Schild, D., Thompson, 
L.H. and Takeda, S. (2001) Chromosome Instability and Defective Recombinational 
Repair in Knockout Mutants of the Five Rad51 Paralogs. Mol. Cell. Biol., 21, 2858-2866. 
89. Godin, S., Wier, A., Kabbinavar, F., Bratton-Palmer, D.S., Ghodke, H., Van Houten, B., 
VanDemark, A.P. and Bernstein, K.A. (2013) The Shu complex interacts with Rad51 
through the Rad51 paralogues Rad55-Rad57 to mediate error-free recombination. Nucleic 
Acids Res, 41, 4525-4534. 
90. Sasanuma, H., Tawaramoto, M.S., Lao, J.P., Hosaka, H., Sanda, E., Suzuki, M., Yamashita, 
E., Hunter, N., Shinohara, M., Nakagawa, A. et al. (2013) A new protein complex 
promoting the assembly of Rad51 filaments. Nature communications, 4, 1676. 
91. Kawabata, M., Kawabata, T. and Nishibori, M. (2005) Role of recA/RAD51 family 
proteins in mammals. Acta Medica Okayama, 59, 1-9. 
92. Suwaki, N., Klare, K. and Tarsounas, M. (2011) RAD51 paralogs: roles in DNA damage 
signalling, recombinational repair and tumorigenesis. Semin Cell Dev Biol, 22, 898-905. 
93. Pennington, K.P. and Swisher, E.M. (2012) Hereditary ovarian cancer: beyond the usual 
suspects. Gynecol. Oncol., 124, 347-353. 
94. Filippini, S.E. and Vega, A. (2013) Breast cancer genes: beyond BRCA1 and BRCA2. 
Frontiers in bioscience, 18, 1358-1372. 
95. Somyajit, K., Subramanya, S. and Nagaraju, G. (2012) Distinct roles of FANCO/RAD51C 
protein in DNA damage signaling and repair: implications for Fanconi anemia and breast 
cancer susceptibility. J. Biol. Chem., 287, 3366-3380. 
96. Vaz, F., Hanenberg, H., Schuster, B., Barker, K., Wiek, C., Erven, V., Neveling, K., Endt, 
D., Kesterton, I., Autore, F. et al. (2010) Mutation of the RAD51C gene in a Fanconi 
anemia-like disorder. Nat. Genet., 42, 406-409. 
97. Shamseldin, H.E., Elfaki, M. and Alkuraya, F.S. (2012) Exome sequencing reveals a novel 
Fanconi group defined by XRCC2 mutation. J. Med. Genet., 49, 184-186. 
98. Park, D.J., Lesueur, F., Nguyen-Dumont, T., Pertesi, M., Odefrey, F., Hammet, F., 
Neuhausen, S.L., John, E.M., Andrulis, I.L., Terry, M.B. et al. (2012) Rare mutations in 
XRCC2 increase the risk of breast cancer. American journal of human genetics, 90, 734-
739. 
99. Huang, M.E., Rio, A.G., Nicolas, A. and Kolodner, R.D. (2003) A genomewide screen in 
Saccharomyces cerevisiae for genes that suppress the accumulation of mutations. Proc 
Natl Acad Sci U S A, 100, 11529-11534. 
 148 
100. Shepherd, R., Forbes, S.A., Beare, D., Bamford, S., Cole, C.G., Ward, S., Bindal, N., 
Gunasekaran, P., Jia, M., Kok, C.Y. et al. (2011), Database : the journal of biological 
databases and curation. 2011/05/26 ed, Vol. 2011, pp. bar018. 
101. Alvaro, D., Lisby, M. and Rothstein, R. (2007) Genome-Wide Analysis of Rad52 Foci 
Reveals Diverse Mechanisms Impacting Recombination. PLoS Genet., 3, e228. 
102. Clark, N.L., Alani, E. and Aquadro, C.F. (2012) Evolutionary rate covariation reveals 
shared functionality and coexpression of genes. Genome Res, 22, 714-720. 
103. Clark, N.L., Gasper, J., Sekino, M., Springer, S.A., Aquadro, C.F. and Swanson, W.J. 
(2009) Coevolution of interacting fertilization proteins. PLoS Genet., 5, e1000570. 
104. Clark, N.L. and Aquadro, C.F. (2010) A novel method to detect proteins evolving at 
correlated rates: identifying new functional relationships between coevolving proteins. Mol 
Biol Evol, 27, 1152-1161. 
105. Clark, N.L., Alani, E. and Aquadro, C.F. (2013) Evolutionary rate covariation in meiotic 
proteins results from fluctuating evolutionary pressure in yeasts and mammals. Genetics, 
193, 529-538. 
106. Findlay, G.D., Sitnik, J.L., Wang, W., Aquadro, C.F., Clark, N.L. and Wolfner, M.F. 
(2014) Evolutionary Rate Covariation Identifies New Members of a Protein Network 
Required for Drosophila melanogaster Female Post-Mating Responses. PLoS Genet., 10, 
e1004108. 
107. Bernstein, K.A., Reid, R.J., Sunjevaric, I., Demuth, K., Burgess, R.C. and Rothstein, R. 
(2011) The Shu complex, which contains Rad51 paralogues, promotes DNA repair through 
inhibition of the Srs2 anti-recombinase. Mol Biol Cell, 22, 1599-1607. 
108. Makarova, K.S., Aravind, L. and Koonin, E.V. (2002) SWIM, a novel Zn-chelating domain 
present in bacteria, archaea and eukaryotes. Trends Biochem. Sci., 27, 384-386. 
109. Banerjee, R., Dubois, D.Y., Gauthier, J., Lin, S.X., Roy, S. and Lapointe, J. (2004) The 
zinc-binding site of a class I aminoacyl-tRNA synthetase is a SWIM domain that modulates 
amino acid binding via the tRNA acceptor arm. Eur. J. Biochem., 271, 724-733. 
110. Liu, J., Gagnon, Y., Gauthier, J., Furenlid, L., L'Heureux, P.J., Auger, M., Nureki, O., 
Yokoyama, S. and Lapointe, J. (1995) The zinc-binding site of Escherichia coli glutamyl-
tRNA synthetase is located in the acceptor-binding domain. Studies by extended x-ray 
absorption fine structure, molecular modeling, and site-directed mutagenesis. J. Biol. 
Chem., 270, 15162-15169. 
111. Hong, S. and Kim, K.P. (2013) Shu1 promotes homolog bias of meiotic recombination in 
Saccharomyces cerevisiae. Mol Cells, 36, 446-454. 
112. St Pierre, S.E., Ponting, L., Stefancsik, R. and McQuilton, P. FlyBase 102--advanced 
approaches to interrogating FlyBase. Nucleic Acids Res, 42, D780-788. 
 149 
113. Graveley, B.R., May, G., Brooks, A.N., Carlson, J.W., Cherbas, L., Davis, C.A., Duff, M., 
Eads, B., Landolin, J., Sandler, J., Wan, K.H., Andrews, J., Brenner, S.E., Cherbas, P., 
Gingeras, T.R., Hoskins, R., Kaufman, T., Celniker, S.E. . (2011.4.13). 
114. Rong, L., Palladino, F., Aguilera, A. and Klein, H.L. (1991) The hyper-gene conversion 
hpr5-1 mutation of Saccharomyces cerevisiae is an allele of the SRS2/RADH gene. 
Genetics, 127, 75-85. 
115. Burgess, R.C., Lisby, M., Altmannova, V., Krejci, L., Sung, P. and Rothstein, R. (2009) 
Localization of recombination proteins and Srs2 reveals anti-recombinase function in vivo. 
J Cell Biol, 185, 969-981. 
116. Thomas, B.J. and Rothstein, R. (1989) Elevated recombination rates in transcriptionally 
active DNA. Cell, 56, 619-630. 
117. Zhao, X., Muller, E.G. and Rothstein, R. (1998) A suppressor of two essential checkpoint 
genes identifies a novel protein that negatively affects dNTP pools. Mol. Cell, 2, 329-340. 
118. James, P., Halladay, J. and Craig, E.A. (1996) Genomic libraries and a host strain designed 
for highly efficient two-hybrid selection in yeast. Genetics, 144, 1425-1436. 
119. Sherman, F., Fink, G.R. and Hicks, J.B. (1986) Methods in Yeast Genetics. Cold Spring 
Harbor Laboratory Press, Cold Spring Harbor, NY. 
120. Guindon, S. and Gascuel, O. (2003) A simple, fast, and accurate algorithm to estimate large 
phylogenies by maximum likelihood. Syst Biol, 52, 696-704. 
121. Edgar, R.C. (2004) MUSCLE: multiple sequence alignment with high accuracy and high 
throughput. Nucleic Acids Res., 32, 1792-1797. 
122. Sato, T., Yamanishi, Y., Kanehisa, M. and Toh, H. (2005) The inference of protein-protein 
interactions by co-evolutionary analysis is improved by excluding the information about 
the phylogenetic relationships. Bioinformatics, 21, 3482-3489. 
123. Yang, Z. (2007) PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol, 
24, 1586-1591. 
124. Balakrishnan, R., Park, J., Karra, K., Hitz, B.C., Binkley, G., Hong, E.L., Sullivan, J., 
Micklem, G. and Cherry, J.M. (2012) YeastMine--an integrated data warehouse for 
Saccharomyces cerevisiae data as a multipurpose tool-kit. Database : the journal of 
biological databases and curation, 2012, bar062. 
125. Wilson, R.J., Goodman, J.L. and Strelets, V.B. (2008) FlyBase: integration and 
improvements to query tools. Nucleic Acids Res., 36, D588-593. 
126. Lea, D.E. and Coulson, C.A. (1949) The distribution of the numbers of mutants in bacterial 
populations. J. Genetics, 49, 264-285. 
 150 
127. Holthausen, J.T., Wyman, C. and Kanaar, R. (2010) Regulation of DNA strand exchange 
in homologous recombination. DNA Repair (Amst), 9, 1264-1272. 
128. Sugiyama, T. and Kowalczykowski, S.C. (2002) Rad52 protein associates with replication 
protein A (RPA)-single-stranded DNA to accelerate Rad51-mediated displacement of RPA 
and presynaptic complex formation. J. Biol. Chem., 277, 31663-31672. 
129. Sung, P. (1997) Function of yeast Rad52 protein as a mediator between replication protein 
A and the Rad51 recombinase. J. Biol. Chem., 272, 28194-28197. 
130. Kans, J.A. and Mortimer, R.K. (1991) Nucleotide sequence of the RAD57 gene of 
Saccharomyces cerevisiae. Gene, 105, 139-140. 
131. Lovett, S.T. (1994) Sequence of the RAD55 gene of Saccharomyces cerevisiae: similarity 
of RAD55 to prokaryotic RecA and other RecA-like proteins. Gene, 142, 103-106. 
132. Fortin, G.S. and Symington, L.S. (2002) Mutations in yeast Rad51 that partially bypass the 
requirement for Rad55 and Rad57 in DNA repair by increasing the stability of Rad51-DNA 
complexes. The EMBO journal, 21, 3160-3170. 
133. McDonald, J.P. and Rothstein, R. (1994) Unrepaired heteroduplex DNA in Saccharomyces 
cerevisiae is decreased in RAD1 RAD52-independent recombination. Genetics, 137, 393-
405. 
134. Ivanov, E.L., Sugawara, N., Fishman-Lobell, J. and Haber, J.E. (1996) Genetic 
requirements for the single-strand annealing pathway of double-strand break repair in 
Saccharomyces cerevisiae. Genetics, 142, 693-704. 
135. Stark, J.M., Pierce, A.J., Oh, J., Pastink, A. and Jasin, M. (2004) Genetic steps of 
mammalian homologous repair with distinct mutagenic consequences. Mol. Cell. Biol., 24, 
9305-9316. 
136. Lovett, S.T. and Mortimer, R.K. (1987) Characterization of null mutants of the RAD55 
gene of Saccharomyces cerevisiae: effects of temperature, osmotic strength and mating 
type. Genetics, 116, 547-553. 
137. Symington, L.S. (2002) Role of RAD52 epistasis group genes in homologous 
recombination and double-strand break repair. Microbiol Mol Biol Rev, 66, 630-670, table 
of contents. 
138. Hays, S.L., Firmenich, A.A. and Berg, P. (1995) Complex formation in yeast double-strand 
break repair: participation of Rad51, Rad52, Rad55, and Rad57 proteins. Proc. Natl. Acad. 
Sci. U S A, 92, 6925-6929. 
139. Johnson, R.D. and Symington, L.S. (1995) Functional differences and interactions among 
the putative RecA homologs Rad51, Rad55, and Rad57. Mol. Cell. Biol., 15, 4843-4850. 
 151 
140. Benson, F.E., Baumann, P. and West, S.C. (1998) Synergistic actions of Rad51 and Rad52 
in recombination and DNA repair. Nature, 391, 401-404. 
141. Gasior, S.L., Wong, A.K., Kora, Y., Shinohara, A. and Bishop, D.K. (1998) Rad52 
associates with RPA and functions with rad55 and rad57 to assemble meiotic 
recombination complexes. Genes Dev., 12, 2208-2221. 
142. New, J.H., Sugiyama, T., Zaitseva, E. and Kowalczykowski, S.C. (1998) Rad52 protein 
stimulates DNA strand exchange by Rad51 and replication protein A. Nature, 391, 407-
410. 
143. Fung, C.W., Fortin, G.S., Peterson, S.E. and Symington, L.S. (2006) The rad51-K191R 
ATPase-defective mutant is impaired for presynaptic filament formation. Mol. Cell. Biol., 
26, 9544-9554. 
144. Sugawara, N., Wang, X. and Haber, J.E. (2003) In vivo roles of Rad52, Rad54, and Rad55 
proteins in Rad51-mediated recombination. Mol Cell, 12, 209-219. 
145. Modesti, M., Ristic, D., van der Heijden, T., Dekker, C., van Mameren, J., Peterman, E.J., 
Wuite, G.J., Kanaar, R. and Wyman, C. (2007) Fluorescent human RAD51 reveals multiple 
nucleation sites and filament segments tightly associated along a single DNA molecule. 
Structure, 15, 599-609. 
146. Hilario, J., Amitani, I., Baskin, R.J. and Kowalczykowski, S.C. (2009) Direct imaging of 
human Rad51 nucleoprotein dynamics on individual DNA molecules. Proc. Natl. Acad. 
Sci. U S A, 106, 361-368. 
147. Antony, E., Tomko, E.J., Xiao, Q., Krejci, L., Lohman, T.M. and Ellenberger, T. (2009) 
Srs2 disassembles Rad51 filaments by a protein-protein interaction triggering ATP 
turnover and dissociation of Rad51 from DNA. Mol. Cell, 35, 105-115. 
148. Seong, C., Colavito, S., Kwon, Y., Sung, P. and Krejci, L. (2009) Regulation of Rad51 
recombinase presynaptic filament assembly via interactions with the Rad52 mediator and 
the Srs2 anti-recombinase. J. Biol. Chem., 284, 24363-24371. 
149. Colavito, S., Macris-Kiss, M., Seong, C., Gleeson, O., Greene, E.C., Klein, H.L., Krejci, 
L. and Sung, P. (2009) Functional significance of the Rad51-Srs2 complex in Rad51 
presynaptic filament disruption. Nucleic Acids Res, 37, 6754-6764. 
150. Karpenshif, Y. and Bernstein, K.A. (2012) From yeast to mammals: recent advances in 
genetic control of homologous recombination. DNA Repair, 11, 781-788. 
151. Hu, Y., Raynard, S., Sehorn, M.G., Lu, X., Bussen, W., Zheng, L., Stark, J.M., Barnes, 
E.L., Chi, P., Janscak, P. et al. (2007) RECQL5/Recql5 helicase regulates homologous 
recombination and suppresses tumor formation via disruption of Rad51 presynaptic 
filaments. Genes Dev., 21, 3073-3084. 
 152 
152. Moldovan, G.L., Dejsuphong, D., Petalcorin, M.I., Hofmann, K., Takeda, S., Boulton, S.J. 
and D'Andrea, A.D. (2012) Inhibition of homologous recombination by the PCNA-
interacting protein PARI. Mol. Cell, 45, 75-86. 
153. Barber, L.J., Youds, J.L., Ward, J.D., McIlwraith, M.J., O'Neil, N.J., Petalcorin, M.I.R., 
Martin, J.S., Collis, S.J., Cantor, S.B., Auclair, M. et al. (2008) RTEL1 Maintains Genomic 
Stability by Suppressing Homologous Recombination. Cell, 135, 261-271. 
154. Hey, T., Lipps, G. and Krauss, G. (2001) Binding of XPA and RPA to damaged DNA 
investigated by fluorescence anisotropy. Biochemistry (Mosc). 40, 2901-2910. 
155. Lisby, M., Rothstein, R. and Mortensen, U.H. (2001) Rad52 forms DNA repair and 
recombination centers during S phase. Proc. Natl. Acad. Sci. U S A, 98, 8276-8282. 
156. Heyer, W.D. (2007) Biochemistry of eukaryotic homologous recombination. Top. Curr. 
Genet., 17, 95-133. 
157. Symington, L.S., Rothstein, R. and Lisby, M. (2014) Mechanisms and Regulation of 
Mitotic Recombination in Saccharomyces cerevisiae. Genetics, 198, 795-835. 
158. Godin, S.K., Meslin, C., Kabbinavar, F., Bratton-Palmer, D.S., Hornack, C., Mihalevic, 
M.J., Yoshida, K., Sullivan, M., Clark, N.L. and Bernstein, K.A. (2015) Evolutionary and 
functional analysis of the invariant SWIM domain in the conserved Shu2/SWS1 protein 
family from Saccharomyces cerevisiae to Homo sapiens. Genetics, 199, 1023-1033. 
159. Davis, A.P. and Symington, L.S. (2001) The yeast recombinational repair protein Rad59 
interacts with Rad52 and stimulates single-strand annealing. Genetics, 159, 515-525. 
160. Esta, A., Ma, E., Dupaigne, P., Maloisel, L., Guerois, R., Le Cam, E., Veaute, X. and Coic, 
E. (2013) Rad52 sumoylation prevents the toxicity of unproductive Rad51 filaments 
independently of the anti-recombinase Srs2. PLoS Genet., 9, e1003833. 
161. St Onge, R.P., Mani, R., Oh, J., Proctor, M., Fung, E., Davis, R.W., Nislow, C., Roth, F.P. 
and Giaever, G. (2007) Systematic pathway analysis using high-resolution fitness profiling 
of combinatorial gene deletions. Nat. Genet., 39, 199-206. 
162. Petukhova, G., Van Komen, S., Vergano, S., Klein, H. and Sung, P. (1999) Yeast Rad54 
promotes Rad51-dependent homologous DNA pairing via ATP hydrolysis-driven change 
in DNA double helix conformation. J. Biol. Chem., 274, 29453-29462. 
163. Mehio, W., Kemp, G.J., Taylor, P. and Walkinshaw, M.D. (2010) Identification of protein 
binding surfaces using surface triplet propensities. Bioinformatics, 26, 2549-2555. 
164. Smith, J. and Rothstein, R. (1999) An allele of RFA1 suppresses RAD52-dependent double-
strand break repair in Saccharomyces cerevisiae. Genetics, 151, 447-458. 
 153 
165. Shah, P.P., Zheng, X., Epshtein, A., Carey, J.N., Bishop, D.K. and Klein, H.L. (2010) 
Swi2/Snf2-related translocases prevent accumulation of toxic Rad51 complexes during 
mitotic growth. Mol. Cell, 39, 862-872. 
166. Wright, W.D. and Heyer, W.D. (2014) Rad54 functions as a heteroduplex DNA pump 
modulated by its DNA substrates and Rad51 during D loop formation. Mol. Cell, 53, 420-
432. 
167. Jensen, R.B., Ozes, A., Kim, T., Estep, A. and Kowalczykowski, S.C. (2013) BRCA2 is 
epistatic to the RAD51 paralogs in response to DNA damage. DNA Repair (Amst), 12, 306-
311. 
168. Van Komen, S., Macris, M., Sehorn, M.G. and Sung, P. (2006) Purification and assays of 
Saccharomyces cerevisiae homologous recombination proteins. Methods Enzymol., 408, 
445-463. 
169. Raschle, M., Van Komen, S., Chi, P., Ellenberger, T. and Sung, P. (2004) Multiple 
interactions with the Rad51 recombinase govern the homologous recombination function 
of Rad54. J. Biol. Chem., 279, 51973-51980. 
170. Song, B. and Sung, P. (2000) Functional interactions among yeast Rad51 recombinase, 
Rad52 mediator, and replication protein A in DNA strand exchange. J. Biol. Chem., 275, 
15895-15904. 
171. Lindsley, J.E. and Wang, J.C. (1993) On the coupling between ATP usage and DNA 
transport by yeast DNA topoisomerase II. J Biol Chem, 268, 8096-8104. 
172. San Filippo, J., Chi, P., Sehorn, M.G., Etchin, J., Krejci, L. and Sung, P. (2006) 
Recombination mediator and Rad51 targeting activities of a human BRCA2 polypeptide. 
J. Biol. Chem., 281, 11649-11657. 
173. Taylor, M.R., Spirek, M., Chaurasiya, K.R., Ward, J.D., Carzaniga, R., Yu, X., Egelman, 
E.H., Collinson, L.M., Rueda, D., Krejci, L. et al. (2015) Rad51 Paralogs Remodel Pre-
synaptic Rad51 Filaments to Stimulate Homologous Recombination. Cell, 162, 271-286. 
174. Cloud, V., Chan, Y.L., Grubb, J., Budke, B. and Bishop, D.K. (2012) Rad51 is an accessory 
factor for Dmc1-mediated joint molecule formation during meiosis. Science, 337, 1222-
1225. 
175. Hong, S. and Kim, K.P. (2013) Shu1 promotes homolog bias of meiotic recombination in 
Saccharomyces cerevisiae. Mol Cells, 36, 446-454. 
176. Busygina, V., Sehorn, M.G., Shi, I.Y., Tsubouchi, H., Roeder, G.S. and Sung, P. (2008) 
Hed1 regulates Rad51-mediated recombination via a novel mechanism. Genes & 
development, 22, 786-795. 
 154 
177. Tsubouchi, H. and Roeder, G.S. (2006) Budding yeast Hed1 down-regulates the mitotic 
recombination machinery when meiotic recombination is impaired. Genes & development, 
20, 1766-1775. 
178. Say, A.F., Ledford, L.L., Sharma, D., Singh, A.K., Leung, W.K., Sehorn, H.A., Tsubouchi, 
H., Sung, P. and Sehorn, M.G. (2011) The budding yeast Mei5-Sae3 complex interacts 
with Rad51 and preferentially binds a DNA fork structure. DNA Repair, 10, 586-594. 
 
